Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,platelet-derived growth factor binding (GO:0048407),-0.7755534774726496,-1.900155784038181,0.0,0.24845516987120406,0.162,6/11,14.73%,COL4A1;COL3A1;PDGFRA;COL1A2;COL1A1;COL6A1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.7925032251137129,1.8292160047232662,0.0,0.05017051404996918,0.048,8/35,2.77%,SLA;PTK2B;BTK;FGR;LYN;HCK;SYK;TEC
prerank,phosphotyrosine residue binding (GO:0001784),0.7669289378615666,1.8234621099112045,0.0,0.031238244597150626,0.059,12/37,5.42%,VAV1;FGR;SH3BP2;HCK;SYK;STAP1;PLCG2;GRB2;VAV2;NCK2;LDLRAP1;SAMSN1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.8478720698849093,1.7778657753223335,0.0027063599458728013,0.06878724567857411,0.167,6/15,8.32%,PTAFR;P2RX1;P2RX7;P2RX4;P2RY12;GPR34
prerank,protein phosphorylated amino acid binding (GO:0045309),0.743129595206973,1.7743177493098867,0.0,0.05703346172661591,0.185,13/42,6.62%,VAV1;FGR;SH3BP2;HCK;SYK;STAP1;PLCG2;GRB2;VAV2;NCK2;LDLRAP1;SAMSN1;YWHAB
prerank,protein phosphatase 1 binding (GO:0008157),0.7863322194581844,1.7613681651041964,0.0012033694344163659,0.06247648919430125,0.241,3/21,5.90%,LILRB1;PPP1R3E;PPP1R11
prerank,chemokine binding (GO:0019956),0.7553572784451247,1.751772498393856,0.0023501762632197414,0.06626294308486495,0.29,6/30,5.85%,CX3CR1;CCR2;ITGA4;ITGB3;CXCR4;HMGB1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.7334675000996249,1.7195157186801953,0.0,0.12049037201758098,0.521,8/34,6.59%,BTK;MYO1G;ARHGAP9;DAPP1;IQGAP2;ARAP1;ADAP2;GAB2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.8563807971417551,1.7142434405331977,0.0027210884353741495,0.11667011050299438,0.557,4/13,4.55%,PIK3CG;PIK3CD;PIK3CB;PIP4K2A
prerank,kinase activator activity (GO:0019209),0.746315815986882,1.7129579945934594,0.001142857142857143,0.10591552966104605,0.564,9/30,10.57%,NCKAP1L;TREM2;GPRC5B;FGF13;RGCC;WNK1;EPO;MALT1;DUSP19
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.8641112272717733,1.7019480878985103,0.005763688760806916,0.11775871599653144,0.649,3/10,2.52%,CYBB;NCF4;NCF2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.7973413995339074,1.6865955929547978,0.005256241787122208,0.13992668241037717,0.744,4/15,10.68%,CX3CR1;CCR2;GPR17;CMKLR1
prerank,chemokine receptor binding (GO:0042379),0.724418158189436,1.6829827930352916,0.001152073732718894,0.13623345560424022,0.761,12/35,18.57%,PF4;CX3CR1;CXCL5;CXCL2;CCL8;CCL14;CCL13;CCL2;ITCH;CXCL16;CCL25;CKLF
prerank,anion:anion antiporter activity (GO:0015301),-0.577134430107019,-1.6806994661451187,0.030837004405286344,1.0,0.811,8/17,25.59%,SLC26A2;SLC26A7;SLC25A4;SLC25A11;SLC19A1;SLC4A2;SLC25A5;SLC26A6
prerank,MHC protein binding (GO:0042287),0.7591045786210943,1.6805632337579286,0.007416563658838072,0.13106955775028234,0.771,3/20,1.33%,TUBB;LILRB1;CD74
prerank,SH2 domain binding (GO:0042169),0.7317820983743741,1.6783172473105656,0.005773672055427252,0.12711666632606747,0.785,6/31,3.76%,SLAMF1;LILRB1;BLNK;SH3PXD2B;NUP62;LAT2
prerank,C-C chemokine receptor activity (GO:0016493),0.7635006466553907,1.6766957456900464,0.006234413965087282,0.12198692284099424,0.798,3/21,4.58%,CX3CR1;CCR2;CXCR4
prerank,CXCR chemokine receptor binding (GO:0045236),0.8406053590413642,1.6619532044831173,0.0,0.14855915186258564,0.867,3/11,2.27%,PF4;CXCL5;CXCL2
prerank,C-C chemokine binding (GO:0019957),0.7447013063699952,1.6569366987030465,0.007453416149068323,0.15201498707704314,0.885,3/22,4.58%,CX3CR1;CCR2;CXCR4
prerank,lipoprotein particle binding (GO:0071813),0.7471934438301658,1.6542976274635184,0.011306532663316583,0.150984848886228,0.898,9/20,12.78%,TREM2;PCSK9;LPL;MSR1;STAB2;STAB1;LIPC;THBS1;SORL1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.8004265302177925,1.6521006238352849,0.014666666666666666,0.1485186716811898,0.912,5/14,7.82%,CYBB;NCF4;NCF2;MICAL1;KMO
prerank,low-density lipoprotein particle binding (GO:0030169),0.7597631069489909,1.632415670813843,0.01288659793814433,0.19362978582870183,0.964,8/16,12.78%,TREM2;PCSK9;MSR1;STAB2;STAB1;LIPC;THBS1;SORL1
prerank,amyloid-beta binding (GO:0001540),0.6461870491145448,1.6290225271826462,0.0,0.19392053139529866,0.975,19/79,9.31%,LILRB3;LILRB1;TREM2;GSAP;CALCR;ITGB2;FCGR2B;CD74;CLSTN1;TLR2;ITGA2;MSR1;APOE;LDLRAP1;APBA1;C1QA;CACNA1A;BCHE;ITGAM
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.7397303382418424,1.6262679520106353,0.013513513513513514,0.19246373014194865,0.976,11/22,14.61%,ATP6V0D2;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;ATP6V0D1;ATP2C1;ATP6V0A1;ATP2A3;ATP6V0B
prerank,chemokine activity (GO:0008009),0.7076762493276413,1.6225382444087986,0.005875440658049354,0.19438501875143926,0.978,10/31,18.57%,PF4;CXCL5;CXCL2;CCL8;CCL14;CCL13;CCL2;CXCL16;CCL25;CKLF
prerank,phospholipase binding (GO:0043274),0.8035058428619817,1.617887352610835,0.013513513513513514,0.19985376941131594,0.983,3/13,0.95%,BTK;BLNK;SYK
prerank,chemokine receptor activity (GO:0004950),0.722367781672815,1.6160244656607914,0.014723926380368098,0.19753929947070886,0.985,5/24,10.68%,CX3CR1;CCR2;CXCR4;GPR17;CMKLR1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.7333950534289688,1.605165154566332,0.017434620174346202,0.22019685702047428,0.988,3/21,5.57%,P2RX1;P2RX7;P2RX4
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.7187514983524175,1.5998050873056608,0.008484848484848486,0.22739759198329845,0.99,5/25,6.59%,MYO1G;DAPP1;PLEK;ADAP2;GAB2
prerank,cytokine receptor activity (GO:0004896),0.6391142182177036,1.5972956370813383,0.0,0.22718723343382272,0.991,15/83,5.93%,IL10RA;CX3CR1;FLT3;CCR2;CSF3R;CD74;CSF2RB;IL10RB;IL21R;IL12RB2;IL6R;IFNAR1;CD44;IFNGR2;GPR17
prerank,lipase activity (GO:0016298),0.6739765489221493,1.5965732602449387,0.006674082313681869,0.22137698522244048,0.991,8/43,4.92%,PLBD1;LPL;DAGLB;ABHD12;DDHD1;CEL;LIPA;SMPD3
prerank,phospholipase activity (GO:0004620),0.6445922705898863,1.5912007101754353,0.0010570824524312897,0.23012173519900958,0.995,20/67,17.09%,PLBD1;PLD4;PLCB2;PNPLA7;LPL;ABHD12;DDHD1;SMPD3;ASPG;PLD3;LIPC;ABHD4;PRDX6;ABHD3;GDE1;ABHD16A;GDPD3;PDIA3;PLAAT3;PNPLA3
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.6213135654378286,1.5863003139602425,0.0,0.23772212530676207,0.996,19/100,8.70%,BTK;DENND1C;MYO1G;ARHGAP9;DAPP1;NCF4;PLEKHN1;SH3PXD2B;IQGAP2;ZFYVE26;ARAP1;SNX24;ZFYVE28;ADAP2;GAB2;DENND1A;TECPR1;SNX27;DENND1B
prerank,MHC class I protein binding (GO:0042288),0.7741324142752547,1.5800079626412662,0.016689847009735744,0.2481014748449832,0.998,5/13,13.07%,TUBB;LILRB1;DERL1;TAP1;ATP5F1A
prerank,mannose binding (GO:0005537),0.7817542062861182,1.5789137580224064,0.030261348005502064,0.2432796624687185,0.998,2/12,1.78%,CLEC4D;LMAN1L
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.7845215239701815,1.5714802542917163,0.020463847203274217,0.25720044883108506,0.999,3/12,2.72%,PIK3CG;PIK3CD;PIK3CB
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.8075202360417069,1.5686049496238648,0.02638888888888889,0.2577222794512972,0.999,3/11,6.71%,AQP1;HCN4;CNGB1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.8072452836944564,1.5632891779384077,0.025174825174825177,0.2663139236363144,1.0,3/10,2.72%,PIK3CG;PIK3CD;PIK3CB
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.7496865359094926,1.5629148996234108,0.02913907284768212,0.25336856921660206,1.0,7/16,10.51%,ATP6V0D2;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V0D1;ATP6V0A1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.7496865359094926,1.5629148996234108,0.02913907284768212,0.25336856921660206,1.0,7/16,10.51%,ATP6V0D2;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V0D1;ATP6V0A1
prerank,dynactin binding (GO:0034452),0.7808020314203611,1.5586513313228052,0.024320457796852647,0.2584982944519457,1.0,3/12,2.06%,HOOK3;SPTBN5;SNX5
prerank,kinesin binding (GO:0019894),0.6889099000197535,1.557695217343882,0.026004728132387706,0.2548993428453859,1.0,9/27,9.38%,PLEKHM2;NEFH;SPTBN5;CLSTN1;KLC2;NEK6;SNCA;ACTB;ATCAY
prerank,triglyceride lipase activity (GO:0004806),0.7133356349672161,1.54608581136096,0.02574002574002574,0.28220625551439177,1.0,6/20,17.09%,LPL;DAGLB;CEL;LIPC;LIPE;PNPLA3
prerank,GTPase activator activity (GO:0005096),0.6004132259882001,1.545694823245448,0.0,0.27674921025137983,1.0,78/313,11.84%,ARHGAP45;ARHGAP30;NCKAP1L;FGD2;DOCK2;VAV1;CYTH4;DOCK8;DENND1C;ARHGAP25;RGS10;TBC1D9;PREX1;ARHGAP9;ABR;ARHGAP15;RIN2;SIPA1L2;SMAP2;ARHGAP39;IQGAP2;ARHGAP22;TBC1D10C;RIN3;RINL;THY1;ARHGAP24;GNAQ;ELMO1;VAV2;ARHGEF18;RASA4;ARAP1;FNIP1;ASAP1;RIC8A;RASGRP2;VAV3;ARFGEF1;RAB3GAP2;TBC1D16;TBC1D22A;TAGAP;RGL2;FGD6;USP6NL;DENND2C;RP2;DOCK11;MYO9B;DOCK10;GAPVD1;DOCK4;TBC1D10A;DENND1A;RASGRP3;FLCN;ITSN1;DENND1B;SIPA1;ARHGAP10;DENND4B;ARHGAP1;ACAP2;ARFGEF2;RAP1GAP2;EIF2B2;TBC1D2;DENND4C;ARHGEF17;TBC1D17;RAPGEF1;NRP1;DENND4A;TBC1D2B;ARHGAP27;CYTH1;ADAP1
prerank,diacylglycerol kinase activity (GO:0004143),0.7768270628071984,1.542624802184388,0.04,0.2795371598975466,1.0,7/11,12.73%,DGKZ;DGKK;DGKE;DGKG;DGKD;AGK;DGKI
prerank,protein tyrosine kinase binding (GO:1990782),0.6224835008507575,1.540220394904552,0.005230125523012552,0.28045575521243493,1.0,15/71,7.98%,TREM2;BLNK;ITGAX;CASS4;SIRPA;CBL;ANGPT4;DUSP3;PTPN1;FIZ1;SHC2;TP53;NEDD9;DOCK4;FLT3LG
prerank,receptor tyrosine kinase binding (GO:0030971),0.626402746214756,1.535826137345407,0.011739594450373533,0.2877494598278945,1.0,17/56,13.66%,BLNK;ITGAX;STAP1;CBL;ANGPT4;DUSP3;PTPN1;FIZ1;SHC2;GAB2;TP53;DOCK4;FLT3LG;SH2B3;NRG1;GAS6;TRADD
prerank,carboxylic ester hydrolase activity (GO:0052689),0.6100768672987293,1.5234422991748102,0.0020768431983385254,0.3208402315640154,1.0,25/85,17.09%,PNPLA7;LPL;DAGLB;ABHD12;ESD;CEL;LIPA;ASPG;PON3;PLA2G7;BCHE;LIPC;PAFAH1B2;ABHD4;PGAP1;PRDX6;ABHD3;LIPE;GDE1;ABHD16A;GDPD3;TARS2;PGLS;PLAAT3;PNPLA3
prerank,GTPase regulator activity (GO:0030695),0.5916001703632255,1.522691612616646,0.0,0.31639044769609226,1.0,48/212,11.84%,ARHGAP45;ARHGAP30;NCKAP1L;ARHGAP25;RGS10;TBC1D9;PREX1;ARHGAP9;ABR;ARHGAP15;RIN2;SIPA1L2;SIRPA;SMAP2;ARHGAP39;IQGAP2;ARHGAP22;TBC1D10C;THY1;ARHGAP24;GNAQ;RASA4;ARAP1;ASAP1;RIC8A;VAV3;ARFGEF1;RAB3GAP2;TBC1D16;TBC1D22A;TAGAP;USP6NL;RP2;MYO9B;TBC1D10A;RASGRP3;FLCN;SIPA1;ARHGAP10;ARHGAP1;ACAP2;RAP1GAP2;TBC1D2;TBC1D17;NRP1;TBC1D2B;ARHGAP27;ADAP1
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.42150606347518255,-1.5216019711740856,0.024793388429752067,1.0,0.997,11/32,21.70%,KCNQ3;KCNQ5;KCNA1;KCNS3;KCNA2;KCNB2;KCNC1;KCNC3;KCNH1;KCNQ2;KCNQ4
prerank,cysteine-type endopeptidase activity (GO:0004197),0.6080600999537182,1.5207662415706236,0.006147540983606557,0.3159322464939097,1.0,26/78,16.22%,CTSS;CTSB;LGMN;CTSC;CTSK;CTSL;ESPL1;CAPN15;PYCARD;USP35;CASP1;CFLAR;MALT1;CTSZ;USP7;USP48;CASP7;USP18;CASP8;USP9X;CAPN2;USP8;CAPN3;USP29;USP16;PDIA3
prerank,phosphatidylinositol kinase activity (GO:0052742),0.7398687370897601,1.5184362523750397,0.04768211920529802,0.31667118456183857,1.0,4/15,4.77%,PIK3CG;PIK3CD;PIK3CB;PI4K2A
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.5914360821007258,1.5089969457210657,0.0010030090270812437,0.3404022047616777,1.0,38/147,11.79%,FGD2;DOCK2;VAV1;CYTH4;DOCK8;DENND1C;PREX1;ABR;RIN2;RIN3;RINL;ELMO1;VAV2;ARHGEF18;FNIP1;RIC8A;RASGRP2;VAV3;ARFGEF1;RAB3GAP2;RGL2;FGD6;DENND2C;DOCK11;DOCK10;GAPVD1;DOCK4;DENND1A;ITSN1;DENND1B;DENND4B;ARFGEF2;EIF2B2;DENND4C;ARHGEF17;RAPGEF1;DENND4A;CYTH1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.5926013629309339,1.499166942284338,0.008205128205128205,0.3672860273846801,1.0,11/73,12.36%,CALCR;GP1BA;CX3CR1;CYSLTR2;EDNRB;GALR1;CCKBR;SORCS3;CYSLTR1;GPR37;LTB4R2
prerank,tau protein binding (GO:0048156),0.6317846064323361,1.4967318457556518,0.030133928571428572,0.3688515804355862,1.0,21/40,21.61%,BAG2;LGMN;PPP2CB;S100B;SNCA;APOE;ACTB;HDAC6;FYN;PPP2CA;STUB1;GSK3A;HSP90AA1;BIN1;PICALM;TAOK1;ROCK2;GSK3B;MARK1;BRSK1;PIN1
prerank,protein tyrosine kinase activity (GO:0004713),0.5902991443175468,1.4945098216673915,0.00303951367781155,0.3696079094873842,1.0,12/108,4.28%,SLA;PTK2B;BTK;FGR;LYN;HCK;SYK;FLT3;CSF1R;TYK2;TEC;TTN
prerank,ankyrin binding (GO:0030506),0.6887227259107757,1.493369559485146,0.03942181340341656,0.36632188403291616,1.0,3/19,3.19%,PTPRC;KCNJ11;SLC8A1
prerank,cysteine-type peptidase activity (GO:0008234),0.6008987956354275,1.4897926671431354,0.008281573498964804,0.37095200319690763,1.0,29/73,17.04%,CTSS;CTSB;LGMN;CTSC;OTULINL;CTSK;CTSL;ESPL1;OTULIN;USP35;CASP1;MALT1;CTSZ;TINAGL1;USP7;USP48;CASP7;USP18;GGH;CASP8;USP9X;CAPN2;USP8;CAPN3;USP29;USP21;USP16;PDIA3;ATG4A
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.5663510508845331,-1.4892660468826282,0.07279693486590039,1.0,1.0,8/12,32.75%,CRYZL1;DHRS4;AIFM2;NQO2;CBR4;NDUFS7;CRYZ;NQO1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.7059274121764747,1.4873652125376613,0.06141522029372497,0.36584119629485967,1.0,6/16,15.42%,PTPRC;PTPRE;PTPRU;PTPRO;PTPRT;PTPRA
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.7059274121764747,1.4873652125376613,0.06141522029372497,0.36584119629485967,1.0,6/16,15.42%,PTPRC;PTPRE;PTPRU;PTPRO;PTPRT;PTPRA
prerank,water transmembrane transporter activity (GO:0005372),0.7495239917621216,1.4827754563095235,0.06259097525473072,0.37515271176076503,1.0,2/11,8.14%,AQP1;AQP11
prerank,sterol transfer activity (GO:0120015),0.7015642325616894,1.4811964176374703,0.0517464424320828,0.37434551768912083,1.0,7/17,19.11%,ABCA1;NPC2;ABCG1;OSBP;STARD4;STARD5;GRAMD1C
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.7353511866392615,1.4808172862253683,0.055944055944055944,0.36924236189480464,1.0,5/12,13.66%,BLNK;STAP1;GAB2;SH2B3;TRADD
prerank,WW domain binding (GO:0050699),0.6649181616349163,1.4806768638381915,0.04399524375743163,0.3635616465087158,1.0,6/26,11.44%,NFE2;TCEAL3;TCEAL6;KIF20B;LITAF;TCEAL8
prerank,ligand-gated ion channel activity (GO:0015276),-0.4153825200606389,-1.4761910679449604,0.07534246575342465,1.0,1.0,7/30,12.81%,GRIA3;GRIN3A;GRIK4;GRIA2;GABRB1;GRIN2B;GRIN1
prerank,aspartic-type peptidase activity (GO:0070001),0.7766584599755045,1.4754765624984618,0.047619047619047616,0.3746604516957376,1.0,4/10,9.82%,NAPSA;CTSD;DDI2;CTSE
prerank,ephrin receptor binding (GO:0046875),0.6812000030064368,1.475336774146747,0.0484472049689441,0.3692393567726692,1.0,6/21,6.35%,LYN;PIK3CG;CBL;GRB2;PTPN1;EFNA2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.6744216958372244,1.4734326574452274,0.032418952618453865,0.3701554494736229,1.0,5/24,6.39%,PTK2B;MAPKAPK3;CAMK1D;MYLK3;MKNK1
prerank,CCR chemokine receptor binding (GO:0048020),0.6520232289491827,1.4705013163979266,0.0425531914893617,0.37440747335577873,1.0,5/28,11.55%,CCR2;CCL8;CCL14;CCL13;CCL2
prerank,glutamate receptor activity (GO:0008066),-0.5075810588614305,-1.4692166966893623,0.06220095693779904,1.0,1.0,5/19,10.77%,GRM7;GRIK4;GRIA2;GRM5;GRM1
prerank,lipase activator activity (GO:0060229),0.7473430141676656,1.4636827825171164,0.069164265129683,0.3910374199709433,1.0,5/10,17.77%,BTK;CCL8;FYN;SRC;PDPK1
prerank,P-type ion transporter activity (GO:0015662),0.7259853687686324,1.4622468844821834,0.08522727272727272,0.3898493365758377,1.0,6/12,13.41%,ATP7A;ATP6V1E1;ATP2C1;ATP2B1;ATP2B3;ATP2A3
prerank,Toll-like receptor binding (GO:0035325),0.7390008270940095,1.4606602734458165,0.07092198581560284,0.3890859788281461,1.0,3/11,2.43%,TLR1;UNC93B1;TLR2
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.6369062007653178,1.4545338415436346,0.05092592592592592,0.4043685812477007,1.0,3/29,1.28%,MGAM;HPSE;GUSB
prerank,steroid hydroxylase activity (GO:0008395),0.6976256194542598,1.448009337953967,0.07446808510638298,0.42121594922599465,1.0,1/16,0.47%,CYP1A1
prerank,ligand-gated channel activity (GO:0022834),-0.4178717512889689,-1.4446625993589441,0.07042253521126761,1.0,1.0,7/29,12.81%,GRIA3;GRIN3A;GRIK4;GRIA2;GABRB1;GRIN2B;GRIN1
prerank,3'-5' DNA helicase activity (GO:0043138),0.6927231242641044,1.444419153854124,0.08100929614873838,0.4274026491894398,1.0,5/16,10.17%,MCM5;DHX9;NAV2;MCM6;MCM2
prerank,cholesterol transfer activity (GO:0120020),0.6935189424033454,1.4423670537421316,0.07569721115537849,0.4285661023288379,1.0,6/16,19.11%,ABCA1;NPC2;ABCG1;STARD4;STARD5;GRAMD1C
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.602119927042502,-1.4415057880083806,0.08098591549295775,1.0,1.0,6/10,22.86%,GNAS;IGSF11;SHANK3;SHANK1;SHANK2;SHISA7
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.7105532707808144,1.4401037857349486,0.08552631578947369,0.4305146204339563,1.0,2/14,3.05%,AKR1A1;DHRS3
prerank,phospholipase activator activity (GO:0016004),0.7429320343384721,1.43882959429134,0.07840236686390532,0.4290973287333417,1.0,5/10,17.77%,BTK;CCL8;FYN;SRC;PDPK1
prerank,thyroid hormone receptor binding (GO:0046966),0.630339351952135,1.4368526660571808,0.07529411764705882,0.42952270783257895,1.0,6/28,3.64%,BRD8;GAS2L1;MED17;GTF2H1;NSD1;TACC1
prerank,actin monomer binding (GO:0003785),0.6505346316470787,1.4314579676732062,0.07187112763320942,0.4424047886149095,1.0,9/22,12.64%,CORO1A;MYL3;MRTFA;MTSS1;TMSB4X;PFN2;PFN1;TWF2;TMSB10
prerank,chemoattractant activity (GO:0042056),0.6405417121480701,1.4266841078519086,0.0647921760391198,0.45272711355162093,1.0,5/26,8.95%,GPNMB;LGALS3;HMGB1;VEGFB;NTF3
prerank,acetylcholine receptor activity (GO:0015464),-0.44910943064805164,-1.4185493674985283,0.07179487179487179,1.0,1.0,5/22,21.96%,CHRM2;CHRFAM7A;CHRNA7;CHRM3;CHRNB1
prerank,lysophospholipase activity (GO:0004622),0.6629802100417987,1.4170322090456677,0.09009009009009009,0.48051556199672957,1.0,7/20,15.84%,PNPLA7;ABHD12;ASPG;ABHD4;GDE1;ABHD16A;GDPD3
prerank,metal ion:proton antiporter activity (GO:0051139),0.6969903281080511,1.4158547521610647,0.10231923601637108,0.47841125960331254,1.0,4/13,7.37%,SLC11A1;SLC9A4;SLC9A9;SLC9A1
prerank,DNA replication origin binding (GO:0003688),0.6522822742851417,1.4154074093475686,0.07663782447466007,0.47394570041449663,1.0,9/23,13.79%,MCM5;ORC3;DHX9;MCM6;MCM2;ORC4;MCM9;KAT7;CDC6
prerank,protein tyrosine phosphatase activity (GO:0004725),0.5727374913720381,1.4074137353344995,0.0364963503649635,0.49597871331951837,1.0,15/71,11.36%,PTPRC;PTPN7;UBASH3B;PTPRJ;DUSP3;PTPN1;PTPN18;PALD1;PTPRE;PTP4A2;MTMR3;PTP4A1;PTPRU;PTPRO;TIMM50
prerank,endoribonuclease activity (GO:0004521),0.5990759671531815,1.405789801840522,0.07381776239907728,0.495910018996451,1.0,8/32,11.72%,SLFN14;ERN1;NOB1;SND1;ZC3H12D;ENDOV;RNASEL;AGO3
prerank,MAP kinase kinase activity (GO:0004708),0.6762914943275369,1.3941197478783758,0.10914051841746249,0.5328749552072539,1.0,6/15,14.53%,MAPKAPK3;MAPK14;MAP2K6;MAP2K3;MAP2K2;LRRK2
prerank,bHLH transcription factor binding (GO:0043425),0.6434980021430065,1.3884640675459605,0.09768637532133675,0.5475032018427005,1.0,5/19,8.71%,ASCL1;BHLHE41;USF1;LMO2;SMAD3
prerank,tumor necrosis factor receptor binding (GO:0005164),0.6866924247211613,1.3861474511483427,0.12704918032786885,0.5500047008625589,1.0,6/12,9.92%,TNF;TRAF2;TRAF3;TRAP1;BABAM2;TRAF5
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7022428918734092,1.3859677893343516,0.13662790697674418,0.5443137539019364,1.0,2/10,3.38%,PRKAR2B;PKIB
prerank,mitogen-activated protein kinase binding (GO:0051019),0.5989537489830763,1.385344338310373,0.09501738122827347,0.5407012633266468,1.0,7/29,10.11%,MAPKAPK3;NFATC1;PTPRJ;MAPK14;GCH1;DUSP10;TPR
prerank,ligand-gated cation channel activity (GO:0099094),0.5484724527198919,1.3803719154448724,0.05578512396694215,0.5522951764295814,1.0,7/75,5.98%,PTK2B;KCNJ11;P2RX1;P2RX7;KCNK6;P2RX4;CCDC51
prerank,protein kinase regulator activity (GO:0019887),0.5448907771712476,1.380156146426238,0.028629856850715747,0.546802231780563,1.0,17/95,10.57%,NCKAP1L;GMFG;PRKAR2B;TAOK3;GPRC5B;FGF13;CCND3;SNCA;RGCC;DNAJC3;CCND2;YWHAB;WNK1;EPO;QARS1;CCNL1;DUSP19
prerank,protein kinase activator activity (GO:0030295),0.5687033034060144,1.3768276761948999,0.047619047619047616,0.552769678384933,1.0,23/60,19.10%,NCKAP1L;GPRC5B;FGF13;RGCC;WNK1;EPO;ABI1;DBF4;DUSP19;MAP2K2;PARP16;NRG1;GAS6;STK3;STRADA;ERCC6;ALS2;INCENP;IRGM;STK4;IQGAP1;TAOK1;RPTOR
prerank,cytokine activity (GO:0005125),0.5427146438657188,1.3760606730406604,0.012060301507537688,0.5492958727780682,1.0,19/131,12.63%,PF4;TGFB1;CXCL5;IL1A;CXCL2;SLURP1;OSM;CCL8;TNF;IL18;TIMP1;NDP;HMGB1;EPO;CCL14;INHBA;CCL13;CCL2;NRG1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.5795221332926986,1.3758564471128223,0.08967082860385925,0.5440043577391142,1.0,9/38,8.72%,BLNK;CD3E;STAP1;LAT;NUP62;NCK2;LDLRAP1;GAB2;MMS19
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6768671800219845,1.3750484121649833,0.11659807956104253,0.5408012947837112,1.0,3/13,3.63%,ITGB3;PTPRJ;ERN1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.6750202689277086,1.374073176723284,0.10596026490066225,0.5385223623717688,1.0,4/13,15.27%,EHHADH;SREBF2;ECI1;ECH1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.631281530502053,1.373084062462913,0.14340588988476313,0.5361917639608523,1.0,6/18,12.93%,TGFB1;TGFBR1;TGFBR2;TGFBRAP1;SMAD3;BAMBI
prerank,retinoic acid binding (GO:0001972),-0.5436572280005627,-1.3643854395463422,0.14814814814814814,1.0,1.0,1/12,0.35%,NR2F2
prerank,G protein-coupled receptor activity (GO:0004930),0.5244738123140776,1.362002536288742,0.006,0.5696443782756918,1.0,26/239,11.03%,GPR141;CNR2;LPAR6;CALCR;PTAFR;CX3CR1;ADGRE1;P2RY6;CYSLTR2;ADGRG5;ADGRE5;FFAR2;MRGPRF;CXCR4;LGR6;S1PR4;GALR1;ADGRG3;GPR17;P2RY12;GPR34;GPR183;XPR1;CYSLTR1;CMKLR1;GPR37
prerank,carbohydrate kinase activity (GO:0019200),0.6886376650120298,1.3618724454916658,0.12336719883889695,0.5642597009082315,1.0,5/11,15.88%,HK3;NAGK;POMK;HK2;XYLB
prerank,phospholipase inhibitor activity (GO:0004859),0.6863782023596283,1.3608217809409227,0.14616497829232997,0.5621338536103209,1.0,4/10,9.80%,ANGPTL3;SNCA;ANXA1;ANXA4
prerank,cholesterol binding (GO:0015485),0.5638560433843435,1.3547571231713302,0.08657047724750278,0.578658122598825,1.0,18/47,21.44%,TSPO;ABCA1;NPC2;ABCG1;NPC1;SOAT2;ERLIN1;ERLIN2;OSBPL10;STARD4;VDAC2;VDAC1;OSBPL8;STARD5;GRAMD1C;OSBPL7;STARD3;SCARB2
prerank,protein phosphatase binding (GO:0019903),0.5236630674988327,1.3465972101517927,0.038306451612903226,0.6028697223208277,1.0,29/117,17.46%,CD22;LILRB1;LGALS3;SIRPA;PPP1R3E;KCNN4;MAPK14;PPP6R1;TRAF2;AKAP5;TRAF3;PPP1R11;CTNNB1;TP53;MAP3K5;SLC9A1;MTMR3;ENSA;STRN;BOD1L1;ADCY8;CTTNBP2NL;PTPRT;PTPA;CD33;SMG7;PPP3CB;IQGAP1;ANK1
prerank,E-box binding (GO:0070888),0.5722032269945944,1.3434118267675978,0.11805555555555555,0.608728697371838,1.0,7/34,8.69%,ASCL1;SREBF2;MITF;BHLHE41;TAL1;SNAI1;CIART
prerank,SH3 domain binding (GO:0017124),0.5479122531470201,1.3416896168442904,0.08402489626556017,0.6089972812565719,1.0,14/62,12.52%,SH3BP2;CD3E;CBL;GRB2;ELMO1;WIPF1;AKAP5;DNM2;MICAL1;WASF2;ABI1;ZNF106;ARHGAP27;SYNJ1
prerank,C2H2 zinc finger domain binding (GO:0070742),0.6783006186663381,1.3397814877048697,0.15177304964539007,0.6100234549515945,1.0,1/11,1.17%,GATA1
prerank,hormone activity (GO:0005179),0.5500137321777382,1.3365072687790651,0.09458023379383634,0.6170645554251833,1.0,6/54,10.80%,TSHB;METRNL;PPY;VGF;INHBA;CHGB
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.4905195756528046,-1.3351137259755599,0.14942528735632185,1.0,1.0,7/14,14.48%,RECK;COL4A3;TIMP2;SPOCK2;TIMP3;NGF;BST2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.6892889803577,1.3246349334437402,0.17118402282453637,0.6551106152659587,1.0,3/10,13.47%,APOBEC1;CDA;LACC1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.5324857690532341,1.323127674988408,0.0893970893970894,0.6543778190682701,1.0,18/74,14.28%,HK3;PIK3CG;DGKZ;PIK3CD;PIK3CB;CHKB;DGKK;DGKE;NADK;DGKG;DGKD;AGK;FAM20C;PAPSS1;POMK;DGKI;SHPK;HK2
prerank,serine-type endopeptidase activity (GO:0004252),0.5288232379453865,1.3213281394975112,0.08061224489795918,0.6549326670991392,1.0,5/80,4.68%,KLK3;PCSK9;F10;MASP1;RHBDF2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.5075305434036145,1.3207105997410546,0.026052104208416832,0.6510860054461671,1.0,46/188,14.60%,RUNX1;AHRR;CIITA;GATA1;NFE2L2;POU2F2;BASP1;DHX9;TNF;SNCA;ATF3;CEBPA;FOXO3;DDIT3;SPI1;MAFK;HDAC5;HMGB1;XRCC5;FLI1;TFEB;TP53;TBL1XR1;NKX2-1;TAL1;YY1;CREB3L1;CEBPB;MEF2C;SMAD3;HSF1;HNRNPL;ARID4A;HDAC4;RNF10;TBL1X;CREB3L2;RBBP5;ATF6B;NFKB1;FOXK1;SOX6;IRF1;SOX2;BRD7;SOX4
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.5390722082115926,-1.312556399767939,0.17522658610271905,1.0,1.0,6/10,14.50%,ATF2;USP22;HAT1;BRCA2;NAA60;MSL3
prerank,protein phosphatase inhibitor activity (GO:0004864),0.5888100957869273,1.3106821134757738,0.14628297362110312,0.6824562066104775,1.0,6/26,11.22%,LGALS3;MGAT5;SAG;PPP1R11;ENSA;BOD1L1
prerank,copper ion binding (GO:0005507),0.5560622638574042,1.30972733573301,0.12794612794612795,0.6797201068183303,1.0,7/42,6.70%,IL1A;SNCA;ATP7A;ATOX1;RNF7;P2RX4;TP53
prerank,single-stranded DNA helicase activity (GO:0017116),0.6078232993406777,1.3051442092323773,0.16166883963494133,0.690251782541298,1.0,5/19,13.34%,MCM5;DHX9;MCM6;MCM2;DNA2
prerank,hexosaminidase activity (GO:0015929),0.6577475365083401,1.304095082636071,0.2110215053763441,0.6880696679258745,1.0,3/12,6.91%,HEXB;HEXA;OGA
prerank,calcium channel inhibitor activity (GO:0019855),-0.5016268800977942,-1.302272997597373,0.15328467153284672,1.0,1.0,4/11,26.19%,FKBP1A;SLC30A1;PACSIN3;CALM2
prerank,cation:chloride symporter activity (GO:0015377),-0.537152878680779,-1.3004435396957692,0.1962025316455696,1.0,1.0,2/10,1.03%,SLC12A2;SLC12A7
prerank,MAP kinase phosphatase activity (GO:0033549),0.6403960908586257,1.2977477171371081,0.19753086419753085,0.7065003578948491,1.0,3/12,8.91%,DUSP3;DUSP29;DUSP10
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.32428118146900553,-1.297328362991313,0.05555555555555555,1.0,1.0,13/60,7.11%,ROR1;CRIM1;NTRK3;AXL;EGFR;ALK;EPHA7;EFEMP1;EPHA3;EPHB4;EPHB2;PDGFRA;ROR2
prerank,GABA receptor binding (GO:0050811),0.6687129839509396,1.2937801329894747,0.20605187319884727,0.716146306560674,1.0,3/11,9.62%,PLCL2;AKAP5;ARFGEF2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.46027259986328434,-1.291084088647379,0.1440329218106996,1.0,1.0,6/15,30.79%,SLC26A2;SLC26A7;SLC39A8;SLC26A6;CFTR;SLC26A8
prerank,serotonin receptor activity (GO:0099589),-0.4126984727724215,-1.2906093856778065,0.13372093023255813,1.0,1.0,3/22,6.88%,CHRM2;HTR2C;HTR7
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.4126984727724215,-1.2906093856778065,0.13372093023255813,1.0,1.0,3/22,6.88%,CHRM2;HTR2C;HTR7
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.4126984727724215,-1.2906093856778065,0.13372093023255813,1.0,1.0,3/22,6.88%,CHRM2;HTR2C;HTR7
prerank,sodium channel regulator activity (GO:0017080),0.558117362606834,1.290329867654354,0.14702581369248036,0.723319701577185,1.0,12/37,20.21%,PCSK9;SCN4B;FGF13;PKP2;PRSS8;NEDD4L;FXYD5;SGK3;YWHAH;FXYD6;PTPN3;FXYD1
prerank,phosphatase inhibitor activity (GO:0019212),0.5978094132115187,1.2877283742195533,0.18102372034956304,0.7272358003563929,1.0,5/20,11.22%,LGALS3;MGAT5;SAG;ENSA;BOD1L1
prerank,lipoprotein particle receptor binding (GO:0070325),0.559090675414052,1.2875192576563814,0.18309859154929578,0.7217806368185455,1.0,9/27,19.92%,PCSK9;APOE;LDLRAP1;CLTC;LRP1;AP2M1;MESD;PICALM;RELN
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.5674794915349948,1.2873004714811145,0.16105769230769232,0.7165141994565234,1.0,8/28,18.45%,MAPKAPK3;MAPK14;MAP2K6;MAP2K3;MAP2K2;LRRK2;RPS6KA2;MAP2K5
prerank,phosphatase binding (GO:0019902),0.5009025035394157,1.284895943415273,0.07388663967611336,0.7195853339083894,1.0,16/105,8.71%,CD22;LGALS3;SIRPA;CTSC;KCNN4;MAPK14;PPP6R1;TRAF2;TRAF3;CTNNB1;CEP192;TP53;MAP3K5;WNK1;MTMR3;SMAD3
prerank,sterol binding (GO:0032934),0.5239986266420537,1.2848812929911442,0.13748657357679914,0.7136518970239956,1.0,16/56,15.24%,TSPO;ABCA1;NPC2;ABCG1;NPC1;OSBPL11;SOAT2;ERLIN1;ERLIN2;OSBPL10;GPR183;OSBP;STARD4;VDAC2;VDAC1;OSBPL8
prerank,CoA-ligase activity (GO:0016405),-0.4641112624097236,-1.2845631053045856,0.15730337078651685,1.0,1.0,6/14,29.46%,ACSL1;ACSS2;ACSS1;ACSBG1;SLC27A2;AACS
prerank,alanine transmembrane transporter activity (GO:0022858),0.6361914183520104,1.2762693921948058,0.199442119944212,0.7403925541383258,1.0,6/12,23.01%,SLC7A8;SLC36A1;SLC36A4;SLC1A4;SLC38A7;SLC6A6
prerank,Hsp90 protein binding (GO:0051879),0.5470686601550635,1.2755637629982304,0.1981242672919109,0.736775646787639,1.0,12/33,17.78%,CYP1A1;PTGES3;ERN1;CSNK2A1;HSF1;AHSA1;HDAC6;NOD2;STUB1;CHORDC1;HIF1A;NPAS2
prerank,glutamate receptor binding (GO:0035254),-0.44809878414587906,-1.2752593875683715,0.15137614678899083,1.0,1.0,9/17,15.99%,GNAS;SYNDIG1;IGSF11;HOMER3;SHANK3;SHANK1;SHANK2;CAMK2A;HOMER2
prerank,glycerophospholipid flippase activity (GO:0140333),0.6315902271673167,1.2751950305652073,0.2144927536231884,0.7322401532879763,1.0,5/11,15.26%,ATP8A1;ATP8A2;ABCB4;ABCA4;ABCA3
prerank,1-phosphatidylinositol binding (GO:0005545),0.6122873981799959,1.2744532886916535,0.20239680426098536,0.7292206350570917,1.0,8/15,18.20%,SNX9;ZFYVE9;WDFY1;EPB41;FRMPD2;WDFY3;SNX10;PICALM
prerank,receptor antagonist activity (GO:0048019),0.6035245520119036,1.2678349080920384,0.1981981981981982,0.7490211628157512,1.0,3/17,13.45%,DKK2;IL18BP;PXDN
prerank,Hsp70 protein binding (GO:0030544),0.5514153768809107,1.2675899185848432,0.18309859154929578,0.7438353437516321,1.0,7/31,13.60%,CYP1A1;ERN1;SNCA;DNAJC8;GPR37;NOD2;STUB1
prerank,insulin-like growth factor I binding (GO:0031994),0.6228159789789991,1.2675076267738221,0.20634920634920634,0.7382914258154061,1.0,2/13,3.96%,ITGB3;ITGA6
prerank,semaphorin receptor activity (GO:0017154),0.6341741012424678,1.2639495401242997,0.21602288984263232,0.7462937919110466,1.0,3/11,11.23%,PLXNC1;PLXNB2;NRP1
prerank,protein kinase C binding (GO:0005080),0.526799391106902,1.2631381477346864,0.1772428884026258,0.7433337329579901,1.0,11/43,12.18%,PLEK;PKP2;PRKD2;ADCY6;HDAC5;PRKCB;HINT1;PKN1;NELL1;HDAC9;TWF2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5640288179536269,1.261785706901417,0.20631067961165048,0.7424289465922799,1.0,7/22,18.20%,PCSK9;APOE;LDLRAP1;CLTC;AP2M1;MESD;PICALM
prerank,insulin-like growth factor binding (GO:0005520),0.6057382813976167,1.260074744653351,0.2178988326848249,0.7433300359055494,1.0,2/15,3.96%,ITGB3;ITGA6
prerank,transcription cis-regulatory region binding (GO:0000976),0.48010932421621894,1.2577078517966673,0.013,0.7468780299136922,1.0,83/406,14.65%,RUNX1;NFE2;NPAS4;MMP12;AHRR;ASCL1;CIITA;GATA1;NFE2L2;POU2F2;BASP1;RREB1;CREB3;BARX2;RXRB;NR1H4;TNF;SNCA;MLXIP;NFXL1;ATF3;CEBPA;FOXO3;DDIT3;SPI1;MAFK;HOXC8;HDAC5;HMGB1;XRCC5;FLI1;TEAD1;TRPS1;TFEB;ZFP69;ZNF177;TP53;MEF2A;ACTN4;TBL1XR1;NKX2-1;TAL1;LONP1;YY1;CREB3L1;ZFP90;CEBPB;FOXN2;SNAI1;MEF2C;CDC5L;TFAP2B;RB1;SMAD3;IRF2;HSF1;CREBRF;HNRNPL;ARID4A;HDAC4;NFX1;RNF10;TBL1X;CREB3L2;RBBP5;SOX9;NR2C2;ETV6;E2F6;ATF6B;SNAPC3;MAX;TIPARP;FOXN3;NFKB1;FOXK1;SOX6;CUX1;IRF1;SOX2;BRD7;SOX4;SREBF1
prerank,chemorepellent activity (GO:0045499),-0.39174167712027425,-1.256857500103928,0.16470588235294117,1.0,1.0,8/25,8.55%,SEMA6A;SEMA5A;EPHA7;SEMA3A;SEMA6D;NRG3;SEMA3C;SEMA3D
prerank,ribosomal large subunit binding (GO:0043023),-0.49336010915931594,-1.2535848989308738,0.21926910299003322,1.0,1.0,6/11,25.32%,CPSF6;NEMF;DHX33;NPM1;NMD3;MRRF
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6340968692965288,1.25229929301095,0.2222222222222222,0.7612480494720533,1.0,5/12,14.82%,NAPSA;DDI2;SPPL3;CTSE;SPPL2A
prerank,DNA polymerase activity (GO:0034061),-0.3940610902081856,-1.251483017821061,0.16751269035532995,1.0,1.0,12/22,22.73%,REV3L;REV1;PRIMPOL;POLN;POLA1;POLE4;TERT;POLG;POLE2;POLQ;POLK;POLI
prerank,acid-thiol ligase activity (GO:0016878),-0.46061633176692385,-1.2512122265498835,0.20503597122302158,1.0,1.0,6/13,30.53%,ACSL1;ACSS2;ACSS1;SLC27A2;AACS;AASDH
prerank,leucine zipper domain binding (GO:0043522),0.6287281603656365,1.250526183418187,0.23295454545454544,0.7625748592883798,1.0,4/10,12.41%,DDIT3;MRTFA;NRL;PMF1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.49620730540705993,-1.2481821706452076,0.20257234726688103,1.0,1.0,5/11,35.23%,KCND3;KCNJ3;KCNJ8;KCNE4;KCNH2
prerank,cytokine receptor binding (GO:0005126),0.49741925761608474,1.2478777601658373,0.1366906474820144,0.7665746020962727,1.0,17/83,13.68%,SYK;TYK2;OSM;IL6R;PYCARD;IL18;CD300LF;VEGFB;EPO;TGFBRAP1;SMAD3;SH2B3;TIMM50;SDCBP;PRLR;PXDN;ERAP1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5624150435678357,1.247179381199373,0.21540312876052947,0.7637291418053369,1.0,2/23,2.02%,PLCB2;PLCG2
prerank,Notch binding (GO:0005112),-0.3929674419446437,-1.2452838686694028,0.1282051282051282,1.0,1.0,13/22,35.85%,CCN3;SNED1;SNW1;AAK1;JAG1;JAG2;NOTCH4;HIF1AN;TCIM;KCTD10;GALNT11;DLL4;DLL1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.5241635424354558,1.244848472720284,0.1946607341490545,0.766632540266104,1.0,7/38,8.38%,NCF4;SH3PXD2B;ZFYVE26;ZFYVE28;DENND1A;TECPR1;SNX27
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.6057964157059602,1.2426301286801331,0.23676880222841226,0.769473281934556,1.0,4/14,10.15%,BLVRB;CRYM;QDPR;PYCR2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.5458395267791084,1.241869183620358,0.20838323353293414,0.766641139968397,1.0,12/28,21.10%,EXO1;ELAC2;ENDOV;RPP38;ELAC1;AGO3;RNASEH1;RPP14;PRORP;AGO2;RNASEH2A;DICER1
prerank,nuclear receptor coactivator activity (GO:0030374),0.5023882712845814,1.2380298097581508,0.1898047722342733,0.7755942257587353,1.0,20/52,22.17%,BRD8;MED17;TACC1;ZMIZ2;PRKCB;CCAR1;ACTN4;PPARGC1A;RNF4;ACTN1;PKN1;SRA1;BUD31;THRAP3;TMF1;MED4;MED13;SFR1;FGF2;MED30
prerank,protein kinase binding (GO:0019901),0.4774039384933908,1.237145322943463,0.01,0.7731616593136158,1.0,89/479,12.82%,PTPRC;CD226;TREM2;IRF5;BLNK;FGR;PLEK;CD3E;ITGB2;CASS4;HCLS1;STAP1;LYST;NEFH;MAPKAPK3;LAT;SIRPA;PRKAR2B;PLCG2;GPRC5B;PRKCD;PTPRJ;THY1;MAD2L2;DUSP3;GRB2;PTPN1;RFFL;MAP2K6;TRIM5;NEK6;PKP2;CCND3;GCH1;RGCC;PRKD2;TUBA4A;CIR1;TTN;SKI;TRAF2;DNAJC3;FOXO3;ADCY6;NBEAL2;CCND2;HDAC5;SHC2;PRKCB;MAP2K3;BCL2L1;CEP192;ACTB;MAPRE1;TP53;USF1;NEDD9;WNK1;TICAM1;HINT1;TRAP1;CHEK2;KIF14;AP1B1;TRIM27;MAP3K1;SMAD3;DUSP10;HSF1;QARS1;IBTK;BCAR1;TPR;DUSP19;PKN1;SH2B3;LIMS1;CLTC;SOX9;NELL1;BECN1;ADIPOR1;PRDX3;HDAC9;TWF2;NOD2;MAP3K12;TBL2;EXOC2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.34596770364508955,-1.2371103094624574,0.16666666666666666,1.0,1.0,5/38,4.45%,APP;SERPINH1;SERPINE2;SERPING1;TFPI
prerank,kinase inhibitor activity (GO:0019210),0.529246816309575,1.2362919393190306,0.2219679633867277,0.7707966858280277,1.0,7/33,10.57%,GMFG;TAOK3;SNCA;DNAJC3;YWHAB;QARS1;DUSP19
prerank,endonuclease activity (GO:0004519),0.5084417683738164,1.2350468304396962,0.20474137931034483,0.7700270321082748,1.0,13/49,17.89%,SLFN14;ERN1;NOB1;SND1;ZC3H12D;RNASEL;AGO3;ERCC5;REXO4;OGG1;ZC3H12C;N4BP2;AGO2
prerank,metalloaminopeptidase activity (GO:0070006),-0.415463493991571,-1.2317095877400603,0.20866141732283464,1.0,1.0,7/16,20.31%,LTA4H;MMP14;MMP16;RNPEPL1;NPEPPS;ENPEP;MMP15
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5751343341628026,1.2307842706538903,0.23333333333333334,0.7805091030111295,1.0,8/18,22.07%,TNFAIP8;SNCA;PRDX3;GAS6;PRDX5;BIRC2;BIRC3;MT3
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.4071466903243402,-1.2291731610244125,0.19827586206896552,1.0,1.0,7/18,20.96%,STXBP6;CNN3;BAIAP2L1;BAIAP2;S100A11;ANXA2;PPP1CA
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.5655990745450511,1.2270831714406352,0.24052287581699347,0.7883135865402575,1.0,4/18,12.33%,PIK3R5;WDR91;CCKBR;WDR81
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.5029110590461923,1.2245964175405035,0.192102454642476,0.7914596342827266,1.0,11/54,13.99%,KLK3;ASPG;PIGL;HDAC5;HINT1;ACER3;HDAC4;HDAC6;HDAC9;DARS1;HDAC11
prerank,GABA receptor activity (GO:0016917),-0.3964681525067506,-1.2243838466322903,0.21395348837209302,1.0,1.0,6/21,10.55%,GABRB2;GABRB1;GABRA2;GPR156;GABBR2;GABRB3
prerank,fatty acid synthase activity (GO:0004312),-0.5000394897186156,-1.2243749493088185,0.22727272727272727,0.9769334921576328,1.0,7/10,42.94%,ELOVL5;CBR4;ELOVL1;OXSM;MCAT;ELOVL4;ELOVL2
prerank,ribonuclease activity (GO:0004540),0.49482084119777664,1.222856874515816,0.18991416309012876,0.7923605534324872,1.0,20/56,22.63%,SLFN14;ERN1;NOB1;EXOSC1;SAMHD1;SND1;ELAC2;ZC3H12D;RNASEL;AGO3;RNASEH1;ZC3H12C;AGO2;RNASEH2A;EXOSC3;DIS3L2;DICER1;RNASE6;CNOT7;EXOSC2
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6160984931375606,1.221920675211741,0.2849002849002849,0.7903135170265606,1.0,5/12,12.40%,ARSB;GNS;IDS;SULF2;ARSA
prerank,actin binding (GO:0003779),0.47753999631669086,1.2198870203626526,0.08517034068136273,0.7923091234899021,1.0,46/170,14.92%,MYO1F;LCP1;SPTBN5;IQGAP2;CORO1A;MYL3;SNCA;GAS2L3;CXCR4;MYH9;SYNE1;FLII;MRTFA;MACF1;MYO9B;CAPZB;MTSS1;ACTN4;KCNMA1;LDB3;TMSB4X;MICAL1;P4HB;CAPZA1;CAP1;TNNT3;MYO19;TLNRD1;VCL;PFN2;MAP1B;PARVB;MAEA;PFN1;TWF2;NOD2;COTL1;TMSB10;SMTN;SSH2;ADCY8;SYNPO;MYH10;LRRK2;PDLIM1;FXYD5
prerank,inward rectifier potassium channel activity (GO:0005242),0.5406617296328436,1.2189489221968826,0.23289315726290516,0.7903843851162693,1.0,2/24,3.18%,KCNJ11;KCNK6
prerank,peptide hormone receptor binding (GO:0051428),-0.4848350493361105,-1.2185438019045551,0.22327044025157233,0.9705938855741294,1.0,5/11,34.95%,PSMC5;PTHLH;ADCYAP1;GNRH1;CCK
prerank,ephrin receptor activity (GO:0005003),-0.42584997314672113,-1.2152371221043214,0.1981981981981982,0.9270217323851583,1.0,4/17,4.78%,EPHA7;EPHA3;EPHB4;EPHB2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.42584997314672113,-1.2152371221043214,0.1981981981981982,0.9270217323851583,1.0,4/17,4.78%,EPHA7;EPHA3;EPHB4;EPHB2
prerank,CARD domain binding (GO:0050700),0.5825924852178593,1.2118427040479371,0.2597577388963661,0.8104202428851388,1.0,4/14,16.29%,CARD11;CASP1;NOD2;IRGM
prerank,phosphoric diester hydrolase activity (GO:0008081),0.5183604847084745,1.2110250817383448,0.23348519362186787,0.808227301749125,1.0,9/35,16.22%,PLD4;PLCB2;SMPD3;PLD3;PLCXD3;PDE11A;GDE1;GDPD3;PDIA3
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5307540726207768,1.2098276860576564,0.23837902264600716,0.8071828764354642,1.0,11/30,22.07%,TNFAIP8;PTTG1;CST7;SNCA;PRDX3;GAS6;PRDX5;UBE2Z;BIRC2;BIRC3;MT3
prerank,protein kinase C activity (GO:0004697),0.5929055827141336,1.209593635935217,0.2635046113306983,0.8028327210919413,1.0,6/14,10.83%,PRKCD;PRKCB;PRKCQ;SMG1;PRKCH;PKN1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.4707658563997782,1.2087347123882455,0.09528585757271815,0.800645675159697,1.0,37/173,13.82%,BATF3;ASCL1;IRF8;BCL11A;ZEB2;SREBF2;MITF;SKI;ATF3;FOXO3;LRRFIP1;MYT1L;ZBTB12;ZBTB39;MAFK;BHLHE41;BACH1;TRPS1;ZFP69;ZNF177;YY1;CREB3L1;ZFP90;CEBPB;SNAI1;GTF2IRD1;HSF1;NFX1;TGIF1;JDP2;ETV6;E2F6;GZF1;MAX;NFKB1;FOXK1;ZFHX3
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.30212605859660696,-1.2077198721506206,0.08,0.9274279368692333,1.0,14/60,8.94%,ROR1;NTRK3;AXL;EGFR;ALK;EPHA7;EPHA3;EPHB4;ACVR1;EPHB2;ACVRL1;PDGFRA;ROR2;ACVR1B
prerank,endopeptidase inhibitor activity (GO:0004866),-0.2657297531626637,-1.2056042791302535,0.0625,0.9090437465220067,1.0,19/82,14.48%,APP;SERPINH1;SERPINE2;CAST;SERPING1;RECK;TFPI;COL4A3;TIMP2;SPOCK2;USP14;TIMP3;BIRC6;NGF;ROCK1;SERPINB9;SERPINF1;UBE2O;BST2
prerank,retinoid X receptor binding (GO:0046965),0.61286255247283,1.2045835553972593,0.2627840909090909,0.8103678809665257,1.0,3/11,11.82%,NSD1;TACC1;NRIP1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.5522637083513217,1.2036749552883608,0.25093167701863356,0.8083174648577117,1.0,5/22,10.57%,DUSP3;DUSP29;MTMR3;DUSP10;DUSP19
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.4082859497121376,-1.2022400805095514,0.1843137254901961,0.8966616314772875,1.0,3/16,1.33%,MTM1;SACM1L;MTMR7
prerank,serine-type peptidase activity (GO:0008236),0.4778246564396339,1.2014751673987456,0.18578680203045686,0.8111159391140468,1.0,5/96,4.68%,KLK3;PCSK9;F10;MASP1;RHBDF2
prerank,ADP binding (GO:0043531),0.5380289574629199,1.2012237528635692,0.26814268142681424,0.8070266834614362,1.0,9/25,14.20%,ERN1;ABCG1;MYH9;MYO9B;LONP1;ABCD1;TAP1;ATP5F1A;MYH10
prerank,DNA-binding transcription factor binding (GO:0140297),0.4616636928342179,1.200806618378064,0.111,0.8033316908883156,1.0,29/189,8.71%,ASCL1;CIITA;HCLS1;GATA1;NFE2L2;NFATC1;MAD2L2;DHX9;TLE3;NEK6;SKI;DDIT3;SPI1;FIZ1;BHLHE41;HDAC5;HMGB1;TAF1;CTNNB1;MTA3;TP53;MEF2A;TAL1;USF1;MYOCD;LMO2;MEF2C;RB1;SMAD3
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.5733201593279864,1.1987960372601294,0.2855191256830601,0.8052682062913136,1.0,2/16,4.46%,ALOX12;HAAO
prerank,solute:anion antiporter activity (GO:0140323),-0.4362163904866433,-1.198322865289764,0.23106060606060605,0.8880998193819283,1.0,5/14,30.79%,SLC26A2;SLC26A7;SLC4A2;SLC26A6;SLC26A8
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5204626936423026,1.1959763687326816,0.25677267373380447,0.8102543862363064,1.0,12/27,21.67%,SLC11A1;AQP1;ATP2B1;ZDHHC13;ITPR2;ATP2B3;ATP2A3;TMEM165;MMGT1;TUSC3;MAGT1;SLC12A3
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.3921594338269402,-1.193060990933506,0.2146341463414634,0.8842519495716152,1.0,8/20,26.16%,SLC39A13;SLC39A8;SLC30A1;SLC39A1;SLC39A14;SLC39A3;SLC39A10;SLC39A12
prerank,RNA stem-loop binding (GO:0035613),0.5956028662978681,1.1924959658385796,0.28783783783783784,0.8176940095786215,1.0,6/12,14.20%,DHX9;RC3H2;RC3H1;EPRS1;CPEB3;MYH10
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.6107855646687862,1.1906376997358235,0.30099857346647646,0.8190457631358234,1.0,5/11,12.90%,PYCARD;CASP1;CFLAR;CASP7;CASP8
prerank,acylglycerol lipase activity (GO:0047372),0.6074812397466473,1.189169954413182,0.27932960893854747,0.8194689406368781,1.0,4/11,15.34%,ABHD12;ABHD3;LIPE;ABHD16A
prerank,endopeptidase activity (GO:0004175),0.46136035847494894,1.1888699488195784,0.086,0.8156842838949298,1.0,47/257,16.22%,CTSS;KLK3;MMP12;CTSB;PCSK9;NAPSA;F10;LGMN;CTSC;CTSK;CTSL;ADAMTS8;MASP1;ECE2;EEF1AKMT4-ECE2;ESPL1;RHBDF2;USP35;CASP1;DDI2;PSMB10;MALT1;ZMPSTE24;CTSZ;NLN;CTSE;MMP19;USP7;PSMA2;USP48;CASP7;USP18;PARL;CASP8;PCSK7;PSMB5;USP9X;KLK2;ECEL1;USP8;USP29;PSMB9;PMPCB;USP16;IDE;PDIA3;RHBDF1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.39292701261459045,-1.1877834542185544,0.19786096256684493,0.8803493854399796,1.0,4/21,10.77%,CHRFAM7A;CHRNA7;GRM5;GRM1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.4544534744575808,1.1841110171433995,0.027,0.8269774010627279,1.0,103/597,14.65%,RUNX1;BATF3;NFE2;IRF5;AHRR;ASCL1;CIITA;MEOX1;IRF4;IRF8;MCM5;GATA1;NFE2L2;ORC3;POU2F2;BASP1;NFATC1;HES7;ELF4;DHX9;CREB3L4;CREB3;BARX2;RXRB;FOXD2;TNF;SNCA;SREBF2;RFX1;ATF3;CEBPA;FOXO3;DDIT3;SPI1;ZBTB12;MAFG;MAFK;HOXC8;BHLHE41;HDAC5;HMGB1;XRCC5;FLI1;TEAD1;TFEB;ZNF177;TP53;KLF6;TBL1XR1;NKX2-1;NRL;TAL1;USF1;YY1;CREB3L1;CEBPB;FOXN2;SNAI1;MEF2C;TFAP2B;GMEB2;SMAD3;IRF2;HSF1;ZNF32;HNRNPL;ARID4A;GMEB1;MCM6;HDAC4;MCM2;TGIF1;HOXA6;RNF10;NFIC;TBL1X;KLF13;CREB3L2;RBBP5;ELF2;SOX9;ORC4;JDP2;NR2C2;ZNF740;HSF5;ATF6B;CREB1;MCM9;KAT7;NR4A1;MAX;NFKB1;FOXK1;RFX7;SOX6;CUX1;CDC6;IRF1;SOX2;BRD7;SOX4;SREBF1
prerank,death domain binding (GO:0070513),0.6008459011322639,1.1811068509700233,0.2927536231884058,0.8327381257238258,1.0,5/11,16.29%,BCL2L1;CRADD;DAP;TRADD;IRGM
prerank,potassium:proton antiporter activity (GO:0015386),0.6068768608045666,1.1798174665522976,0.30914368650217705,0.8320732424513757,1.0,4/10,14.66%,SLC9A4;SLC9A9;SLC9A1;SLC9A8
prerank,sodium:proton antiporter activity (GO:0015385),0.5993041065924266,1.17844493996669,0.3022922636103152,0.8320565375077408,1.0,4/11,14.66%,SLC9A4;SLC9A9;SLC9A1;SLC9A8
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.4528920530905894,1.1774575027023682,0.13713713713713713,0.8307059118797832,1.0,45/181,17.26%,HCLS1;GATA1;NFE2L2;NFATC1;MAD2L2;DHX9;MAPK14;TACC1;NR1H4;SPI1;FIZ1;BHLHE41;HDAC5;TAF1;CTNNB1;MTA3;ACTB;TP53;SETD6;MEF2A;ACTN4;TAL1;MYOCD;LMO2;RB1;SMAD3;ARID1A;MDFIC;PPARGC1A;ANXA4;HDAC4;NRIP1;CREB1;SMARCD3;SMARCB1;RERE;PTPRT;BUD31;PIAS1;MTDH;RBPJ;HIF1A;FAF1;TRIP4;PPARD
prerank,kinase binding (GO:0019900),0.45545087233324316,1.17720883696048,0.054,0.8268008255514337,1.0,91/434,15.47%,PTPRC;CD226;IRF5;BLNK;FGR;CD3E;ITGB2;HCLS1;STAP1;LYST;NEFH;LAT;PLCG2;GPRC5B;PRKCD;PTPRJ;THY1;DUSP3;GRB2;PTPN1;RFFL;PFKL;MAP2K6;TRIM5;NEK6;CCND3;RGCC;TUBA4A;CIR1;TTN;SKI;TRAF2;DNAJC3;CEBPA;FOXO3;ADCY6;NBEAL2;CASP1;WWC2;CCND2;SHC2;MAP2K3;CTNNB1;BCL2L1;CEP192;ACTB;MAPRE1;TP53;USF1;WNK1;TAX1BP1;TICAM1;TRAP1;CHEK2;SNAI1;KIF14;DGKD;AP1B1;RB1;TRIM27;MAP3K1;SMAD3;HSF1;QARS1;IBTK;BCAR1;LIMS1;CLTC;BECN1;ADIPOR1;PARP16;PRDX3;NOD2;MAP3K12;TBL2;EXOC2;STUB1;MOB1B;CEP152;TRADD;CDC6;NISCH;KCNA5;LRBA;PPP1CC;VDAC1;PIH1D1;TBC1D14;SRC;BCAR3;STRADA
prerank,syntaxin binding (GO:0019905),0.4765300754665091,1.1768020336379599,0.2640918580375783,0.8233129640138143,1.0,15/61,14.53%,SYT17;ABCA1;VAMP3;VPS18;SYT2;STXBP3;CACNA1A;VPS11;SYT10;SNAP29;VPS54;RAB11A;SNAP23;STX8;LRRK2
prerank,gated channel activity (GO:0022836),0.57406815532327,1.1762658174928526,0.3115646258503401,0.820224253121422,1.0,3/14,10.20%,TMC6;PACC1;TMEM63A
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.3793722268048997,-1.1747839941034375,0.22815533980582525,0.9015077526790986,1.0,11/21,22.73%,REV3L;REV1;PRIMPOL;POLN;POLA1;POLE4;POLG;POLE2;POLQ;POLK;POLI
prerank,hydro-lyase activity (GO:0016836),0.4949416511889148,1.1727703715638962,0.2679162072767365,0.827469996364419,1.0,13/41,20.10%,TBXAS1;EHHADH;ENO3;IREB2;HACD4;ECHS1;ECI1;ACO1;CDYL;NAXD;CBS;ECHDC1;ENO1
prerank,glutathione transferase activity (GO:0004364),0.5288214744834726,1.1711169838160491,0.28128724672228844,0.8287224458976523,1.0,2/23,3.21%,GSTT4;HPGDS
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.3905404812657076,-1.1696703216291515,0.22277227722772278,0.8986276812609072,1.0,7/21,16.99%,PDE10A;PDE7A;PDE1C;PDE8A;PDE9A;PDE2A;PDE8B
prerank,amino acid binding (GO:0016597),-0.33445072243165236,-1.1694653314865704,0.18471337579617833,0.8787689957092302,1.0,9/31,20.08%,GRIN3A;GRM7;CASTOR2;GRIN2B;NOS3;GRIN1;GLRB;NOS1;ASS1
prerank,phosphatidic acid binding (GO:0070300),0.5324576066410543,1.1649234230970522,0.3193384223918575,0.8451226033171602,1.0,3/19,6.76%,PLEKHN1;SMPD3;MICALL1
prerank,vinculin binding (GO:0017166),-0.45268114612236543,-1.1596424391640463,0.2582781456953642,0.8911534820680376,1.0,4/11,9.70%,UTRN;DMD;SORBS3;SYNM
prerank,phospholipase C activity (GO:0004629),0.5215004620737728,1.1587611519463337,0.31528279181708785,0.8623170110969317,1.0,2/25,2.02%,PLCB2;PLCG2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.4021145206520202,-1.1585290402740716,0.2606837606837607,0.8750483058876906,1.0,3/16,5.23%,SLC26A2;CLCN6;SLC26A7
prerank,thioesterase binding (GO:0031996),0.5776151041078799,1.1566903197665956,0.32011331444759206,0.8645436710659864,1.0,5/11,17.93%,TRAF2;TRAF3;TRAF5;ARF6;CDC42
prerank,kinase activity (GO:0016301),0.4542608538807822,1.1560189549736468,0.21875,0.8620177819692503,1.0,21/109,13.18%,LYN;PIK3CG;DGKZ;PIK3CD;MTOR;PIK3CB;CHKB;CKB;DGKK;DGKE;TAF1;NADK;CERK;DGKG;DGKD;CSNK2A1;AGK;PAPSS1;POMK;DGKI;SHPK
prerank,fibroblast growth factor binding (GO:0017134),0.5268043945399193,1.1558118423243657,0.30855018587360594,0.8580449689990821,1.0,6/21,17.43%,ITGB3;RPS2;FGFBP3;THBS1;FIBP;SCN5A
prerank,voltage-gated ion channel activity (GO:0005244),0.5690469655189275,1.1557234014919173,0.3144736842105263,0.8535956960216403,1.0,6/14,20.98%,PKD2;VDAC3;VDAC2;VDAC1;HVCN1;HCN1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.5794644246015823,1.155566436533036,0.31268882175226587,0.8495002413001587,1.0,6/10,16.60%,CACNA1A;CACNB4;CACNB2;CACNB1;CACNA1B;CACNA1D
prerank,receptor ligand activity (GO:0048018),0.4522600287618735,1.154376006232146,0.124,0.8489733797210792,1.0,30/245,13.40%,TSHB;GPNMB;LGALS3;SHH;TGFB1;IL1A;METRNL;SLURP1;MDK;ANGPTL3;OSM;SEMA4D;TNF;IL18;TIMP1;NDP;HMGB1;VEGFB;EPO;PPY;NTF3;VGF;INHBA;SEMA4A;CHGB;ARTN;GRN;NRG1;TAFA1;GAS6
prerank,protein heterodimerization activity (GO:0046982),0.44738027631509886,1.1532906983572948,0.2002002002002002,0.8478791290296882,1.0,40/178,16.30%,NPAS4;CYBB;CD3E;IRAK2;MLXIPL;ABCG1;ATF3;HEXA;DDIT3;BHLHE41;FZD9;TAF1;BCL2L1;TP53;MEF2A;USF1;P4HB;MEF2C;DGKD;TFAP2B;PAFAH1B2;BAK1;ALG2;HSF1;TPM4;VAPB;METTL3;SDCBP;PPP2CA;IKBKG;KATNA1;NR4A1;ADCY8;ATP1B2;UBA2;MIGA1;SNX2;YWHAH;TOP2A;HIF1A
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.574258211870397,1.1532349753204603,0.32737276478679506,0.8435343905179744,1.0,6/12,22.80%,SLC9A4;SLC9A9;SLC9A1;SLC9A8;SLC9A7;LETM1
prerank,hormone receptor binding (GO:0051427),0.5550683314396893,1.1532263339121953,0.3241469816272966,0.8390488219449543,1.0,1/14,2.15%,TYK2
prerank,protein kinase inhibitor activity (GO:0004860),0.4844710163893488,1.149687884485349,0.30245535714285715,0.8463429370336331,1.0,8/42,10.57%,GMFG;TAOK3;SNCA;DNAJC3;YWHAB;QARS1;IBTK;DUSP19
prerank,ATPase regulator activity (GO:0060590),0.4846220798740848,1.1489837327948218,0.31200897867564537,0.8443141066161081,1.0,10/38,14.38%,BAG2;FNIP2;FNIP1;ATP5IF1;AHSA1;PFN1;ATP1B3;TOR1AIP2;ATP1B2;BAG1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4565327929377671,-1.1468706080224824,0.2949640287769784,0.8948086511510364,1.0,7/11,27.37%,TRPC1;ITPR3;RPH3A;TRPC4;TRPC7;TRPC3;CYTH2
prerank,double-stranded RNA binding (GO:0003725),0.46391680170672706,1.1450249975932167,0.29417879417879417,0.8535015821662632,1.0,20/70,17.89%,RFTN1;DHX9;TLR8;TLR7;LRRFIP1;RC3H2;EIF4A1;ADAR;RC3H1;AGO4;EIF4H;ACTN1;APTX;CLTC;AGO3;ADARB1;PRKRA;MTDH;TARBP2;AGO2
prerank,phosphatidylinositol binding (GO:0035091),0.44736141042459304,1.1407462835218494,0.2668711656441718,0.8632619261337284,1.0,23/91,18.20%,DENND1C;PLEKHN1;MYO1E;SNX5;THY1;SNX9;SNX24;PLEKHF2;DENND1A;ZFYVE9;SNX27;ITPR2;DENND1B;WDFY1;EPB41;EXOC8;FRMPD2;SNX2;SNX13;APPL2;WDFY3;SNX10;PICALM
prerank,cardiolipin binding (GO:1901612),0.5883575347394914,1.1402183824609267,0.33043478260869563,0.8606491366567237,1.0,1/10,1.51%,PLEKHN1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.48516602018415295,1.1397330649700899,0.30045871559633025,0.8578672333975862,1.0,16/37,22.57%,VARS1;FARSB;GARS1;RARS1;EPRS1;QARS1;LARS2;CARS2;DARS1;DARS2;TARS2;FARS2;TARS1;YARS1;SARS1;SARS2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.5447935756536259,1.1382919817371353,0.33975240715268223,0.8581343896543406,1.0,2/15,6.98%,PIK3R5;CCKBR
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.4391409493539626,1.1375246978694253,0.16216216216216217,0.8563842182000206,1.0,47/254,14.68%,RUNX1;IRF5;NPAS4;IRF4;GATA1;NFATC1;RREB1;ELF4;SP7;CREB3;BARX2;RXRB;FOXD2;NR1H4;MLXIP;MITF;ATF3;CEBPA;FOXO3;DDIT3;TP53;KLF6;MEF2A;NRL;YY1;CREB3L1;MEF2C;NKRF;CDC5L;TFAP2B;SMAD3;IRF2;CREBRF;GMEB1;LITAF;NFIC;SOX9;NR2C2;ATF6B;CREB1;SMARCD3;NR4A1;ZNF445;NFKB1;IRF1;SOX4;MEIS1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.47307212965965395,1.1374318110511217,0.3052294557097118,0.8523819651679834,1.0,10/51,15.59%,SLC16A10;SLCO2B1;SLC25A16;SLC7A8;SLC16A2;TMEM241;SLC20A2;SLC25A30;SLCO1B1;CLCN4
prerank,retinoic acid receptor binding (GO:0042974),0.5391236836125124,1.1371499617777254,0.32645161290322583,0.8489537151893838,1.0,4/17,11.82%,NSD1;TACC1;ACTN4;NRIP1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5631519396251856,1.1309879346025553,0.3441466854724965,0.8644349929377718,1.0,2/11,13.94%,SLC25A20;SLC25A45
prerank,carboxylic acid binding (GO:0031406),-0.29785792613791473,-1.1278574173466582,0.25984251968503935,0.9399628452658604,1.0,11/38,19.71%,GRIN3A;GRM7;UBR2;SESN3;CASTOR2;GRIN2B;NOS3;GRIN1;GLRB;HIF1AN;NOS1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.5502917104111241,1.1252742577688455,0.35254691689008044,0.878714172598332,1.0,4/14,19.37%,CAPN15;CAPN2;CAPN3;CAPNS1
prerank,calcium ion binding (GO:0005509),0.4366153790822208,1.1244299117061136,0.15515515515515516,0.877113111479631,1.0,51/323,13.37%,MMP12;SHH;SYT17;LCP1;PCDHB6;SMOC2;LPL;TPD52;CABP4;ADAM8;S100B;SDF4;SLC8A1;IDS;HPGDS;MASP1;MAN1C1;SNCA;PKD2;TTN;KCNIP2;MCTP1;RASGRP2;PGS1;ASPH;S100A2;ANXA1;AIF1;AGRN;SYT2;CETN3;RASGRP3;TPT1;ITSN1;ITPR2;PDCD6;SYT10;TPM4;CDH8;ANXA4;ACER3;NAALADL1;DYSF;CDH9;THBS1;CDH12;ARSA;CAMKK2;BRAF;CDH23;NDUFAB1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.4831663706161325,1.12301483753277,0.333716915995397,0.87735998450568,1.0,11/32,23.01%,SLC7A8;SLC38A6;SLC36A1;SLC43A2;SLC25A38;SLC36A4;SLC1A4;SLC43A1;SFXN2;SLC38A7;SLC6A6
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.5663131017608213,1.1221220207467546,0.35422740524781343,0.8758752034849141,1.0,1/11,1.72%,NEIL2
prerank,lysine-acetylated histone binding (GO:0070577),-0.3727759946222804,-1.1218969704794626,0.28502415458937197,0.9215947616032573,1.0,6/20,7.33%,SMARCA4;MLLT3;PSME4;BRD9;ATAD2B;BRD4
prerank,acetylation-dependent protein binding (GO:0140033),-0.3727759946222804,-1.1218969704794626,0.28502415458937197,0.9215947616032573,1.0,6/20,7.33%,SMARCA4;MLLT3;PSME4;BRD9;ATAD2B;BRD4
prerank,glycine binding (GO:0016594),-0.4428137432256495,-1.1216473959468625,0.3375,0.9041819515312838,1.0,4/11,17.41%,GRIN3A;GRIN2B;GRIN1;GLRB
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4070275307304678,-1.1186704659726412,0.28346456692913385,0.8960153462682096,1.0,4/14,16.37%,SLC26A2;SLC26A7;SLC25A14;SLC25A11
prerank,G protein-coupled receptor binding (GO:0001664),0.44497346687753625,1.1185373856010388,0.2769385699899295,0.8834654940867238,1.0,11/132,8.28%,GNA15;ARRB2;GPRC5B;GNAQ;GRK3;GNAZ;SAG;NDP;GNA13;GNA12;PPY
prerank,histone demethylase activity (GO:0032452),-0.33170289794493185,-1.1170169046353282,0.25,0.8841722564039207,1.0,10/27,18.26%,PHF2;KDM5C;JMJD1C;KDM3A;KDM4B;KDM4A;KDM2A;KDM4D;KDM6A;KDM8
prerank,ATP hydrolysis activity (GO:0140603),0.47262161713671813,1.1157988126160387,0.3506637168141593,0.888220414112921,1.0,14/41,17.98%,MYO1E;DHX9;ABCD1;KIF14;KIF20B;MYO19;ATP2B1;TOR3A;ABCA4;DNA2;TOR1A;ABCA3;HSP90AA1;ABCD2
prerank,alkali metal ion binding (GO:0031420),0.5525049423943675,1.1152810337990218,0.37898936170212766,0.8855869182291108,1.0,3/13,14.80%,KCNJ11;HDAC4;CAPN3
prerank,phosphatidate phosphatase activity (GO:0008195),0.5494189223793458,1.1143247678717243,0.3682795698924731,0.8845919093388183,1.0,2/13,8.67%,LPIN2;PLPPR1
prerank,voltage-gated sodium channel activity (GO:0005248),0.5066441225988844,1.1141129501529594,0.3561973525872443,0.8810639194195026,1.0,3/22,4.10%,SCN4B;HCN4;PKD2
prerank,ubiquitin protein ligase binding (GO:0031625),0.42829154560072674,1.1122915408963503,0.227,0.8826123896325174,1.0,57/254,17.04%,ARRB2;TUBB;PRKAR2B;RPL23;LAPTM5;RFFL;SNX9;NEK6;MAP1LC3B;SKI;TANK;TRAF2;CXCR4;TRAF3;CKB;HLTF;XRCC5;ATXN3;ERLIN2;TP53;CASC3;CHEK2;RB1;SMAD3;PPARGC1A;DERL1;ACTG1;VCL;TRAF5;USP7;GPR37;HDAC6;BECN1;RNF40;GPI;NLK;PRKACB;TNFRSF1B;SPOP;DET1;PRDX6;IKBKG;CASP8;STUB1;WFS1;BAG1;UBE2J2;SLF2;RTN4;HIF1A;RPL11;FAF1;FZD8;HSP90AA1;FANCL;CBS;UBE2N
prerank,alpha-tubulin binding (GO:0043014),0.47845705917785813,1.1116871349866244,0.34977064220183485,0.8804637608326947,1.0,16/31,24.43%,TBCEL;SNCA;DIP2B;ARL8A;SETD2;HDAC6;FYN;INO80;ARL8B;EML4;TAOK1;CDK5R1;TTLL7;DNAL1;ARL4C;FNTA
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.36908535526469444,-1.1112269293705308,0.2850678733031674,0.8853976039660213,1.0,6/18,9.87%,FAR1;AKR1B1;ALDH2;ALDH1A1;ALDH3A2;ALDH1A2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.4832796312323635,1.109022559222826,0.35573580533024335,0.8853405348618416,1.0,3/30,4.91%,SLC11A1;ATP7A;SLC25A37
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5645977006706921,1.1058364035035244,0.38142857142857145,0.8912836908490769,1.0,2/10,3.69%,SIRPA;PKP2
prerank,amino acid transmembrane transporter activity (GO:0015171),0.452842767121012,1.1038781558980766,0.34505494505494505,0.8936433045940444,1.0,10/47,13.28%,SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC16A2;SLC43A2;SLC36A4;SLC66A1;SLC38A10
prerank,nuclear receptor binding (GO:0016922),0.4281173613981052,1.1009172931213997,0.3394308943089431,0.8994827877707071,1.0,34/111,19.48%,BRD8;GAS2L1;MED17;GTF2H1;NSD1;TACC1;NR1H4;TAF1;PRKCB;CTNNB1;ACTN4;SMAD3;MMS19;ARID1A;PPARGC1A;STRN;STAT5B;PKN1;NRIP1;SMARCD3;NR4A1;BUD31;YWHAH;THRAP3;HIF1A;TMF1;GTF2B;TRIP4;KDM4C;RXRA;TAF11;MED4;DCAF1;MED13
prerank,vitamin D receptor binding (GO:0042809),0.5417280672451853,1.0975720739697439,0.38450899031811897,0.9062806612225168,1.0,7/14,22.17%,MED17;THRAP3;RXRA;TAF11;MED4;MED13;MED30
prerank,metalloexopeptidase activity (GO:0008235),-0.2689273162601789,-1.094892294693791,0.25301204819277107,0.9221526563937861,1.0,16/51,21.21%,AGBL4;LTA4H;MMP14;FOLH1;CPM;CPQ;ACE;MMP16;RNPEPL1;NPEPPS;CPXM2;CPD;CPXM1;ENPEP;MMP15;AGBL1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5767435134980884,1.0940362625288185,0.38603988603988604,0.9131649956564948,1.0,3/10,10.14%,NSD1;ASH1L;SETD2
prerank,calcium activated cation channel activity (GO:0005227),0.5084539820691458,1.0930835575970124,0.37890625,0.9120182561917267,1.0,3/17,10.20%,KCNN4;KCNMA1;TMEM63A
prerank,ionotropic glutamate receptor activity (GO:0004970),0.510858387768366,1.0907585271606808,0.3788659793814433,0.9152792580142931,1.0,1/17,0.31%,PTK2B
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.42746845772393444,-1.0892804171978003,0.3581081081081081,0.923343708531172,1.0,9/11,57.28%,CHRNA7;CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,ATPase binding (GO:0051117),0.43421198713917525,1.0830863558887582,0.3790238836967809,0.9364221798873121,1.0,24/71,18.67%,ABCA1;TCIRG1;PKD2;ALDOB;ATP6V1E1;FBL;ATP6V0A2;ATXN3;SVIP;ATP5IF1;DERL1;TMTC4;ATP6V0A1;ATP1B3;TOR1AIP2;ATP1B2;WFS1;PIH1D1;SRC;NUFIP1;ZNHIT6;ANK1;SNX10;PTPN3
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.32021256783999597,-1.0797269836666188,0.3176470588235294,0.93539012593879,1.0,7/27,16.37%,SLC26A2;SLC26A7;SLC25A14;SLC39A8;SLC22A6;SLC39A14;SLC25A11
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.4152799354747566,1.0790223273944322,0.298,0.945368611087866,1.0,60/269,17.43%,ARRB2;TUBB;PRKAR2B;RPL23;LAPTM5;RFFL;SNX9;NEK6;MAP1LC3B;SKI;TANK;TRAF2;CXCR4;TRAF3;CKB;HLTF;XRCC5;ATXN3;ERLIN2;TP53;CASC3;CHEK2;RB1;SMAD3;PPARGC1A;DERL1;ACTG1;VCL;TRAF5;USP7;GPR37;HDAC6;BECN1;RNF40;GPI;NLK;PRKACB;TNFRSF1B;SPOP;DET1;PRDX6;IKBKG;CASP8;ITCH;STUB1;WFS1;BAG1;UBE2J2;SLF2;RTN4;HIF1A;RPL11;FAF1;FZD8;HSP90AA1;FANCL;CBS;UBE2N;TRIP4;SCN5A
prerank,transmitter-gated ion channel activity (GO:0022824),-0.32416880440938356,-1.078617576319439,0.31210191082802546,0.9224754923433524,1.0,6/29,10.55%,GABRB2;GRIK4;GRIA2;GABRB1;GABRA2;GABRB3
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4293393118321159,1.0781710467868895,0.3941299790356394,0.9437090903953251,1.0,15/70,19.87%,HEXB;LFNG;GCNT1;HEXA;B4GALT1;CHSY3;POGLUT2;POGLUT1;B3GALNT1;CHSY1;LARGE1;MGAT4B;B4GALNT1;CHPF;GXYLT1
prerank,ribosomal small subunit binding (GO:0043024),0.5106003026030138,1.0761182171983208,0.3934640522875817,0.9462622404927082,1.0,7/17,18.92%,PIM1;ERAL1;EIF1;LARP1;EIF4H;CPEB2;MTIF3
prerank,NADPH binding (GO:0070402),-0.40782753511081177,-1.0758109911026406,0.3673469387755102,0.9153046347009417,1.0,10/13,34.82%,HMGCR;DUS2;MTRR;CBR4;DHFR;LBR;NDOR1;CRYZ;CBR3;GRHPR
prerank,potassium channel activity (GO:0005267),0.4276296491276878,1.0745693888716277,0.39387755102040817,0.9469887068102631,1.0,10/89,7.51%,KCNJ11;AQP1;HCN4;KCNN4;KCNK6;PKD2;CCDC51;TMEM38A;KCNMA1;KCNK13
prerank,ATP binding (GO:0005524),0.414125943125586,1.0733541937506068,0.3133133133133133,0.9468639219453486,1.0,57/266,17.64%,MYO1F;BTK;KCNJ11;MAP4K1;ABCA1;ABCC6;TGFBR1;P2RX7;MTHFS;DHX9;PFKL;ERN1;NEK6;ATP7A;ABCG1;PI4K2A;MYH9;P2RX4;TLK1;MYO9B;MKNK1;CDK11B;MAP3K5;PIM1;LONP1;ABCD1;WNK1;KIF14;TRIP13;MCM6;STK17B;EIF2B2;TAP1;CARS2;RPS6KA4;NLK;PRKACB;TWF2;CDK6;ATP5F1A;STK3;UBA2;MYH10;DARS2;NIM1K;WNK4;PTPA;ERCC6;IDE;TAP2;HSP90AA1;STK4;GCK;RPS6KA5;KSR1;SIK2;N4BP2
prerank,hexosyltransferase activity (GO:0016758),0.4178251677957986,1.0723218522261586,0.3981762917933131,0.945975353737496,1.0,17/101,12.61%,HEXB;PIGM;LFNG;GCNT1;HEXA;GYG1;B4GALT1;CHSY3;PIGV;POGLUT2;GBE1;POGLUT1;FUT9;B3GALNT1;TMTC4;CHSY1;B4GALT7
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.4110723516648766,1.0717199351447204,0.193,0.943756803539047,1.0,118/731,13.88%,RUNX1;BATF3;NFE2;IRF5;NPAS4;ASCL1;MEOX1;IRF4;IRF8;IKZF1;GATA1;STAT5A;NFE2L2;POU2F2;NLRC5;NFATC1;HES7;RREB1;BCL11A;NSD1;MLXIPL;ELF4;DHX9;ZEB2;SP7;CREB3L4;CREB3;RXRB;FOXD2;NR1H4;DNMT3A;SREBF2;RFX1;MLXIP;BPTF;MITF;ZFP30;SKI;ATF3;CEBPA;FOXO3;LRRFIP1;DDIT3;SPI1;MYT1L;ZBTB12;PGBD1;ZBTB39;HIVEP3;MAFG;MAFK;BHLHE41;HDAC5;BACH1;TEAD1;TFEB;CCAR1;TP53;KLF6;MEF2A;NKX2-1;NRL;TAL1;USF1;YY1;CREB3L1;STAT4;CEBPB;ST18;SNAI1;MEF2C;NKRF;TFAP2B;GMEB2;CIART;SMAD3;ZFP14;GTF2IRD1;IRF2;HSF1;ZNF32;GMEB1;STAT5B;HDAC4;NFE2L1;LITAF;ZNF83;TGIF1;HOXA6;NFIC;KLF13;CREB3L2;TRIM24;ZSCAN26;OLIG1;SOX9;HDAC6;JDP2;NR2C2;ZNF740;NRIP1;E2F6;ZNF628;GZF1;HSF5;ATF6B;SNAPC3;CREB1;ZSCAN18;NR4A1;MAX;ZNF445;NFKB1;FOXK1;RFX7;SOX6;ZFHX3;IRF1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4103132350465449,1.0698239628495305,0.198,0.9456249736164003,1.0,117/732,13.88%,RUNX1;BATF3;NFE2;IRF5;NPAS4;ASCL1;MEOX1;IRF4;IRF8;IKZF1;GATA1;STAT5A;NFE2L2;POU2F2;NLRC5;NFATC1;HES7;RREB1;BCL11A;NSD1;MLXIPL;ELF4;DHX9;ZEB2;SP7;CREB3L4;CREB3;RXRB;FOXD2;NR1H4;DNMT3A;SREBF2;RFX1;MLXIP;BPTF;MITF;ZFP30;SKI;ATF3;CEBPA;FOXO3;LRRFIP1;DDIT3;SPI1;MYT1L;ZBTB12;PGBD1;ZBTB39;HIVEP3;MAFG;MAFK;BHLHE41;HDAC5;BACH1;TEAD1;TFEB;CCAR1;TP53;KLF6;MEF2A;NKX2-1;NRL;TAL1;USF1;YY1;STAT4;CEBPB;FOXN2;ST18;SNAI1;MEF2C;NKRF;TFAP2B;GMEB2;CIART;SMAD3;ZFP14;GTF2IRD1;IRF2;HSF1;ZNF32;GMEB1;STAT5B;HDAC4;NFE2L1;LITAF;ZNF83;TGIF1;HOXA6;NFIC;KLF13;ZSCAN26;OLIG1;SOX9;HDAC6;JDP2;NR2C2;ZNF740;NRIP1;E2F6;ZNF628;GZF1;HSF5;ATF6B;SNAPC3;CREB1;ZSCAN18;NR4A1;ZNF445;TIPARP;FOXN3;NFKB1;FOXK1;RFX7;SOX6;ZFHX3;IRF1
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.4048964218455744,-1.0694349066731152,0.34057971014492755,0.9206920411527252,1.0,12/12,59.55%,OPN3;GPR88;ELOVL4;GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,monocarboxylic acid binding (GO:0033293),0.49843170404709913,1.0678339931017555,0.4047919293820933,0.9477227201463134,1.0,2/18,3.77%,PSAP;NR1H4
prerank,semaphorin receptor binding (GO:0030215),-0.3396241584607468,-1.0652720177425865,0.36,0.9194063195906047,1.0,6/23,8.55%,SEMA6A;SEMA5A;SEMA3A;SEMA6D;SEMA3C;SEMA3D
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.3306333970593434,-1.0642774692108838,0.31693989071038253,0.9073222142965912,1.0,8/26,14.69%,ABCG2;SLC16A12;SLC16A9;SLC16A11;SLC5A6;SLC16A4;SLC6A11;SLC27A1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.39139181697634146,-1.0632422187181405,0.345679012345679,0.896016104678374,1.0,4/15,9.48%,SLC25A12;SLC17A6;SLC25A13;SLC1A5
prerank,ion channel inhibitor activity (GO:0008200),0.460339439992949,1.061252220064461,0.42081949058693247,0.9649437291396546,1.0,7/35,15.93%,PCSK9;WNK1;ENSA;NEDD4L;STX8;WNK4;RASA1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5159555953434252,1.0608261579703724,0.41216216216216217,0.9621643891652738,1.0,5/14,14.17%,MINDY4;ATXN3;USP7;MINDY1;USP9X
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.41257420990274896,-1.060417139187544,0.41025641025641024,0.8902071094244657,1.0,5/12,5.20%,BMPR1A;LTBP4;ACVR1;TGFBR3;ACVRL1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.40250077778603854,-1.0590047089406092,0.3944223107569721,0.8810220323632895,1.0,3/14,6.22%,SLC25A12;SLC17A6;SLC25A13
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.41914231409557645,-1.058167133168003,0.39325842696629215,0.8702518771966,1.0,6/11,43.04%,SLC5A3;SLC5A11;SLC2A9;SLC23A1;SLC23A2;SLC2A10
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3690092385402727,-1.0555427079022868,0.35648148148148145,0.864753781165902,1.0,6/18,8.94%,BMPR1A;LTBP4;ACVR1;TGFBR3;ACVRL1;ACVR1B
prerank,protein serine/threonine kinase activity (GO:0004674),0.4059907400537624,1.0546390657103546,0.35535535535535534,0.9779299157423402,1.0,71/335,16.10%,PTK2B;SYK;MAPKAPK3;IRAK2;MAP4K1;TAOK3;TGFBR1;PRKCD;CAMK1D;MTOR;BMP2K;MAPK14;GRK3;ERN1;NEK6;CDK14;PRKD2;TTN;MYLK3;CDK8;RPS6KC1;MAP3K14;TLK1;TAF1;PRKCB;MKNK1;CDK11B;STK10;TGFBR2;MAP3K5;PIM1;PLK4;WNK1;PIM2;SRPK3;TNIK;PLK2;ATP23;CSNK1G2;CHEK2;PRKCQ;CSNK2A2;CSNK2A1;MAP3K1;CASK;SMG1;PRKCH;CDK7;STK17B;STK32C;FAM20C;PKN1;RPS6KA4;NLK;CSNK1A1;ALPK1;MAP3K12;CDK6;BRAF;STK3;STK24;LRRK2;NIM1K;WNK4;GAK;TESK2;SGK3;GSK3A;RPS6KA2;CDK15;MAP3K11
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.30223077015053545,-1.0542059022002293,0.36619718309859156,0.8560194040187505,1.0,6/29,9.48%,SLC25A12;SLC26A2;SLC26A7;SLC25A13;SLC25A14;SLC1A5
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5472489852317747,1.0529531630009554,0.4358600583090379,0.9789253654191692,1.0,4/10,12.90%,CASP1;CFLAR;CASP7;CASP8
prerank,ribosome binding (GO:0043022),0.4419594973401527,1.0526168445756978,0.44,0.9759136077574561,1.0,19/46,25.36%,SLFN14;YTHDF3;TMEM147;CPEB3;NOMO1;SRP19;CPEB4;CCDC47;CPEB2;MTIF3;SERBP1;PYM1;NAA15;EIF3C;EFL1;RACK1;EIF2A;EIF2S1;C1QBP
prerank,exonuclease activity (GO:0004527),-0.2737507206121704,-1.0508544376223303,0.38271604938271603,0.8531014325490675,1.0,20/46,24.02%,REV3L;FAN1;MRE11;ENPP3;ERI1;EXOSC7;APLF;WRN;ISG20L2;EXD2;EXOSC8;APEX2;ZC3H12A;EXOG;EXOSC9;POLG;ENPP2;DCLRE1B;EXD1;EXOSC5
prerank,LRR domain binding (GO:0030275),0.49468682081029874,1.050081542833403,0.41983695652173914,0.9797165051519935,1.0,5/14,18.09%,DDIT3;MRTFA;NRL;PMF1;LRRFIP2
prerank,microtubule minus-end binding (GO:0051011),0.5226314681998296,1.0498841334001336,0.43091655266757867,0.9760919870645794,1.0,4/13,15.94%,MACF1;TUBGCP6;TUBGCP4;CAMSAP2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.5175114977133036,1.048166555445603,0.44972826086956524,0.9773361150061719,1.0,4/13,14.03%,EXO1;ENDOV;DNA2;SLX4
prerank,calcium-activated potassium channel activity (GO:0015269),0.5215766938974695,1.048046967843139,0.44613259668508287,0.9735719012410113,1.0,2/11,7.14%,KCNN4;KCNMA1
prerank,potassium ion antiporter activity (GO:0022821),0.49187954756971397,1.0476184778210698,0.43774574049803405,0.9708300021119066,1.0,3/15,7.37%,SLC9A4;SLC9A9;SLC9A1
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.39200799691614757,-1.0467629532210256,0.3739495798319328,0.8513671331593766,1.0,4/13,8.95%,GDI2;GDI1;GPSM2;GPSM1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.4012529519986543,1.0466401549816864,0.29,0.9698770953362086,1.0,130/831,13.88%,RUNX1;BATF3;NFE2;IRF5;NPAS4;ASCL1;MEOX1;IRF4;IRF8;IKZF1;GATA1;STAT5A;NFE2L2;POU2F2;NLRC5;NFATC1;HES7;RREB1;BCL11A;NSD1;MLXIPL;ELF4;DHX9;ZEB2;SP7;CREB3L4;CREB3;BARX2;RXRB;FOXD2;NR1H4;DNMT3A;SREBF2;RFX1;MLXIP;BPTF;MITF;ZFP30;SKI;NFXL1;ATF3;CEBPA;FOXO3;LRRFIP1;DDIT3;SPI1;MYT1L;ZBTB12;PGBD1;ZBTB39;HIVEP3;MAFG;MAFK;HOXC8;BHLHE41;HDAC5;TAF1;BACH1;TEAD1;TRPS1;TFEB;ZFP69;CCAR1;ZNF177;TP53;KLF6;MEF2A;ACTN4;NKX2-1;NRL;TAL1;USF1;YY1;STAT4;ZFP90;CEBPB;ST18;SNAI1;MEF2C;NKRF;CDC5L;TFAP2B;RB1;GMEB2;CIART;SMAD3;ZFP14;GTF2IRD1;IRF2;HSF1;ZNF32;CREBRF;GMEB1;STAT5B;HDAC4;NFX1;NFE2L1;LITAF;ZNF83;TGIF1;HOXA6;NFIC;KLF13;ZSCAN26;OLIG1;SOX9;HDAC6;JDP2;NR2C2;ETV6;ZNF740;NRIP1;E2F6;ZNF628;GZF1;HSF5;ATF6B;SNAPC3;CREB1;ZSCAN18;NR4A1;MAX;ZNF445;NFKB1;FOXK1;RFX7;SOX6;CUX1;ZFHX3;IRF1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.3900102789504729,-1.0447615890194926,0.36259541984732824,0.84506252073517,1.0,3/13,6.30%,CDH5;BMP4;BMP5
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5349446161580163,1.0433427975261083,0.44287729196050774,0.9757366896464876,1.0,3/10,6.99%,TNFAIP3;ATXN3;STAMBPL1
prerank,protein phosphatase regulator activity (GO:0019888),0.42804009492410416,1.0419718814508674,0.45851063829787236,0.9757533907070578,1.0,15/53,22.17%,LGALS3;MGAT5;PPP6R1;SAG;ENSA;BOD1L1;RCAN1;PPP4R4;PTPA;PPP2R5C;PPP4R2;ANKLE2;PPP2R3A;PPP4R1;RCAN3
prerank,GTPase binding (GO:0051020),0.4050966605871337,1.0391944226407512,0.417,0.9801612969970531,1.0,67/195,23.62%,FGD2;LCP1;UNC13D;IQGAP2;ABCA1;CYRIB;RIN3;RAB34;MYO5A;PPP6R1;RAB3GAP2;FGD6;USP6NL;MYO9B;MICALL1;DOCK4;ARHGAP1;CHML;EPRS1;ARHGDIB;PKN1;ATP6AP1;CYFIP1;BECN1;BICD2;EXOC8;RANBP9;SORL1;EXOC2;EXOC5;BRAF;FNBP1L;GGA2;LRRK2;TMEM127;RNF152;RASA1;ALS2;RABGEF1;NOX1;HSP90AA1;ARFIP2;ARHGEF2;IQGAP1;LAMTOR1;MYO1C;PICALM;ATG14;RAB29;DNM1L;OPTN;ENO1;KIF3A;FMNL1;LZTR1;AIMP1;RIMS1;RRAGB;FLNA;RAPGEF6;TNFAIP1;CCDC186;MYO5B;GOLGA4;OCRL;MYCBP2;FGD3
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.41186799055681844,-1.0389941254713873,0.4041095890410959,0.8493716043346967,1.0,3/11,4.60%,RYR2;RYR3;ITPR3
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4270859844858187,1.0389625903717634,0.44504896626768226,0.9767681968582375,1.0,5/46,4.73%,HEXB;MGAT5;LFNG;GCNT1;HEXA
prerank,nuclear localization sequence binding (GO:0008139),-0.3571820604409185,-1.0389308510172517,0.3474178403755869,0.837889534174553,1.0,9/18,31.83%,IPO5;NUP153;RANBP6;NFKBIA;CABP1;TNPO2;KPNA2;POM121;KPNA6
prerank,heme binding (GO:0020037),0.42451566442802324,1.0374320040597829,0.4495217853347503,0.9774933285982309,1.0,13/65,20.70%,TBXAS1;CYBB;BACH1;CYB5A;CYB561D2;PXDN;SRC;CBS;SDHD;PTGES2;PGRMC1;THAP4;HMOX2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5139382959754764,1.0363253485174306,0.4553191489361702,0.9729177359949664,1.0,3/11,14.38%,BAG2;PFN1;BAG1
prerank,adenyl nucleotide binding (GO:0030554),0.5139382959754764,1.0363253485174306,0.4553191489361702,0.9729177359949664,1.0,3/11,14.38%,BAG2;PFN1;BAG1
prerank,estrogen receptor binding (GO:0030331),0.442036945040128,1.0356383710527381,0.4469078179696616,0.9710638059952388,1.0,10/32,22.43%,NSD1;TACC1;CTNNB1;MMS19;STRN;NRIP1;TRIP4;DCAF1;PADI2;CNOT1
prerank,endopeptidase activator activity (GO:0061133),0.5392732901105868,1.0348087242577535,0.4620991253644315,0.9695276505879729,1.0,2/10,12.47%,VSIR;PSME3
prerank,small GTPase binding (GO:0031267),0.40291573244971873,1.0339806414714294,0.435,0.9680344194492381,1.0,56/170,23.62%,FGD2;UNC13D;IQGAP2;ABCA1;CYRIB;RIN3;RAB34;MYO5A;PPP6R1;RAB3GAP2;FGD6;USP6NL;MYO9B;MICALL1;DOCK4;ARHGAP1;CHML;ARHGDIB;PKN1;ATP6AP1;CYFIP1;BICD2;EXOC8;RANBP9;SORL1;EXOC2;EXOC5;BRAF;GGA2;LRRK2;TMEM127;RNF152;ALS2;RABGEF1;NOX1;ARFIP2;ARHGEF2;IQGAP1;MYO1C;PICALM;RAB29;DNM1L;OPTN;KIF3A;FMNL1;LZTR1;RIMS1;FLNA;RAPGEF6;TNFAIP1;CCDC186;MYO5B;GOLGA4;OCRL;MYCBP2;FGD3
prerank,GTPase inhibitor activity (GO:0005095),0.5009834896705625,1.0333556861828381,0.4349593495934959,0.9660779745683238,1.0,4/13,17.31%,IQGAP2;GPS2;CPEB2;IQGAP1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.397117726264836,1.032982793856592,0.4,0.9632814426671894,1.0,91/431,17.98%,MYO1F;TUBB;TUBB1;BTK;KCNJ11;MAP4K1;ABCA1;ABCC6;RAB39A;TGFBR1;P2RX7;RAB32;MTHFS;DHX9;PFKL;RAP2A;ERN1;NEK6;TUBB3;GCH1;ATP7A;ABCG1;TUBA4A;PI4K2A;RAB14;MYH9;RAP1B;RAB7A;P2RX4;TLK1;ARL8A;MYO9B;MKNK1;CDK11B;DNM2;MAP3K5;PIM1;LONP1;ABCD1;WNK1;RAP2B;KIF14;RAB28;TRIP13;RAB31;ARL5B;ARL4A;MCM6;STK17B;RAB1B;EIF2B2;TAP1;CARS2;RPS6KA4;NLK;ATL1;GBP3;PRKACB;TWF2;CDK6;ATP5F1A;RRAS2;STK3;ARF6;UBA2;TSR1;MYH10;LRRK2;RAP1A;DARS2;NIM1K;WNK4;TUBB6;PTPA;ERCC6;IDE;ARL8B;TAP2;RAB27B;HSP90AA1;STK4;GCK;ARFIP2;RPS6KA5;KSR1;SIK2;N4BP2;RHOA;MTG2;CDC42;ABCD2
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.49718817716926544,1.030978627014551,0.4733969986357435,0.9654703147254086,1.0,1/15,1.63%,SH3PXD2B
prerank,GTPase activity (GO:0003924),0.3988166531702144,1.0303293430946854,0.4457831325301205,0.9637276432018489,1.0,51/192,19.75%,GNA15;RAB8B;RAB32;GNAQ;GNGT2;GFM1;RAP2A;GCH1;GNAZ;RAB14;RAP1B;RAB7A;ARL8A;DNM2;GNA13;GTPBP1;GNA12;GSPT1;TBCC;RAP2B;RAB28;GPN1;RAB31;RAB11A;ARHGDIB;RAB1B;ATL1;GBP3;ABCA4;SAR1A;RRAS2;MMUT;RAB33B;GNAI3;TSR1;LRRK2;RAP1A;GNB5;IRGM;ARL8B;RAB27B;RHOA;MTG2;CDC42;GNAI2;ATL2;RAB29;DNM1L;RHOD;ATL3;MFN1
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4660140528471841,1.0296272404243723,0.4441747572815534,0.9580809122287869,1.0,6/21,15.87%,CDK14;CDK8;CDK11B;CDK7;CDK6;CDK15
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4660140528471841,1.0296272404243723,0.4441747572815534,0.9580809122287869,1.0,6/21,15.87%,CDK14;CDK8;CDK11B;CDK7;CDK6;CDK15
prerank,mechanosensitive ion channel activity (GO:0008381),0.5099585950773533,1.0291709018603397,0.47183098591549294,0.9557714939625168,1.0,2/12,10.20%,TMC6;TMEM63A
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4794352594159449,1.0290810356339914,0.44502617801047123,0.9523412236921811,1.0,3/17,6.00%,ABCA1;ABCG1;ABCB4
prerank,metallocarboxypeptidase activity (GO:0004181),-0.30487380975662637,-1.0284644607347744,0.3674698795180723,0.8543836091503417,1.0,10/26,26.59%,AGBL4;FOLH1;CPM;CPXM2;CPD;CPXM1;AGBL1;CPA6;ACE2;CPE
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.43018476713542697,1.027177770904675,0.45855758880516684,0.9543558131836953,1.0,16/44,23.08%,SMYD5;NSD1;CXXC1;ASH1L;DOT1L;SETD2;RBBP5;TTLL12;SMYD3;SUV39H1;SETD1B;WDR82;EED;SETD5;NSD3;SETDB1
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3291915994765637,-1.026513274939071,0.3723404255319149,0.8480934405163593,1.0,7/23,16.99%,PDE10A;PDE7A;PDE1C;PDE8A;PDE9A;PDE2A;PDE8B
prerank,nucleotide diphosphatase activity (GO:0004551),0.488653028391948,1.0257789403968156,0.45529573590096284,0.9546927085585842,1.0,2/14,6.79%,NUDT17;NUDT4
prerank,BMP receptor binding (GO:0070700),-0.39001421985316886,-1.0253120744566324,0.3857677902621723,0.8401217345967287,1.0,3/12,6.30%,CDH5;BMP4;BMP5
prerank,double-stranded DNA binding (GO:0003690),0.3946817188084408,1.024476966945163,0.425,0.9545701426406936,1.0,69/531,13.64%,BATF3;NFE2;IRF5;ASCL1;MEOX1;IRF4;IRF8;GATA1;PCID2;AIM2;POU2F2;NFATC1;HES7;ELF4;DHX9;CREB3L4;CREB3;BARX2;RXRB;FOXD2;SREBF2;RFX1;ATF3;FOXO3;ZBTB12;MAFG;HOXC8;BHLHE41;HMGB1;XRCC5;FLI1;TEAD1;TFEB;ZNF177;KLF6;NRL;USF1;YY1;CREB3L1;CEBPB;FOXN2;SNAI1;MEF2C;TFAP2B;GMEB2;IRF2;HSF1;ZNF32;GMEB1;TGIF1;HOXA6;NFIC;KLF13;APTX;ELF2;SOX9;JDP2;NR2C2;ZNF740;HSF5;ATF6B;MBD1;CREB1;NR4A1;MAX;ZNF445;FOXK1;RFX7;CUX1
prerank,protein homodimerization activity (GO:0042803),0.3945090020818057,1.0230767354883077,0.419,0.9552349368840577,1.0,125/589,17.17%,LILRB1;SLC11A1;PLEK;IRAK2;LPL;TPD52;CORO1A;PEX11A;CSF1R;RPE;DUSP29;RABEP1;MLXIPL;S100B;HPGDS;MASP1;SNX9;CST7;PSAP;ERN1;TRIM5;ATG7;GCH1;PKD2;ABCG1;APOE;CRYM;IL6R;ATF3;PIP4K2A;CEBPA;ATIC;PYCARD;LRRFIP1;DDIT3;GYG1;COQ9;MUC13;NDP;MYH9;XDH;BHLHE41;TBC1D22A;SYNE1;FZD9;MYO9B;CDA;BCL2L1;TYROBP;STK10;ACTN4;USF1;MAP3K5;TMEM192;KLHL7;ABCD1;PON3;DPY30;CEBPB;KYNU;CHEK2;DGKD;TFAP2B;KIF20B;TRIM27;ATP5IF1;SMAD3;PAFAH1B2;BAK1;PDCD6;SPPL3;TPM4;EPRS1;VAPB;F11R;TPR;ACTN1;NAALADL1;TRIM8;TAP1;SLC8B1;ZDHHC3;PAPSS1;MID2;PTPRO;RNF40;GBP3;PEX7;TPST1;DEFA6;MAP3K12;IKBKG;B2M;MMUT;ADCY8;STUB1;SOX6;CUBN;PTPRT;MIGA1;CADM1;LRRK2;SNX2;DARS2;PRKRA;SPPL2A;ERCC5;PTPA;PSMD7;PDCD6IP;TOP2A;IDE;MAP3K11;ALS2;ZBTB7B;DCK;TARS2;APPL2;HSP90AA1;STK4;CBS;TARBP2;GALM;CPOX;PECAM1
prerank,calcium channel regulator activity (GO:0005246),-0.2912673665690015,-1.0221520731227929,0.38461538461538464,0.8380521947376425,1.0,10/37,27.17%,SRI;FKBP1A;PRKG1;SLC30A1;CACNG8;REM1;PACSIN3;CALM2;CACNB3;NRXN2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.508059795838331,1.0196476116030606,0.4747612551159618,0.9614401235074265,1.0,4/12,13.41%,PYCARD;CASP1;APAF1;ATP2A3
prerank,death receptor activity (GO:0005035),0.515808140042166,1.0191533641739683,0.4563662374821173,0.9591290034395087,1.0,3/11,19.33%,TNFRSF11A;TNFRSF1B;EDA2R
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.45056121195758875,1.0187755349775287,0.46941176470588236,0.9565151215505675,1.0,6/27,14.66%,SLC9A4;SLC8A1;SLC9A9;SLC9A1;SLC8B1;SLC9A8
prerank,sequence-specific DNA binding (GO:0043565),0.39096314568617946,1.0180855662725472,0.417,0.954799527785016,1.0,81/590,13.64%,BATF3;NFE2;IRF5;MMP12;ASCL1;MEOX1;IRF4;IRF8;GATA1;NFE2L2;POU2F2;NFATC1;HES7;ELF4;ZEB2;CREB3L4;CREB3;BARX2;RXRB;FOXD2;NR1H4;SREBF2;TET3;RFX1;BPTF;ATF3;FOXO3;CXXC1;ZBTB12;MAFG;MAFK;HOXC8;BHLHE41;XRCC5;TAF1;FLI1;TEAD1;TFEB;ZNF177;KLF6;MEF2A;NRL;USF1;LONP1;YY1;CREB3L1;CEBPB;FOXN2;SNAI1;MEF2C;TFAP2B;GMEB2;SMAD3;IRF2;HSF1;PPARGC1A;ZNF32;SMG1;GMEB1;HDAC4;TGIF1;HOXA6;NFIC;KLF13;ELF2;SOX9;JDP2;NR2C2;STN1;ZNF740;GZF1;HSF5;ATF6B;MBD1;CREB1;NR4A1;MAX;FOXK1;SAFB2;RFX7;CUX1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.49616641187480903,1.0146494908749968,0.4812332439678284,0.9610770120776189,1.0,4/14,13.41%,PYCARD;CASP1;APAF1;ATP2A3
prerank,outward rectifier potassium channel activity (GO:0015271),0.5172802680656996,1.0113676402133696,0.49572649572649574,0.9666702904296658,1.0,4/11,14.28%,PKD2;KCNIP2;KCNT1;KCNA5
prerank,ubiquitin binding (GO:0043130),0.40492311851097346,1.0108138770985298,0.48380355276907,0.9646593998908992,1.0,21/73,20.78%,OTULINL;NUP62;RNF19B;CXCR4;TNFAIP3;DDI2;SMAD3;IKBKG;MVB12B;TOP2A;USP16;FAF1;VPS28;UBE2N;BIRC2;UBXN2A;PLAA;HSPB1;RAD23B;NSFL1C;PRKN
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4510920995384078,1.0098930708749192,0.47325581395348837,0.9636383865891716,1.0,6/28,9.92%,TNF;TRAF2;TRAF3;TRAP1;BABAM2;TRAF5
prerank,ubiquitin protein ligase activity (GO:0061630),0.39314718390672776,1.007407913174617,0.4854854854854855,0.9672630185794295,1.0,55/228,18.32%,CBL;RNF180;MYLIP;TRIM25;RFFL;RNF149;ZNRF2;RNF19B;TRIM5;MKRN1;UBE2D3;FBXL22;MSL2;VPS18;MGRN1;RNF7;HLTF;PPP1R11;RNF111;HECTD1;RNF150;RC3H2;VPS11;TRIM27;RNF114;RC3H1;RING1;UBE4B;NFX1;NEDD4L;RNF10;TRIM56;TRIM24;TRIM35;RNF216;RNF135;ITCH;STUB1;RNF144B;HUWE1;AREL1;NEURL1B;NEURL3;DTX4;ZNRF1;RNF152;SMURF1;FANCL;TRIM62;ZNRF3;ANAPC11;UBE2K;CDC42;BIRC2;FBXO44
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.4014297816973616,-1.0073664393745723,0.43309859154929575,0.8664714783123709,1.0,4/11,16.42%,DAB2IP;TRAF6;ROR2;PPEF2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.38915105319911575,1.0062014099289707,0.508,0.966948132423585,1.0,67/248,20.02%,GNA15;RAB8B;MYO1E;RAB32;GNAQ;DHX9;GNGT2;GFM1;RAP2A;GCH1;GNAZ;RAB14;MYH9;RAP1B;RAB7A;ARL8A;DNM2;GNA13;GTPBP1;GNA12;GSPT1;TBCC;ABCD1;RAP2B;KIF14;RAB28;GPN1;KIF20B;MYO19;ATP2B1;RAB31;TOR3A;RAB11A;ARHGDIB;RAB1B;ATL1;GBP3;ABCA4;SAR1A;RRAS2;MMUT;DNA2;TOR1A;RAB33B;GNAI3;TSR1;KIF2A;LRRK2;RAP1A;ABCA3;GNB5;IRGM;ARL8B;RAB27B;HSP90AA1;RHOA;MTG2;CDC42;ABCD2;GNAI2;ATL2;RAB29;DNM1L;RHOD;ATL3;MFN1;MYL6
prerank,cAMP binding (GO:0030552),-0.4047635713410288,-1.0037822195044284,0.4440677966101695,0.8652372665710926,1.0,4/11,16.49%,PDE10A;RAPGEF4;RAPGEF2;PDE2A
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.39147333681073193,-1.00316626995149,0.4416058394160584,0.85622310072052,1.0,6/12,16.80%,PHF2;JMJD1C;KDM3A;KDM4B;KDM4A;KDM4D
prerank,palmitoyltransferase activity (GO:0016409),0.43871248603137547,1.0030243879700809,0.48417350527549824,0.9722838136388549,1.0,8/28,14.36%,ZDHHC14;ZDHHC7;ZDHHC13;ZDHHC16;ZDHHC3;YKT6;ZDHHC1;ZDHHC24
prerank,adenylyltransferase activity (GO:0070566),-0.3091610487059775,-0.9994439107437103,0.4174757281553398,0.8561121010728692,1.0,8/21,17.43%,ABL1;PAPOLA;SELENOO;PAPOLG;NMNAT1;GPHN;TUT1;KARS1
prerank,symporter activity (GO:0015293),-0.39705168821737685,-0.9983121542434148,0.4852459016393443,0.8484441056992019,1.0,9/10,57.31%,SLC5A6;MFSD2A;SLC4A4;SLC46A2;SLC28A2;SLC28A3;SLC5A8;SLC28A1;SLC5A12
prerank,single-stranded RNA binding (GO:0003727),0.4176566046545626,0.9969586018279102,0.5060773480662983,0.9848886747442549,1.0,19/43,25.80%,DHX9;TLR8;TLR7;LONP1;ENDOV;AGO4;EIF4H;SRA1;AGO3;AGO2;CNBP;HNRNPF;PTBP1;DDX60;ILF3;ZFR;DDX11;AGO1;JMJD6
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.3761970141354908,-0.9931310240184946,0.46258503401360546,0.8520964624058744,1.0,5/12,22.66%,IRS1;GNAS;SHC1;SOCS2;IGF2
prerank,death receptor binding (GO:0005123),-0.3575842208290903,-0.9929606100815643,0.4470046082949309,0.8423517598526213,1.0,4/15,9.81%,EDA;DAB2IP;NGF;TMBIM1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3871721143494189,0.9909324802119432,0.5195195195195195,0.9977410025093911,1.0,63/232,21.33%,CBL;RNF180;MYLIP;TRIM25;RFFL;RNF149;ZNRF2;RNF19B;TRIM5;MKRN1;UBE2D3;FBXL22;MSL2;VPS18;MGRN1;RNF7;HLTF;PPP1R11;RNF111;HECTD1;RNF150;RC3H2;VPS11;TRIM27;RNF114;RC3H1;RING1;NFX1;NEDD4L;RNF10;TRIM56;TRIM24;TRIM35;RNF216;RNF135;ITCH;STUB1;RNF144B;HUWE1;AREL1;NEURL1B;NEURL3;DTX4;ZNRF1;RNF152;PIAS1;SMURF1;FANCL;TRIM62;ZNRF3;ANAPC11;CDC42;BIRC2;FBXO44;NEURL4;WWP1;KCMF1;CUL3;PRKN;BIRC3;HERC2;RNF125;NSMCE2
prerank,transforming growth factor beta binding (GO:0050431),0.4440095784862046,0.9902208169183367,0.5072992700729927,0.9959479266165209,1.0,7/23,18.76%,NRROS;TGFBR1;TGFBR2;THBS1;VASN;CD36;LTBP3
prerank,phosphate ion binding (GO:0042301),-0.4184815599808377,-0.9898344246588431,0.4577922077922078,0.840889214924094,1.0,5/10,20.60%,ADSS2;RELA;RPH3A;PDE2A;MTHFD2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.47360043244710703,0.9860845767243794,0.5173299101412067,1.0,1.0,2/16,5.45%,NEIL2;OARD1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4845460748550423,0.9860792127195311,0.4916897506925208,1.0,1.0,6/13,20.54%,PRKAR2B;SOX9;GSK3A;CSK;GSK3B;PRKAR1A
prerank,chloride channel regulator activity (GO:0017081),0.4706722444655757,0.9834122389724931,0.49605263157894736,1.0,1.0,7/14,23.15%,WNK1;STX8;WNK4;SGK3;VAMP8;SGK1;STX7
prerank,growth factor receptor binding (GO:0070851),0.3899418185538335,0.9822743402765909,0.5376016260162602,1.0,1.0,14/95,15.27%,ITGB3;PTPRJ;GRB2;ERN1;IL6R;PYCARD;CD300LF;VEGFB;TIMM50;SDCBP;FYN;ERAP1;SNX2;SRC
prerank,adenyl ribonucleotide binding (GO:0032559),0.37856983282885825,0.9810728457051494,0.564,1.0,1.0,58/291,17.64%,MYO1F;BTK;KCNJ11;MAP4K1;ABCA1;ABCC6;TGFBR1;P2RX7;MTHFS;DHX9;PFKL;ERN1;NEK6;ATP7A;ABCG1;PI4K2A;MYH9;P2RX4;TLK1;MYO9B;MKNK1;CDK11B;MAP3K5;PIM1;LONP1;ABCD1;WNK1;KIF14;TRIP13;MCM6;STK17B;EIF2B2;TAP1;CARS2;RPS6KA4;PDE4A;NLK;PRKACB;TWF2;CDK6;ATP5F1A;STK3;UBA2;MYH10;DARS2;NIM1K;WNK4;PTPA;ERCC6;IDE;TAP2;HSP90AA1;STK4;GCK;RPS6KA5;KSR1;SIK2;N4BP2
prerank,nucleotidase activity (GO:0008252),0.4772390098933704,0.9788326339907769,0.5311688311688312,1.0,1.0,3/15,10.21%,NT5C3B;BPNT1;NT5DC3
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.4553668442156354,0.9780278894500132,0.5196335078534031,1.0,1.0,1/17,1.52%,BLVRB
prerank,sodium channel activity (GO:0005272),0.4152054248339125,0.9740726234533583,0.536723163841808,1.0,1.0,3/37,4.10%,SCN4B;HCN4;PKD2
prerank,neuropeptide receptor activity (GO:0008188),0.42131266823959135,0.9738738418490986,0.5239206534422404,1.0,1.0,4/29,11.58%,GALR1;SORCS3;GPR37;TACR1
prerank,gamma-tubulin binding (GO:0043015),-0.31899517861005805,-0.9714729235167915,0.518918918918919,0.8802535547448508,1.0,8/21,14.98%,DIXDC1;PAK1;TUBGCP2;CDK5RAP2;BRCA2;NDRG1;MARK4;BLOC1S2
prerank,organic cation transmembrane transporter activity (GO:0015101),0.44876283837289177,0.9708193828069782,0.4908376963350785,1.0,1.0,2/16,8.66%,SLC7A8;SLC44A2
prerank,RNA polymerase II complex binding (GO:0000993),0.41851628444070815,0.9706090198373579,0.5325714285714286,1.0,1.0,11/32,17.89%,DHX9;ZNF326;UVSSA;SCAF1;PCIF1;RTRAF;ELOF1;ERCC5;GTF2B;PCF11;AGO2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.43545097763940843,0.9665470643000732,0.5333333333333333,1.0,1.0,9/22,19.53%,TNFAIP3;PRPF8;WDR81;TAB2;IKBKG;RNF169;TAB3;PARP10;OPTN
prerank,phosphatidylglycerol binding (GO:1901611),0.47242274982686183,0.965372096957755,0.5212620027434842,1.0,1.0,1/13,1.51%,PLEKHN1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.4912027532403044,0.9644862974038373,0.5079365079365079,1.0,1.0,1/11,2.81%,AKR1A1
prerank,metal ion binding (GO:0046872),0.37101942469943633,0.962863480582095,0.647,1.0,1.0,73/477,15.36%,MMP12;SHH;SYT17;LCP1;PCDHB6;SMOC2;LPL;TPD52;CABP4;ADAM8;RPE;S100B;SDF4;SLC8A1;IDS;HPGDS;MASP1;RAP2A;ERN1;NEK6;MAN1C1;SNCA;PKD2;APOE;TTN;KCNIP2;MCTP1;PI4K2A;RASGRP2;PGS1;ASPH;RP2;S100A2;ANXA1;AIF1;MAP3K5;AGRN;SYT2;CERK;CETN3;RASGRP3;ENDOV;TPT1;TRIM27;ITSN1;ITPR2;PPA2;PDCD6;SYT10;TPM4;CDH8;ANXA4;ACER3;NAALADL1;DYSF;CDH9;THBS1;NLK;PRKACB;CDH12;ARSA;CAMKK2;BRAF;CDH23;NDUFAB1;STK3;UBA2;LRRK2;NIM1K;CAPN3;LRP1;EFHD2;CCDC47
prerank,beta-tubulin binding (GO:0048487),0.4197919928948023,0.9620407833394495,0.5612009237875288,1.0,1.0,11/31,21.22%,UXT;FGF13;ARL8A;GJB6;VAPB;CCT5;ARL8B;EML4;TAOK1;CDK5R1;TTLL7
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3943682250682818,0.9620000198873513,0.5531686358754028,1.0,1.0,7/49,10.73%,SYT17;MCTP1;ANXA1;SYT2;SYT10;ANXA4;DYSF
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.3527755307494243,-0.9617409242987707,0.4833948339483395,0.8953667486651639,1.0,7/13,17.11%,ALDH2;ALDH1A1;ALDH3A2;ALDH1A2;ADH5;ALDH1L1;ALDH1L2
prerank,MHC class II protein complex binding (GO:0023026),0.4926715926629259,0.9613879846175715,0.5171919770773639,1.0,1.0,1/11,1.33%,CD74
prerank,single-stranded DNA binding (GO:0003697),0.3808525362262197,0.9609643801929914,0.5834186284544524,1.0,1.0,23/93,20.39%,MCM5;FAM111A;DHX9;NABP1;HMGB1;SAMHD1;LONP1;MCM6;MCM2;APTX;STN1;MCM9;PCBP1;ERCC5;TWNK;REXO4;RAD51B;ERCC1;TOP1;FUBP3;RAD51D;CDC45;RAD23B
prerank,chloride channel inhibitor activity (GO:0019869),0.49346565531089986,0.9601735654996105,0.5276162790697675,1.0,1.0,5/10,23.15%,WNK1;STX8;WNK4;VAMP8;STX7
prerank,rRNA binding (GO:0019843),0.4099651911182939,0.9581808375825315,0.5728699551569507,1.0,1.0,9/42,16.37%,RPL23;EMG1;CIRBP;GTF3A;ERAL1;RPS14;RRS1;RCC1L;RPL11
prerank,poly-pyrimidine tract binding (GO:0008187),-0.30507314094996135,-0.958140361991777,0.5,0.8937751232986103,1.0,6/23,12.34%,DAZAP1;SSB;U2AF2;FMR1;RBMS3;HNRNPU
prerank,GABA-A receptor activity (GO:0004890),-0.32710320427753475,-0.956414594756532,0.508695652173913,0.8881016088890578,1.0,4/18,10.55%,GABRB2;GABRB1;GABRA2;GABRB3
prerank,regulatory RNA binding (GO:0061980),0.40111450796715226,0.9550011115458068,0.5358744394618834,1.0,1.0,12/38,21.10%,DHX9;TLR7;RC3H1;PUM2;AGO4;AGO3;SOX2;TUT7;TARBP2;AGO2;ZC3H7A;DICER1
prerank,hyaluronic acid binding (GO:0005540),0.4949351978868105,0.953746645989535,0.5443037974683544,1.0,1.0,2/10,5.80%,CD44;STAB2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.4900969864409157,0.9500648791946675,0.532561505065123,1.0,1.0,2/10,4.82%,RPE;RENBP
prerank,hexose transmembrane transporter activity (GO:0015149),0.4761151030676304,0.9492737279537342,0.5572625698324022,1.0,1.0,1/12,4.15%,SLC2A3
prerank,ferrous iron binding (GO:0008198),0.42770569892103616,0.9487991273269505,0.5304136253041363,1.0,1.0,6/21,19.67%,SNCA;HAAO;FTL;FTH1;TET2;FTO
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.38784875183941175,0.9470738666886966,0.5705263157894737,1.0,1.0,15/60,17.79%,PPM1H;PPP2CB;MTMR3;RPAP2;TIMM50;PPP2CA;ILKAP;LRRC39;LRRK2;PPP1CC;PHLPP1;PTEN;PPP3CB;PPM1M;PPP4C
prerank,mRNA methyltransferase activity (GO:0008174),-0.3586772163290839,-0.9465930398576096,0.5074074074074074,0.9030931332868481,1.0,5/12,14.68%,METTL14;NSUN2;METTL16;RNMT;CMTR1
prerank,aminopeptidase activity (GO:0004177),-0.2815321811132055,-0.9463846846861725,0.5569620253164557,0.8935785744098574,1.0,9/26,20.31%,LTA4H;MMP14;MMP16;RNPEPL1;NPEPPS;BLMH;KDM8;ENPEP;MMP15
prerank,endodeoxyribonuclease activity (GO:0004520),0.4441269957617494,0.946366673795641,0.5632754342431762,1.0,1.0,9/20,25.94%,EXO1;ENDOV;DNA2;ERCC5;ERCC1;DCLRE1C;ERCC4;ZRANB3;MBD4
prerank,RNA methyltransferase activity (GO:0008173),0.4328349512312668,0.9462966766024691,0.5583437892095358,1.0,1.0,4/19,14.11%,FBL;METTL4;METTL3;BCDIN3D
prerank,retinoid binding (GO:0005501),-0.29839227452835293,-0.9445352971600158,0.5604395604395604,0.8886323222404315,1.0,2/22,9.87%,NR2F2;ALDH1A2
prerank,muscle alpha-actinin binding (GO:0051371),0.44980125234154245,0.9434564859556164,0.5490196078431373,1.0,1.0,3/15,7.20%,PKD2;TTN;LDB3
prerank,voltage-gated cation channel activity (GO:0022843),0.37111880818622955,0.9424829295233352,0.6136595310907238,1.0,1.0,12/97,14.35%,PTK2B;KCNJ11;HCN4;PKD2;KCNMA1;CACNA1A;CACNB4;CACNB2;CACNB1;CACNA1B;KCNA5;KCNA6
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.3631959206932245,-0.9420130279927397,0.517799352750809,0.8856758915666835,1.0,6/12,29.48%,PDE7A;PDE8A;PDE2A;PDE8B;PDE4D;PDE4C
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.38461229153531473,0.9417781424803306,0.5790031813361611,1.0,1.0,12/53,16.72%,SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC43A2;SLC25A38;SLC36A4;SLC66A1;SLC25A18;CTNS;SLC1A4;SLC43A1
prerank,zinc ion binding (GO:0008270),0.36383846205264325,0.9379921448693844,0.698,1.0,1.0,86/293,22.72%,MMP12;SHH;ADAM8;PTPN1;NSD1;S100B;SNCA;TET3;GCH1;SKI;RBSN;TIMP1;SORD;P2RX4;SAMHD1;CDA;TP53;KDM7A;CRIP2;SMAD3;RC3H1;WDFY1;EPRS1;ACER3;HDAC4;LITAF;HPF1;NAALADL1;TRIM8;POLR2L;TRIM24;LIMS1;RASSF1;SEC24D;ZCCHC4;MBD1;TAB2;ERAP1;CHORDC1;ATAD3A;CSRP1;TAB3;USP16;IDE;GTF2B;PITRM1;ARHGEF2;RPS27;KDM4C;BIRC2;RXRA;SLU7;TNFSF10;MSRB2;KLF7;CHD4;RNPEP;TET2;KDM5A;SMPD1;KDM5B;ATP13A2;ZMYND11;TES;PRKN;SIRT5;RNF125;CDADC1;TARS1;KDM2B;CXXC5;MT3;ZFP37;MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;MDM4;ADAMTS3;LNPEP;GRIN2A;NUDT12
prerank,endopeptidase regulator activity (GO:0061135),0.39110566304653105,0.9378771479852118,0.576271186440678,1.0,1.0,6/40,15.74%,VSIR;CST7;RENBP;SPINT2;PSME3;A2M
prerank,titin binding (GO:0031432),-0.34938775847423487,-0.9374339894356476,0.5361216730038023,0.8874210745575255,1.0,7/13,36.78%,ACTN2;CALM3;TRIM63;MYBPC1;CALM2;CAMK2D;ANKRD23
prerank,I-SMAD binding (GO:0070411),0.4551245938040086,0.9358986802091169,0.5391061452513967,1.0,1.0,3/13,8.71%,TGFBR1;CTNNB1;SMAD3
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.40208980545785444,0.9352077651876983,0.5735981308411215,1.0,1.0,11/31,17.81%,UBE2D3;TAF1;UBE2S;UBE2E3;UBE2H;CDC34;UBE2G2;UBE2J2;UBE2N;UBE2Z;UBE2K
prerank,GTP binding (GO:0005525),0.3642158509625799,0.9344797665462573,0.6659959758551308,1.0,1.0,38/172,19.74%,TUBB;TUBB1;RAB39A;RAB32;RAP2A;TUBB3;GCH1;TUBA4A;RAB14;RAP1B;RAB7A;ARL8A;DNM2;RAP2B;RAB28;RAB31;ARL5B;ARL4A;RAB1B;EIF2B2;ATL1;GBP3;RRAS2;ARF6;TSR1;LRRK2;RAP1A;TUBB6;ARL8B;RAB27B;ARFIP2;RHOA;MTG2;CDC42;ATL2;RAB29;RHOD;ATL3
prerank,anion channel activity (GO:0005253),0.3764110236355213,0.9344710808661365,0.5812236286919831,1.0,1.0,13/61,15.59%,LRRC8D;CLCC1;VDAC3;CLIC1;GABRA5;CLCN7;GLRA2;GABRA4;VDAC2;VDAC1;SLC1A4;LRRC8C;CLCN4
prerank,phospholipase A2 activity (GO:0004623),0.42181452210557163,0.933822418205843,0.571773220747889,1.0,1.0,8/26,23.51%,PLA2G7;PRDX6;ABHD3;PLAAT3;PNPLA3;PLA2G5;PLA2G6;PLA2G4E
prerank,protease binding (GO:0002020),0.37179637905858826,0.9337663611690052,0.6382978723404256,1.0,1.0,26/99,20.78%,ITGB3;RFFL;PSAP;TNF;TTN;PYCARD;TNFAIP3;TIMP1;CFLAR;TP53;CRADD;DERL1;CLTC;CCBE1;TWNK;A2M;PTEN;FURIN;TRIP4;BIN1;FLOT1;ITGB1;RIOK3;DPP4;GSK3B;PRKN
prerank,enoyl-CoA hydratase activity (GO:0004300),0.4836487092185052,0.9312679050860343,0.5930735930735931,1.0,1.0,3/10,11.35%,EHHADH;ECHS1;ECI1
prerank,methylated histone binding (GO:0035064),0.37558791436596767,0.9307964132285951,0.5967741935483871,1.0,1.0,18/62,20.16%,BPTF;NCAPG2;CXXC1;MORC3;TAF1;KDM7A;ATRX;CHD1;TRIM24;RBBP5;TTLL12;MTF2;CDYL;MORC4;LRWD1;PHF1;KDM5A;ZMYND11
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.41664563938654736,0.9306079316777253,0.56865127582017,1.0,1.0,8/24,21.35%,ZDHHC14;ZDHHC7;ZDHHC3;YKT6;ZDHHC1;ZDHHC24;ZDHHC21;ZDHHC2
prerank,clathrin adaptor activity (GO:0035615),0.44304919355902617,0.9301309054047628,0.56951871657754,0.9983735828996716,1.0,5/15,15.42%,LDLRAP1;AP2S1;STON2;STON1;AP2M1
prerank,DNA polymerase binding (GO:0070182),0.4292486195080064,0.9300408446131673,0.5635220125786163,0.9954338013302337,1.0,3/18,6.95%,PTGES3;HMGB1;LONP1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3975825692805874,0.9286054825526077,0.5778032036613272,0.995538598340954,1.0,10/33,17.89%,DHX9;ZNF326;UVSSA;RTRAF;ELOF1;ERCC5;SPTY2D1;GTF2B;PCF11;AGO2
prerank,PDZ domain binding (GO:0030165),0.37106176433849625,0.9281563646124091,0.6057692307692307,0.9934310286896737,1.0,23/61,24.40%,GNG12;FZD3;DOCK4;TBC1D10A;KIF14;ATP2B1;F11R;MAP2K2;SNTG2;ATP2B3;CADM1;PLEKHA1;GRIA1;FZD8;PTEN;KIDINS220;PLEKHA2;FZD2;PRKN;GNG5;NSF;ATP2B4;ATP2B2
prerank,GDP binding (GO:0019003),0.3755221234908978,0.9272572020640205,0.6191489361702127,0.9921920294105706,1.0,14/63,16.64%,RAB8B;RAP2A;RAB14;RAP1B;RAB7A;RAP2B;RAB28;RAB31;RRAS2;ARF6;GNAI3;RAP1A;ARL8B;RAB27B
prerank,solute:proton symporter activity (GO:0015295),-0.32044834925010074,-0.927011052929019,0.5431034482758621,0.9058021664109701,1.0,2/16,1.66%,SLC2A13;SLC33A1
prerank,myosin binding (GO:0017022),0.38446197384186914,0.9268366934281578,0.6093418259023354,0.9900433953996458,1.0,9/55,9.82%,CORO1A;NCKIPSD;CXCR4;PYCARD;RAB14;ARFGEF1;SPATA6;RAB39B;RAB11A
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4266464628116359,0.9240089718380747,0.5825,0.993377346847998,1.0,3/20,9.18%,CARD11;MPP1;CASK
prerank,transition metal ion binding (GO:0046914),0.3567677917036427,0.9238845314904907,0.76,0.9905596390261782,1.0,120/397,24.03%,MMP12;SHH;IL1A;ADAM8;MGAT5;PTPN1;NSD1;S100B;SNCA;TET3;GCH1;ATP7A;SKI;RBSN;ATOX1;GYG1;RNF7;TIMP1;SORD;P2RX4;SAMHD1;B4GALT1;CDA;TP53;PIM1;KDM7A;CRIP2;SMAD3;RC3H1;FTL;WDFY1;EPRS1;ACER3;HDAC4;LITAF;HPF1;NAALADL1;ADPRM;TRIM8;FAM20C;POLR2L;TRIM24;LIMS1;RASSF1;SEC24D;ZCCHC4;MBD1;TAB2;B4GALT7;AGMO;LACC1;ERAP1;GALNT2;CHORDC1;ATAD3A;FTH1;CSRP1;TAB3;LARGE1;MGAT5B;USP16;IDE;GTF2B;PITRM1;ARHGEF2;PPM1M;RPS27;GALNT1;KDM4C;FDX1;BIRC2;LOXL3;RXRA;SLU7;TNFSF10;MSRB2;KLF7;CHD4;RNPEP;TET2;KDM5A;MGAT1;SMPD1;KDM5B;ATP13A2;ZMYND11;TES;PRKN;SIRT5;NEK4;RNF125;CDADC1;TARS1;KDM2B;CXXC5;XXYLT1;MT3;ZFP37;MT1G;MT1B;MT1X;MT1F;MT1E;MT1M;MT1H;MT1A;MDM4;ADAMTS3;LNPEP;GRIN2A;NUDT12;HMGCL;SCD;EEA1;MYCBP2;TIMM8B;POMGNT1;UBA5;GALNT3;RNF2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.471476782909813,0.9226650317724727,0.5874635568513119,0.9901954407724239,1.0,3/10,12.61%,B4GALT1;A3GALT2;B4GALT7
prerank,cell adhesion mediator activity (GO:0098631),0.41389578462648396,0.9214581862675206,0.5802919708029197,0.9897408350733579,1.0,8/24,20.03%,SIRPA;EMB;NINJ1;NPTN;CD47;VSTM2L;PALLD;CNTN4
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.3755836942912491,0.9196083185992419,0.6073354908306364,0.9907608698695508,1.0,12/55,17.42%,SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC16A2;SLC36A4;SLC16A1;ABCC1;SLC38A10;SLC16A6;SLC13A3;SLC16A13
prerank,guanyl ribonucleotide binding (GO:0032561),0.35868811585854776,0.9196056257899188,0.7041123370110332,0.9877551931433372,1.0,38/196,17.93%,TUBB;TUBB1;RAB8B;RAB39A;RAB32;RAP2A;TUBB3;GCH1;TUBA4A;RAB14;RAP1B;RAB7A;ARL8A;DNM2;CNGB1;RAP2B;RAB28;RAB31;ARL5B;ARL4A;RAB1B;EIF2B2;PDE11A;ATL1;GBP3;RRAS2;ARF6;GNAI3;TSR1;LRRK2;RAP1A;TUBB6;ARL8B;RAB27B;ARFIP2;RHOA;MTG2;CDC42
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.3602147042497794,-0.917928142389309,0.5525423728813559,0.9196205782326554,1.0,4/12,10.55%,GABRB2;GABRB1;GABRA2;GABRB3
prerank,histone deacetylase activity (GO:0004407),0.4205330162523345,0.9176534525090718,0.5808457711442786,0.988800879738292,1.0,5/19,13.99%,HDAC5;HDAC4;HDAC6;HDAC9;HDAC11
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.44900657528812626,0.9168324790194587,0.5730337078651685,0.9875180421248652,1.0,2/12,8.98%,TENT4B;TENT5C
prerank,tropomyosin binding (GO:0005523),0.4262737693359626,0.9167637200310701,0.5822454308093995,0.9846947061969287,1.0,2/16,8.17%,PYCARD;TNNT3
prerank,Wnt-activated receptor activity (GO:0042813),0.4427601791523461,0.9160348828137336,0.5816186556927297,0.983156163904589,1.0,4/15,9.91%,FZD10;FZD9;FZD3;LRP5
prerank,transferrin receptor binding (GO:1990459),-0.3812707745299365,-0.9156910010063273,0.56957928802589,0.9153908103976381,1.0,4/10,13.29%,SNX4;RGMA;CHUK;CD81
prerank,manganese ion binding (GO:0030145),0.3740884589639504,0.9145216358424672,0.6077777777777778,0.9833726844377928,1.0,20/48,24.58%,MGAT5;GYG1;B4GALT1;PIM1;ADPRM;FAM20C;B4GALT7;GALNT2;LARGE1;MGAT5B;PPM1M;GALNT1;MGAT1;ATP13A2;NEK4;XXYLT1;HMGCL;POMGNT1;GALNT3;ABL2
prerank,transcription coregulator binding (GO:0001221),0.37698085537757664,0.9142917472269523,0.6217948717948718,0.980869577503095,1.0,19/50,24.34%,RPL23;NEK6;CTNNB1;LMO2;FAM89B;SMAD3;HDAC6;MTF2;PPARD;PHF1;CTBP2;PER1;EED;CTBP1;WIZ;UBE2I;TEAD2;CHD6;CNOT2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.43865046509568306,0.9121300720916777,0.5789473684210527,0.9825087174472318,1.0,4/13,19.03%,GABRA5;GLRA2;GABRA4;GABRG1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.32651468559001573,-0.9119279944700691,0.5666666666666667,0.9149995444715945,1.0,2/14,1.33%,MTM1;MTMR7
prerank,DNA binding (GO:0003677),0.34916962586355554,0.9098053989337752,0.843,0.9842223978195316,1.0,143/694,20.42%,NFE2;IRF5;MMP12;CIITA;MEOX1;IRF4;MCM5;IKZF1;GATA1;PCID2;FAM111A;AIM2;NFE2L2;POU2F2;HES7;MLXIPL;DHX9;TLR8;ZEB2;SP7;BARX2;YAF2;NABP1;FOXD2;NR1H4;DNMT3A;BPTF;CEBPA;FOXO3;LRRFIP1;DDIT3;EXO1;MAFK;HMGB1;XRCC5;TAF1;SAMHD1;BRIP1;FLI1;GTF3C4;TEAD1;TP53;MEF2A;NKX2-1;NRL;USF1;LONP1;YY1;RC3H2;CEBPB;CDC5L;ENDOV;TFAP2B;SMAD3;ARID1A;IRF2;HSF1;PPARGC1A;ARID3B;SURF6;RPL6;RNF4;ARID4A;MCM6;HDAC4;MCM2;APTX;SOX9;DENND4A;NR2C2;STN1;GZF1;MTF2;MBD1;SNAPC3;MCM9;PMS1;NR4A1;MAX;SMARCB1;DNA2;SAFB2;SOX6;CUX1;PCBP1;IRF1;INO80;HUWE1;MBD5;SOX2;ZDHHC1;SREBF1;MEIS1;POU6F1;C1D;ERCC5;SPTY2D1;TWNK;NR2C1;REXO4;ERCC6;THRAP3;TOP2A;NUFIP1;OGG1;RBPJ;SMARCAD1;HIF1A;RAD51B;APLP2;SNAPC4;PPARD;ZGPAT;TIGD2;NFYA;RPS27;NPAS2;CNBP;ZNF638;ZNF35;RXRA;JUNB;PHF1;CUX2;POU2F3;CHD4;ERCC1;MAFB;TOP1;FUBP3;ZIC4;TINF2;RAD51D;QRICH1;KDM5A;MAU2;KDM5B;HHEX;ZMYND11;CRLF3;CDC45;RAD23B;POU2F1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3513771952025376,0.9071022783232788,0.78,0.9870825989121157,1.0,76/346,18.32%,CBL;RNF180;MYLIP;TRIM25;RFFL;RNF149;ZNRF2;RNF19B;TRIM5;MKRN1;CDC23;UBE2D3;TRAF2;SEL1L;FBXL22;MSL2;VPS18;MGRN1;RNF7;TNFAIP3;TRAF3;HLTF;PPP1R11;TAF1;RNF111;HECTD1;KLHL21;UBE2S;RNF150;RC3H2;MALT1;VPS11;TRIM27;RNF114;UBE2E3;RC3H1;RNF4;RING1;TRAF5;NFX1;NEDD4L;UBE2H;RNF10;TRIM56;TRIM24;MAEA;RNF40;TRIM35;CDC34;RNF216;FBXL3;RMND5B;RNF135;ITCH;UBE2G2;STUB1;RNF144B;HUWE1;AREL1;NEURL1B;NEURL3;UBE2J2;DTX4;ZNRF1;RNF152;SMURF1;FANCL;UBE2N;TRIM62;ZNRF3;ANAPC11;UBE2Z;UBE2K;CDC42;BIRC2;FBXO44
prerank,histone methyltransferase binding (GO:1990226),0.459189627014584,0.906703103098557,0.5894886363636364,0.9851230490456212,1.0,6/11,25.14%,PRDM12;CTNNB1;PHF1;LCORL;WIZ;HSP90AB1
prerank,antiporter activity (GO:0015297),0.417950007974762,0.9061486345847043,0.6032540675844806,0.9834033268393902,1.0,9/20,28.62%,SLC25A16;TMEM241;SLC25A30;CLCN4;SLC35C2;SLC35E1;SLC35A1;SLC35E2A;SLC35E2B
prerank,adrenergic receptor binding (GO:0031690),-0.31448672544647055,-0.9058932121403694,0.582995951417004,0.9202001501093439,1.0,6/16,18.12%,ARRDC3;GNAS;RAPGEF2;SAV1;MAGI2;UCHL1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.393247075893397,0.9054677641670471,0.607728337236534,0.9820157061206632,1.0,2/29,3.38%,PRKAR2B;PKIB
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.3627305167139045,0.9052393125834448,0.6642259414225942,0.9796231576547165,1.0,11/72,12.29%,MYO1G;LDLRAP1;ADAP2;FLII;SLC9A1;AMER1;PFN2;PFN1;TWF2;EXOC1;SDCBP
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.3419844949162633,-0.9042781161803173,0.5770609318996416,0.9145386347789151,1.0,4/12,13.91%,NUDT5;ENTPD5;SLC25A42;CANT1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3628405791619767,0.9033592066637584,0.6545265348595213,0.9805756458022085,1.0,19/69,23.51%,CERS6;ASPG;SOAT2;ZDHHC14;ZDHHC7;ZDHHC13;ZDHHC16;ZDHHC3;ZDHHC1;PLAAT3;GTF2B;DGAT2;MOGAT1;NMT1;ZDHHC21;NAA15;ZDHHC2;CERS4;PLA2G4E
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.36330995460883825,0.9033571275236209,0.6498422712933754,0.9777251352039464,1.0,14/75,17.68%,EHHADH;AKR1A1;DHRS3;HPGD;SORD;DHRS11;HSD17B11;SPR;SDR42E1;ME3;LDHA;IMPDH2;PHGDH;PGD
prerank,flavin adenine dinucleotide binding (GO:0050660),0.37231428833468955,0.9033475308837311,0.6411637931034483,0.9749021245334728,1.0,7/53,10.09%,CYBB;CYB5R1;XDH;ACADL;MICAL1;KMO;ILVBL
prerank,cadherin binding (GO:0045296),0.34776542990184245,0.903341128860772,0.7957957957957958,0.9721009035979304,1.0,98/315,20.59%,CBL;SNX5;TRIM25;PTPRJ;PTPN1;KLC2;SNX9;PKP2;ASAP1;ITGA6;RPS2;ATIC;LRRFIP1;MYH9;P2RX4;MACF1;CTNNB1;ANXA1;CAPZB;MAPRE1;YWHAB;MICALL1;ARGLU1;SND1;GAPVD1;CLIC1;WASF2;TBC1D10A;CLINT1;CAPZA1;PLIN3;LARP1;CCT8;ARHGAP1;ABI1;RARS1;RPL6;CDH8;EIF4H;VCL;VAPB;F11R;PRDX1;AHSA1;TBC1D2;SCYL1;PFN1;CDH9;PTPRO;YKT6;CDH12;TLN1;TWF2;PRDX6;NUMB;STX5;VASN;FNBP1L;CDH23;STK24;HCFC1;PCBP1;ARHGAP18;PTPRT;EXOC3;SNX2;PDLIM1;USP8;FXYD5;EPS15;ATXN2L;FASN;GOLGA3;SRC;EFHD2;RTN4;DCHS1;CDH19;LDHA;ARFIP2;GCN1;IQGAP1;GIPC1;ADD1;PICALM;ITGB1;SCRIB;SERBP1;RPL7A;LASP1;RPL15;MB21D2;ENO1;RPL29;CDK5R1;USO1;PKM;TES
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.3734194410348424,-0.9028013835745591,0.5669781931464174,0.9092598234024138,1.0,8/10,54.47%,SLC6A11;SLC6A1;SLC10A1;SLC10A3;SLC10A6;SLC6A13;SLC10A4;SLC10A5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.45684514468646037,0.9015996490859702,0.6008771929824561,0.9726685310766441,1.0,11/11,54.35%,DDAH1;PADI2;ALLC;PADI6;PADI3;AGMAT;PADI4;PADI1;ARG1;DDAH2;ARG2
prerank,RNA polymerase binding (GO:0070063),-0.31343222001362314,-0.9010287239092336,0.5639810426540285,0.90463258100605,1.0,5/18,7.97%,SCAF8;PPIB;ANP32B;PHRF1;CCNT1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.38130694451058345,0.9009218052483627,0.6140552995391705,0.9711492586271957,1.0,11/34,17.81%,UBE2D3;TAF1;UBE2S;UBE2E3;UBE2H;CDC34;UBE2G2;UBE2J2;UBE2N;UBE2Z;UBE2K
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.37198536592574755,-0.8932924548321147,0.6024464831804281,0.9138084660418275,1.0,6/10,39.29%,INCA1;KAT2B;CDKN1A;CDKN2C;CDKN2D;CDKN2B
prerank,ubiquitin-dependent protein binding (GO:0140036),0.4639303255356832,0.8899540735720961,0.6171171171171171,0.9898701822732417,1.0,3/10,16.08%,LAPTM5;ANKRD13A;IDE
prerank,phospholipid transfer activity (GO:0120014),-0.28133205861202853,-0.8895546625985541,0.6515837104072398,0.9137894468820725,1.0,9/21,23.14%,PITPNM2;PITPNC1;TNFAIP8L3;GLTP;PITPNB;MTTP;PRELID2;PRELID3A;PLTP
prerank,voltage-gated chloride channel activity (GO:0005247),-0.36789088369619355,-0.8882551822019227,0.5872093023255814,0.9079616714964673,1.0,2/10,10.19%,CLCN6;CLCN2
prerank,MAP-kinase scaffold activity (GO:0005078),-0.3582120728807402,-0.8866944534563861,0.6020761245674741,0.9030642249809199,1.0,4/11,9.06%,SH3RF1;AKAP13;SPAG9;MAPK8IP3
prerank,voltage-gated potassium channel activity (GO:0005249),0.3534704243332821,0.884710212796757,0.6937307297019527,0.9972437703776085,1.0,6/80,7.14%,KCNJ11;HCN4;KCNK6;PKD2;KCNIP2;KCNMA1
prerank,methylation-dependent protein binding (GO:0140034),0.3574954263892289,0.8825893150612918,0.6691729323308271,0.9983697665254068,1.0,16/57,20.16%,BPTF;NCAPG2;CXXC1;MORC3;KDM7A;ATRX;CHD1;TRIM24;RBBP5;MTF2;CDYL;MORC4;LRWD1;PHF1;KDM5A;ZMYND11
prerank,mannosyltransferase activity (GO:0000030),0.4015352468487671,0.8824947183000013,0.6054590570719603,0.9957405604767361,1.0,4/21,10.14%,PIGM;PIGV;ALG2;TMTC4
prerank,O-acyltransferase activity (GO:0008374),0.38570689379117534,0.881277910880062,0.6408209806157354,0.9951267427076335,1.0,4/30,12.19%,LPCAT1;SOAT2;LPCAT2;PRDX6
prerank,translation elongation factor activity (GO:0003746),0.43312487667149224,0.8790148545951956,0.6472148541114059,0.9967144614075959,1.0,2/14,6.89%,GFM1;GTPBP1
prerank,channel activity (GO:0015267),0.36200528325278014,0.8780124823245914,0.6507230255839822,0.9958560388360267,1.0,4/41,13.91%,AQP1;AQP11;TMEM120A;TRPV3
prerank,microtubule binding (GO:0008017),0.34180601126015053,0.877832784825578,0.788,0.9933618194457037,1.0,40/222,15.94%,HOOK3;UXT;NEFH;GAS2L1;FGF13;MAP1LC3B;GAS2L3;CCDC88B;MDM1;TPGS1;CCDC69;MACF1;MAPRE1;DNM2;CLIP2;IRAG2;GJB6;STARD9;CETN3;KIF14;KIF20B;KIF23;VAPB;RAB11A;TUBGCP6;TUBGCP4;MAP1B;CCDC181;MID2;HDAC6;CEP57L1;KATNA1;HAUS8;KIF2A;HOOK2;LRRK2;FMN1;DST;SVBP;CAMSAP2
prerank,frizzled binding (GO:0005109),-0.2483652898754495,-0.8764385066499004,0.6776859504132231,0.9178793119087626,1.0,11/34,25.99%,WNT4;RNF43;WNT5A;WNT6;WNT5B;FZD1;MYOC;CCDC88C;WNT16;DVL2;WNT11
prerank,histone deacetylase binding (GO:0042826),0.3470951779176252,0.874467815494185,0.7249488752556237,0.9966514077731604,1.0,24/88,20.95%,CIR1;SPI1;BHLHE41;HDAC5;MTA3;YWHAB;TP53;MEF2A;TAL1;USF1;MEF2C;HDAC4;PKN1;ZMYND15;HDAC6;HDAC9;AKAP8L;TOP2A;HSP90AA1;DACT1;CHD4;RBBP4;PRKN;TFAP4
prerank,glucuronosyltransferase activity (GO:0015020),0.4037739036793468,0.8741493490584118,0.6343001261034048,0.9944571155849642,1.0,5/19,25.68%,CHSY1;LARGE1;CHPF;B3GAT2;EXT2
prerank,cation transmembrane transporter activity (GO:0008324),0.3531732766956271,0.8729153188966643,0.6483870967741936,0.9939652407236181,1.0,7/48,11.13%,SLC7A8;SLC38A6;SLC36A1;SLC25A38;SLC36A4;SLC8B1;SLC66A1
prerank,calcium-release channel activity (GO:0015278),0.41275946697163834,0.8726276523907043,0.6206896551724138,0.9916906803117153,1.0,3/17,8.68%,RASA3;PKD2;ITPR2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.4027106483224895,0.8708562268636231,0.6379525593008739,0.9921689182370245,1.0,5/20,19.24%,OTULINL;USP7;USP9X;USP21;DESI2
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.36124197841604894,0.8681882822741619,0.659477866061294,0.9943756137397859,1.0,12/35,23.10%,MMP12;TAF1;TP53;SNAPC3;SMARCB1;PIH1D1;GTF2B;AGO2;POU2F1;TAF1C;H3-3A;GTF2A1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.39358126362974927,0.8680745288963239,0.630937880633374,0.991852730281079,1.0,6/21,17.70%,AKAP5;ARFGEF1;WASF2;ARFGEF2;AKAP8L;AKAP9
prerank,BMP binding (GO:0036122),-0.3507443627446859,-0.8661813379437704,0.6190476190476191,0.932914655203889,1.0,1/11,2.45%,NBL1
prerank,growth factor activity (GO:0008083),0.35348129166242187,0.8631969322320436,0.7330552659019812,0.997764407787561,1.0,9/74,12.63%,MDK;ANGPTL3;OSM;VEGFB;NTF3;INHBA;ARTN;GRN;NRG1
prerank,tau-protein kinase activity (GO:0050321),-0.28744169793900465,-0.8631563050879265,0.6487804878048781,0.9308407130303081,1.0,7/20,16.86%,TAOK2;DYRK1A;ROCK1;PHKG2;MARK4;SIK3;TTBK1
prerank,peptidase inhibitor activity (GO:0030414),0.3683428606988589,0.8620921809546951,0.6964078794901506,0.9969681224622875,1.0,4/33,8.84%,CST7;RENBP;TIMP1;SPINT2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.34186590589517124,0.8610683662147135,0.7417695473251029,0.996062387896179,1.0,22/91,21.18%,MYO1G;SH3PXD2B;LDLRAP1;ADAP2;FLII;SLC9A1;AMER1;PFN2;PFN1;TWF2;EXOC1;SDCBP;SNX14;SNX18;PLEKHA5;PICALM;TULP3;LAPTM4B;FCHO2;ATP13A2;KCNJ2;MARK1
prerank,intracellular chloride channel activity (GO:0061778),-0.29492206077818606,-0.8610542552993616,0.6612903225806451,0.9194072369409586,1.0,9/16,37.92%,TTYH3;ANO4;TTYH1;ANO5;ANO8;ANO2;ANO6;ANO1;NMUR2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.29492206077818606,-0.8610542552993616,0.6612903225806451,0.9194072369409586,1.0,9/16,37.92%,TTYH3;ANO4;TTYH1;ANO5;ANO8;ANO2;ANO6;ANO1;NMUR2
prerank,ribonuclease P activity (GO:0004526),0.43331759360862854,0.8607641886717281,0.6362339514978602,0.9938564491120214,1.0,3/11,15.01%,RPP38;RPP14;PRORP
prerank,tRNA binding (GO:0000049),0.35884582554529515,0.8603087454543499,0.6851441241685144,0.9919737497511185,1.0,12/43,22.57%,SEPSECS;ELP1;TRMT10A;CTU1;DARS2;YRDC;FARS2;AIMP1;RPUSD4;ELP5;SARS1;SARS2
prerank,galactosyltransferase activity (GO:0008378),0.4312716849573772,0.8601949143961868,0.6387362637362637,0.9894753097706965,1.0,5/11,21.70%,B4GALT1;A3GALT2;B4GALT7;B4GALT6;B4GALT2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.2568446401301833,-0.8560826288232511,0.722972972972973,0.9223565429008802,1.0,14/27,29.01%,MED21;PRIMPOL;MED20;PRIM1;POLR3B;POLR2C;POLR3F;POLR1F;POLR1H;POLR2J;POLR2D;POLRMT;POLR1D;POLR1C
prerank,androgen receptor binding (GO:0050681),-0.26578260481008914,-0.8547147975275912,0.6827956989247311,0.9173162756293424,1.0,11/25,24.55%,FOXP1;SMARCA4;KDM3A;CALR;SNW1;RNF14;PARK7;TGFB1I1;ARID5A;PRPF6;TRIM68
prerank,nuclear import signal receptor activity (GO:0061608),-0.30067976518887857,-0.8539692394992295,0.6394849785407726,0.9108170378660021,1.0,7/15,31.83%,TNPO3;IPO5;RANBP6;HIKESHI;TNPO2;KPNA2;KPNA6
prerank,solute:sodium symporter activity (GO:0015370),-0.25093154184011013,-0.8527767152315214,0.7448275862068966,0.9052086030303168,1.0,6/27,27.58%,SLC4A10;SLC5A6;SLC5A7;SLC5A3;SLC5A11;SLC20A1
prerank,R-SMAD binding (GO:0070412),0.3965902070072227,0.8519669142917734,0.6567357512953368,1.0,1.0,4/18,17.38%,RGCC;SMAD3;SMURF1;LDLRAD4
prerank,NADP binding (GO:0050661),-0.24156036390118873,-0.8494224628262478,0.7551020408163265,0.9050515026286778,1.0,18/32,31.80%,ME1;CRYZL1;HMGCR;GMDS;DUS2;NOS3;MTRR;CBR4;NOS1;NNT;DHFR;LBR;NDOR1;DHCR7;CRYZ;CBR3;TM7SF2;HSD11B1
prerank,glucose transmembrane transporter activity (GO:0005355),0.4007139540897324,0.84781423947082,0.6709511568123393,1.0,1.0,1/17,4.15%,SLC2A3
prerank,nuclear export signal receptor activity (GO:0005049),0.4219711680585604,0.8475986490467644,0.6530324400564175,1.0,1.0,3/11,12.04%,XPO1;CSE1L;XPO6
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.44315970648814595,0.8459463879599258,0.6666666666666666,1.0,1.0,1/10,2.23%,SLCO2B1
prerank,RNA binding (GO:0003723),0.32314185107723636,0.8457806154425237,0.99,1.0,1.0,331/1321,21.58%,SEPSECS;LGALS3;APOBEC1;RBM47;RFTN1;PCSK9;PCID2;CORO1A;RPL23;RPL17;RBM38;MYO5A;TRIM25;EMG1;GRB2;PTPN1;DHX9;TLR8;TLR7;RPL10A;GFM1;KCTD12;UTP20;PCDH20;ACIN1;NPM3;SF3B2;SF3B1;MKRN1;FBL;ZNF326;BCCIP;ELP1;PPIE;RBM39;RPS2;DHX38;EXOSC1;TENT4B;LRRFIP1;EIF5B;RRBP1;NXF1;MYH9;SCAF11;LAS1L;SAMSN1;IREB2;THOC2;SYNE1;HLTF;HMGB1;ANP32A;XRCC5;SAMHD1;RPL18A;BTF3;CHCHD1;CIRBP;MACF1;CDK11B;MRPL41;MAPRE1;CCAR1;FASTKD3;ACTN4;NUDT4;SND1;GTPBP1;RPS15A;LONP1;TNRC6A;GSPT1;YY1;TCF20;YTHDF3;RC3H2;CSTF1;TMSB4X;P4HB;CASC3;SNRPD2;TRAP1;ELAC2;ZC3H12D;GRSF1;EIF4A1;NKRF;CDC5L;ERAL1;ENDOV;TPT1;LARP4B;MOV10;RBM15B;EIF1;PRPF38B;ADAR;LARP1;CMSS1;RC3H1;KRR1;PPARGC1A;ZCCHC7;TDRD7;SMG1;PCBP3;RPP38;EPRS1;PUM2;SURF6;AGO4;RPL6;DDX27;FASTKD1;HNRNPL;EIF4H;CPEB3;MCRS1;NFX1;PRDX1;RBMX2;TPR;ACTN1;NAP1L1;DDX39B;RBM27;ZC3H18;RPL26;SON;TRMT1;TRIM56;RPS20;SNIP1;RNASEL;LGALS1;LUC7L3;DIAPH1;EIF4G3;APTX;FAU;PFN1;RPS16;CLTC;TRMT10A;CHERP;ACO1;CTU1;ZNF106;PTBP2;GRN;SECISBP2;AGO3;RNASEH1;METTL3;DDX18;PRPF8;PIN4;TRA2B;TWF2;DYNC1H1;UTP11;NOP9;HEATR1;RPS14;TBL2;PPIL4;RRS1;ADARB1;ATP5F1A;RPP14;RPGR;DNA2;FAM50A;SAFB2;DARS1;MSI2;RPL19;POLDIP3;PCBP1;ZYX;UPF3B;RCC1L;HUWE1;RTRAF;MRPL15;DDX1;TSR1;MYH10;HNRNPD;RO60;ALKBH5;SRP19;CSRP1;DARS2;YRDC;NOC2L;PPP1CC;PUM3;PRKRA;IGF2BP3;IMP3;PPIG;RPL9;MRPS9;ATXN2L;PES1;C1D;LRP1;CPEB4;FASN;RBM42;NOC3L;FAM120C;AKAP8L;CCDC47;METAP2;MTDH;REXO4;NOL7;HEATR6;THRAP3;TOP2A;NUFIP1;EWSR1;RPS11;RTN4;PDIA3;PUS7;LSM8;RPL11;SMG7;ZC3H12C;MEX3D;CPEB2;TEP1;TUT7;TASOR;RPS23;HSP90AA1;FARS2;TARBP2;GCN1;UBE2N;RPS4X;MRPS21;LRRC47;NGDN;MRPL39;MANF;CRNKL1;RPS27;RBPMS2;PCF11;AGO2;SEC63;CNBP;DDX41;ZNF638;RPL4;MRPS14;ADD1;DDX31;RBM34;PABPC4;GOLGB1;FYTTD1;MRPL3;FCF1;RBMS2;TOP1;FUBP3;DUSP14;SNRNP200;HNRNPF;SRSF6;ERH;SNRNP35;PNN;SERBP1;WDR75;SRSF2;CLNS1A;PYM1;ROCK2;PABPN1;MRPS26;RPL7A;RPL15;HSPB1;ENO1;EXOSC3;SART1;MRPL10;RPL29;ZC3H7A;USO1;SLBP;DDX51;RRP7A;UTP3;SRSF10;SRSF3;VIRMA;ARCN1;PKM;MRPL54;TES;NCOA5;NAA15;HEXIM1;AIMP1;SRFBP1;STRAP;R3HDM2;RPL22;BAG4;IMP4;RPS7;RIMS1;DICER1;PTBP1;TOE1;HNRNPA0;ZFP36L1;EIF2S2;LSM14A;DCP1B;RPUSD4;LIN28B;YARS1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4119420771435869,0.8456315529471335,0.6662125340599455,0.9981496343940938,1.0,5/14,20.71%,ELAC2;RPP38;RPP14;PRORP;TSEN2
prerank,calcium:sodium antiporter activity (GO:0005432),0.4311105654619467,0.8447340698167948,0.655223880597015,0.9969778410456666,1.0,2/10,10.60%,SLC8A1;SLC8B1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.4307978162306423,0.8439153942872497,0.6681547619047619,0.9956842076431074,1.0,3/10,19.03%,GABRA5;GABRA4;GABRG1
prerank,neurexin family protein binding (GO:0042043),0.42757331193712156,0.8439110590161063,0.6623376623376623,0.993062643779933,1.0,2/10,8.73%,CEL;SYTL4
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.2954704500530335,-0.8437748418251951,0.6594827586206896,0.9088787410673106,1.0,6/15,17.11%,ALDH2;ALDH1A1;ALDH3A2;ALDH1A2;ALDH1L1;ALDH1L2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.43655633345360845,0.8398253755181981,0.6601796407185628,0.9970387481004206,1.0,3/10,16.08%,LAPTM5;ANKRD13A;IDE
prerank,nuclease activity (GO:0004518),0.34622064630693383,0.8388109317248553,0.7328326180257511,0.9961537414051651,1.0,20/52,26.04%,EXO1;SAMHD1;SND1;RNASEL;RNASEH1;DNA2;DDX1;ERCC5;REXO4;OGG1;N4BP2;RNASEH2A;DIS3L2;RNASE6;REXO1;DNASE1L1;XRN2;RNASE12;DFFB;RNASE3
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.3481155501610421,0.8387038055869551,0.7370737073707371,0.9936932067434817,1.0,3/48,4.10%,P2RX1;AQP1;PKD2
prerank,N-acetyltransferase activity (GO:0008080),-0.2753463798818111,-0.8381789992804544,0.7035175879396985,0.912746388672183,1.0,3/19,9.68%,ESCO1;SAT1;NAT10
prerank,mRNA 5'-UTR binding (GO:0048027),0.3795984664649557,0.8362564004923897,0.6853658536585366,0.9949898815752112,1.0,10/24,25.61%,LARP1;RPL26;RPS14;CCT5;MYH10;IGF2BP3;RPS7;RPS13;RPL41;RPL5
prerank,3'-5' exonuclease activity (GO:0008408),-0.2138745065981417,-0.8361823249526875,0.8205128205128205,0.9090014250644998,1.0,16/45,25.24%,REV3L;PAN2;MRE11;DIS3;ERI1;EXOSC7;APLF;WRN;EXD2;TATDN1;EXOSC9;POLG;PARN;EXD1;EXOSC5;CNOT6L
prerank,potassium ion leak channel activity (GO:0022841),0.40325574781413254,0.8353778463670657,0.6662180349932705,0.9938551695496973,1.0,2/15,7.51%,KCNK6;KCNK13
prerank,general transcription initiation factor binding (GO:0140296),-0.2559343601830506,-0.8329146789114714,0.7295597484276729,0.9080104751905491,1.0,8/25,16.36%,AR;TBP;DR1;PSMC1;RELA;TAF13;PSMC5;RUVBL1
prerank,sequence-specific mRNA binding (GO:1990825),0.421142075036905,0.8306192318186704,0.6825633383010432,0.9989187972828426,1.0,1/10,2.82%,DHX9
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.4165603666737088,0.8288851353078068,0.6839887640449438,0.999109951223672,1.0,1/11,5.90%,PPP1R11
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.400537878305268,0.8288385259284166,0.6666666666666666,0.9965755355375954,1.0,5/15,18.20%,LPCAT1;LPCAT2;ABHD4;PNPLA3;LCLAT1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.41075973742333255,0.8259272003508765,0.6976421636615812,0.9986503073100833,1.0,3/12,12.44%,CDK8;CDK7;CDK6
prerank,adenylate cyclase binding (GO:0008179),0.4261578039286506,0.8253631415203444,0.6818181818181818,0.9970182003336124,1.0,2/10,8.17%,AKAP5;CAP1
prerank,5'-nucleotidase activity (GO:0008253),0.41348598026753014,0.8245575171116162,0.6943699731903485,0.9956499972866537,1.0,2/13,10.21%,NT5C3B;NT5DC3
prerank,protein phosphatase 2A binding (GO:0051721),0.37375953555015023,0.8241148921779233,0.7016029593094945,0.9937888045748998,1.0,8/23,16.39%,TP53;ENSA;STRN;BOD1L1;ADCY8;CTTNBP2NL;PTPA;SMG7
prerank,phosphoric ester hydrolase activity (GO:0042578),0.34124916269428757,0.822353642424983,0.7301075268817204,0.9939223572160594,1.0,10/49,15.84%,PTPRJ;DUSP3;SAMHD1;PLCXD3;DUSP10;FRA10AC1;PTPRO;PXYLP1;PPP1CC;GDPD3
prerank,transcription corepressor binding (GO:0001222),0.362260619636363,0.8194905849440758,0.7282479141835518,0.9960353893018189,1.0,10/27,21.99%,NEK6;FAM89B;HDAC6;MTF2;PHF1;CTBP2;PER1;EED;CTBP1;WIZ
prerank,voltage-gated anion channel activity (GO:0008308),0.39365822704199793,0.8153133562510649,0.689280868385346,0.9998117045919395,1.0,4/15,15.59%,VDAC3;VDAC2;VDAC1;CLCN4
prerank,peptidoglycan binding (GO:0042834),0.42038533475948353,0.8139166391097461,0.6873198847262247,0.9993691544486679,1.0,2/10,12.24%,TLR2;NOD2
prerank,deoxyribonuclease activity (GO:0004536),-0.2958989064292162,-0.8117150628736931,0.7108433734939759,0.9406800200115372,1.0,3/14,11.75%,MRE11;MAP1S;APLF
prerank,neuropeptide binding (GO:0042923),0.3767200336121809,0.8113015300219324,0.699614890885751,1.0,1.0,3/18,19.97%,GPR37;SORL1;GPR149
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.39954251803223484,0.8089354925623078,0.7026647966339411,1.0,1.0,6/12,24.34%,CNOT8;TOE1;PNLDC1;CNOT7;CNOT1;CNOT2
prerank,sialyltransferase activity (GO:0008373),0.3731999483460593,0.8065680596627408,0.7148102815177478,1.0,1.0,4/20,10.45%,ST8SIA4;ST6GALNAC4;ST3GAL1;ST8SIA1
prerank,deubiquitinase activity (GO:0101005),0.32054796711493594,0.8064819768323169,0.8203285420944558,1.0,1.0,19/88,16.00%,MINDY4;OTULIN;TANK;USP35;TNFAIP3;ATXN3;OTUD3;STAMBPL1;USP7;USP48;USP31;USP18;MINDY1;USP9X;USP8;JOSD2;USP29;USP21;USP16
prerank,metallopeptidase activity (GO:0008237),0.31240917024133963,0.8045961144422202,0.8297872340425532,1.0,1.0,17/113,17.05%,MMP12;COPS6;ADAM8;ADAMTS8;ECE2;EEF1AKMT4-ECE2;ZMPSTE24;NLN;MMP19;PRPF8;ERAP1;ECEL1;METAP2;PSMD7;PMPCB;IDE;PITRM1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.4103931864266638,0.8044273731526937,0.6846038863976084,0.9980335164747832,1.0,2/10,10.80%,EXO1;MGME1
prerank,tubulin binding (GO:0015631),0.3108322047437106,0.8034751325399639,0.928,0.9968595269181403,1.0,62/295,19.49%,HOOK3;UXT;NEFH;GAS2L1;TBCEL;FGF13;SNCA;MAP1LC3B;GAS2L3;CCDC88B;DIP2B;MDM1;TPGS1;CCDC69;ARL8A;DNM2;CLIP2;IRAG2;GJB6;STARD9;CETN3;KIF14;KIF20B;KIF23;VAPB;RAB11A;TUBGCP6;TUBGCP4;TPR;SETD2;MAP1B;CCDC181;TTLL12;MID2;HDAC6;CEP57L1;FYN;RAB11FIP5;KATNA1;AGBL5;INO80;CCT5;HAUS8;KIF2A;HOOK2;LRRK2;AGTPBP1;FMN1;DST;SVBP;TTLL1;ARL8B;EML4;ARHGEF2;KIF21A;NCALD;KIF1B;MAPRE2;TAOK1;CCDC66;RAD51D;DNM1L
prerank,translation initiation factor activity (GO:0003743),0.3400027861350413,0.8027569522346018,0.7290249433106576,0.9954959330353385,1.0,18/36,28.71%,EIF3K;EIF5B;EIF4A1;EIF1;EIF2B2;EIF4G3;AGO2;MTIF3;EIF2S2;EIF3E;EIF3M;EIF3C;EIF2A;EIF2S1;EIF1B;EIF4E;EIF3A;EIF4A2
prerank,anion transmembrane transporter activity (GO:0008509),0.402476755635418,0.8027309715287739,0.7063829787234043,0.9930820938053335,1.0,1/12,2.23%,SLCO2B1
prerank,mRNA binding (GO:0003729),0.3084719306585349,0.7953053401094298,0.91,1.0,1.0,66/249,21.48%,RBM47;DHX9;SF3B1;PPIE;RPS2;IREB2;THOC2;CIRBP;TP53;YTHDF3;RC3H2;ZC3H12D;GRSF1;EIF4A1;LARP4B;LARP1;RC3H1;TDRD7;PCBP3;PUM2;ANGEL2;HNRNPL;CPEB3;TPR;RPL26;SNIP1;LUC7L3;EIF4G3;RNF40;ACO1;PTBP2;SECISBP2;METTL3;TRA2B;RPS14;ADARB1;PCBP1;UPF3B;CCT5;MYH10;PUM3;IGF2BP3;CPEB4;ZC3H12C;CPEB2;MARF1;RBPMS2;PCF11;AGO2;CNBP;PABPC4;FYTTD1;RBMS2;FUBP3;SRSF6;SNRNP35;SERBP1;SLBP;PKM;RPS7;PTBP1;HNRNPA0;ZFP36L1;EIF2S2;LSM14A;DCP1B
prerank,poly(U) RNA binding (GO:0008266),-0.25978036993867787,-0.7950406917097742,0.7559808612440191,0.964230076056713,1.0,4/20,10.45%,DAZAP1;SSB;FMR1;RBMS3
prerank,FMN binding (GO:0010181),-0.30014951334916506,-0.792611302698542,0.7474402730375427,0.9608044213421753,1.0,5/11,25.07%,DUS2;NOS3;MTRR;NOS1;NDOR1
prerank,"DNA binding, bending (GO:0008301)",-0.29586446007036427,-0.7922585473862878,0.7608695652173914,0.9536771365140937,1.0,2/14,1.44%,FOXC1;FOXD1
prerank,phosphatase activity (GO:0016791),0.3184322719825123,0.7914154935328813,0.7946336429308566,1.0,1.0,10/73,14.70%,LPIN2;PTPRJ;DUSP3;PLPPR1;DUSP10;FRA10AC1;APTX;PTPRO;PXYLP1;PPP1CC
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.34008878150613364,0.7912845415557752,0.7428243398392652,1.0,1.0,9/33,17.89%,DHX9;ZNF326;UVSSA;RTRAF;ELOF1;ERCC5;GTF2B;PCF11;AGO2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.39752980790361486,0.7907802642644619,0.7376586741889986,1.0,1.0,2/12,7.43%,ITGB3;VEGFB
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.2733465505091568,-0.7896921682355333,0.8283261802575107,0.9505994181340216,1.0,4/16,9.48%,SLC25A12;SLC25A13;SLC25A14;SLC1A5
prerank,metalloendopeptidase activity (GO:0004222),0.31026626919351397,0.7886864344005182,0.8237747653806048,1.0,1.0,7/76,10.54%,MMP12;ADAMTS8;ECE2;EEF1AKMT4-ECE2;ZMPSTE24;NLN;MMP19
prerank,SUMO binding (GO:0032183),0.39162238235090907,0.7880833621356962,0.7166212534059946,0.9990521558918461,1.0,5/13,21.17%,RNF111;RNF4;UBA2;SERBP1;HERC2
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.3201429478680109,-0.7879960391626085,0.7206349206349206,0.9460916526059868,1.0,4/11,13.74%,HNRNPA2B1;HNRNPA1;NABP2;CTC1
prerank,peptidase activator activity (GO:0016504),0.3606552684062255,0.7873228870609474,0.7440993788819876,0.9977028944033631,1.0,2/22,4.42%,VSIR;TANK
prerank,microtubule motor activity (GO:0003777),-0.20332264639582825,-0.7872448419562514,0.85,0.9398941695832435,1.0,17/51,23.03%,KIF5B;KIF3C;DYNC1I1;SMC3;KIF16B;KIF26B;KIF3B;KIF5A;KIF24;KIF13A;KIF18A;DNAH2;KIF26A;KIF9;KIFC2;KIF7;KIF1A
prerank,epidermal growth factor receptor binding (GO:0005154),-0.24707397775852785,-0.7856946531464823,0.7714285714285715,0.9353657776045716,1.0,11/25,28.65%,SNX4;EFEMP1;ATXN2;SHC1;LINGO1;HBEGF;CCDC88A;HIP1;EGF;CNOT9;FER
prerank,N-acyltransferase activity (GO:0016410),0.3385171743376787,0.7812169415875897,0.7709750566893424,1.0,1.0,11/32,26.38%,CERS6;NAA50;PLAAT3;NMT1;NAA80;GNPNAT1;TGM2;CERS4;PLA2G4E;SIRT7;NAA10
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3637627205885056,0.7809766660783528,0.7460122699386503,1.0,1.0,6/19,18.40%,ANGPT4;ABI1;NRG1;GAS6;ERCC6;GREM1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.33909655711273406,0.7802005233361519,0.7692307692307693,1.0,1.0,12/34,20.23%,DBF4;MAP2K2;PARP16;STK3;STRADA;ALS2;INCENP;IRGM;STK4;IQGAP1;TAOK1;CDK5R1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.3036954916924288,-0.7786407201126355,0.7342657342657343,0.9402391071916619,1.0,4/11,17.53%,SAMD8;SGMS2;AASDHPPT;PIGF
prerank,chloride channel activity (GO:0005254),0.3129527398329402,0.7775903239003563,0.7955271565495208,1.0,1.0,10/59,15.59%,PACC1;CLCC1;CLIC1;GABRA5;CLCN7;GLRA2;TTYH2;GABRA4;SLC1A4;CLCN4
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3771182801062609,0.7760488055308483,0.7378768020969856,1.0,1.0,4/14,23.58%,NME6;AK8;AK5;AK1
prerank,CoA hydrolase activity (GO:0016289),-0.27098423613330336,-0.7744468596220734,0.7456140350877193,0.9397530121336133,1.0,4/16,10.61%,HIBCH;ACOT11;ACOT13;ACAA2
prerank,Tat protein binding (GO:0030957),0.39584033007210123,0.7741951895492193,0.7309859154929578,1.0,1.0,3/10,13.09%,ACTB;MDFIC;SMARCB1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.3355389488428937,0.7733042292999809,0.7658592848904268,0.9996510677842916,1.0,9/32,21.86%,TET3;HSPBAP1;KDM7A;ALKBH5;RIOX2;KDM4C;TET2;FTO;KDM2B
prerank,ligand-gated anion channel activity (GO:0099095),-0.2579431805264252,-0.7730185253470221,0.7816593886462883,0.9350164616080475,1.0,4/17,10.55%,GABRB2;GABRB1;GABRA2;GABRB3
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.3621917579524304,0.7686450512492329,0.7375328083989501,1.0,1.0,1/18,5.97%,DHRS11
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.39735755999366923,0.7680345493518218,0.7435897435897436,1.0,1.0,5/11,21.06%,NAA40;NAA50;NAA25;NAA15;NAA80
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.3035643931847898,-0.76494250981011,0.7724137931034483,0.9330332266456509,1.0,5/10,25.30%,DUSP16;DUSP1;DUSP7;DUSP8;DUSP6
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.3035643931847898,-0.76494250981011,0.7724137931034483,0.9330332266456509,1.0,5/10,25.30%,DUSP16;DUSP1;DUSP7;DUSP8;DUSP6
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3168869574564224,0.7629129746352786,0.8153347732181425,1.0,1.0,14/49,20.39%,TNFAIP3;BABAM2;HDAC6;PRPF8;WDR81;TAB2;IKBKG;MINDY1;RNF169;TAB3;EPS15;PARP10;OPTN;RAD23B
prerank,leak channel activity (GO:0022840),0.3548171528135241,0.7586825437969194,0.7506493506493507,1.0,1.0,2/18,7.51%,KCNK6;KCNK13
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.370447954038301,0.7560674348256697,0.7450980392156863,1.0,1.0,2/13,11.13%,SLC7A7;SLC66A1
prerank,N-methyltransferase activity (GO:0008170),-0.2456873656807821,-0.7543384346291601,0.8603603603603603,0.9413020773459964,1.0,14/20,42.35%,SETD3;METTL5;RNMT;NNMT;PRMT1;TRMT11;N6AMT1;FDXACB1;DIMT1;PEMT;METTL15;METTL18;TFB2M;GNMT
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.22508999731685897,-0.7513688900133261,0.8531468531468531,0.9388108644666658,1.0,13/27,29.01%,MED21;MED20;TERT;POLR3B;POLR2C;POLR3F;POLR1F;POLR1H;POLR2J;POLR2D;POLRMT;POLR1D;POLR1C
prerank,myosin V binding (GO:0031489),0.36511493129141004,0.750599907613861,0.7606602475928473,1.0,1.0,4/15,16.64%,RAB14;RAB39B;RAB11A;RAB27B
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.3724445636295589,0.7504076522622832,0.7561307901907357,1.0,1.0,2/13,6.35%,LPCAT1;LPCAT2
prerank,cAMP response element binding (GO:0035497),0.3852923138484997,0.7444083439764909,0.7691197691197691,1.0,1.0,3/10,12.49%,CREB3L1;CREB3L2;CREB1
prerank,pseudouridine synthase activity (GO:0009982),-0.2716236478533892,-0.7409307412227233,0.8205128205128205,0.9468790942654001,1.0,9/13,41.35%,PUS10;TRUB2;PUS1;PUS7L;RPUSD1;TRUB1;PUSL1;RPUSD2;RPUSD3
prerank,ribonuclease P RNA binding (GO:0033204),0.3754757909710077,0.7383620568913158,0.7784342688330872,1.0,1.0,2/10,13.15%,RPP38;RPP14
prerank,telomeric DNA binding (GO:0042162),0.3170260549062842,0.7347356010100958,0.7977272727272727,1.0,1.0,12/32,24.85%,XRCC5;SMG1;STN1;HNRNPD;SMG7;UPF2;TINF2;TERF2;TELO2;TERF2IP;TEN1;RPA1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.27102561473291736,-0.7319880802162602,0.837037037037037,0.9526079514897569,1.0,6/13,23.22%,THUMPD3;TARBP1;TRMT10B;TRMT5;WDR4;TRMT11
prerank,proton transmembrane transporter activity (GO:0015078),-0.19462984416030946,-0.7316673731327171,0.908256880733945,0.9461010832715099,1.0,10/39,21.75%,SLC33A1;UQCRH;COX5A;NDUFA4;DMAC2L;COX15;UQCRC1;UQCRQ;NNT;COX5B
prerank,pentosyltransferase activity (GO:0016763),0.3145105533777554,0.7316084843750321,0.8226711560044894,1.0,1.0,11/36,21.54%,ART4;PARP8;PNP;PARP16;TNKS2;TIPARP;LACC1;LARGE1;PARP10;SIRT5;PARP3
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.3172757252727218,0.730727477492411,0.7977011494252874,1.0,1.0,3/31,6.45%,AQP1;PKD2;TMEM38A
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.2911142168148405,-0.7279193075700584,0.8204225352112676,0.9441564572195543,1.0,3/11,8.34%,UBR5;UBOX5;RBX1
prerank,MAP kinase activity (GO:0004707),0.3528897121232858,0.7251096081923238,0.7817460317460317,1.0,1.0,2/14,11.40%,MAPK14;NLK
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.22205984884502983,-0.7224412636042362,0.9010989010989011,0.9443603538825986,1.0,10/24,28.82%,PPIP5K2;IP6K1;IP6K2;AK3;ITPKC;PMVK;AK4;CMPK2;NME2;CMPK1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.22303137572873155,-0.7218276091046394,0.8497409326424871,0.9382883058784971,1.0,7/22,19.27%,CPEB1;RBMS3;ELAVL3;EXOSC8;ZC3H12A;DHX36;EXOSC9
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.32514977954574387,0.7210281872375074,0.8271308523409364,1.0,1.0,10/25,25.10%,ART4;PARP8;PARP16;TNKS2;TIPARP;PARP10;SIRT5;PARP3;PARP1;PARP9
prerank,pre-mRNA binding (GO:0036002),0.3172358084406307,0.7196513688498267,0.8148584905660378,1.0,1.0,9/28,21.15%,HNRNPL;PRPF8;TRA2B;RBM41;TARBP2;SLU7;SRSF6;SLBP;PTBP1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.29740915506799265,-0.7194848305385453,0.7975077881619937,0.9344363945170087,1.0,5/10,29.98%,OPLAH;CRMP1;DPYSL2;CAD;DPYSL3
prerank,transcription coactivator binding (GO:0001223),0.33024593509049854,0.7182162814956649,0.8218673218673219,1.0,1.0,2/20,8.71%,RPL23;SMAD3
prerank,histone acetyltransferase binding (GO:0035035),0.3282353635504242,0.7160299121856132,0.8207317073170731,1.0,1.0,5/21,17.13%,TP53;MEF2A;EID1;HIF1A;TRIP4
prerank,O-methyltransferase activity (GO:0008171),0.3676284744422419,0.7146614208208557,0.7913669064748201,1.0,1.0,3/10,19.85%,COMT;BCDIN3D;COQ3
prerank,voltage-gated calcium channel activity (GO:0005245),0.29887181478619923,0.7136328687743102,0.8449258836944128,1.0,1.0,7/37,16.60%,PKD2;CACNA1A;CACNB4;CACNB2;CACNB1;CACNA1B;CACNA1D
prerank,myosin II binding (GO:0045159),0.36665770182189833,0.71076540084533,0.7922636103151862,1.0,1.0,1/10,2.68%,MYL3
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.2974518881000772,0.710610344877271,0.8491620111731844,1.0,1.0,8/42,20.77%,CCND3;CCND2;CCNL1;CCNE2;CCNYL1;CNPPD1;CDK5R1;HEXIM1
prerank,tRNA methyltransferase activity (GO:0008175),-0.24244100691831866,-0.7043078926287362,0.8571428571428571,0.9461103370745835,1.0,9/16,35.47%,THUMPD3;TARBP1;TRMT5;LCMT2;TRMT44;TRMT13;TYW3;TRMT12;TRMT9B
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.2784663366930283,-0.7040672603635867,0.8772563176895307,0.9398248146159319,1.0,3/12,16.06%,B3GNT2;B3GALT5;B3GALT1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.28051040860373516,0.7034206446660292,0.9069286452947259,1.0,1.0,17/83,16.00%,OTULIN;TANK;USP35;TNFAIP3;ATXN3;OTUD3;STAMBPL1;USP7;USP48;USP31;USP18;USP9X;USP8;JOSD2;USP29;USP21;USP16
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.34975884663594503,0.7022178688926871,0.8151260504201681,1.0,1.0,5/12,23.10%,TAF1;GTF2B;POU2F1;H3-3A;GTF2A1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.28487195426749884,0.7021558333435218,0.8625134264232008,1.0,1.0,10/55,17.27%,PKD2;ATP2C1;ATP2B1;ITPR2;CACNB2;ATP2B3;ATP2A3;TRPV3;CACNA1D;TMEM165
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.29525231519672723,0.7007889649270905,0.8582766439909297,1.0,1.0,11/40,22.07%,DNMT3A;FBL;METTL4;COMT;PCMTD2;METTL9;SUV39H1;AS3MT;METTL2B;METTL2A;TPMT
prerank,omega peptidase activity (GO:0008242),0.2782836436250913,0.7007769323425314,0.9014373716632443,1.0,1.0,18/89,16.00%,OTULIN;TANK;USP35;TNFAIP3;ATXN3;OTUD3;STAMBPL1;USP7;USP48;USP31;USP18;GGH;USP9X;USP8;JOSD2;USP29;USP21;USP16
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3369492197457895,0.6992367488081948,0.8142664872139973,1.0,1.0,3/14,20.72%,KCNIP2;KCNA5;KCNJ2
prerank,FAD binding (GO:0071949),0.31534253342429486,0.6991682195843774,0.8365155131264916,1.0,1.0,3/24,7.82%,CYB5R1;MICAL1;KMO
prerank,ligand-gated calcium channel activity (GO:0099604),0.3217808334868222,0.6990078543861753,0.810062893081761,1.0,1.0,2/19,5.57%,RASA3;P2RX4
prerank,carboxy-lyase activity (GO:0016831),0.31174356392643976,0.6985070272087717,0.8257756563245824,1.0,1.0,6/23,21.84%,DDC;AMD1;PPCDC;ECHDC1;AZIN2;UROD
prerank,neuropeptide receptor binding (GO:0071855),0.33102847709042604,0.696528407240326,0.809775429326288,1.0,1.0,1/14,8.28%,PPY
prerank,mRNA 3'-UTR binding (GO:0003730),0.2778871296504465,0.6961087889384352,0.8902691511387164,1.0,1.0,21/79,21.24%,CIRBP;TP53;LARP4B;LARP1;RC3H1;PUM2;ANGEL2;CPEB3;RNF40;SECISBP2;CCT5;IGF2BP3;CPEB4;MEX3D;CPEB2;PABPC4;RBMS2;SERBP1;RPS7;HNRNPA0;ZFP36L1
prerank,disordered domain specific binding (GO:0097718),0.31631285701581124,0.6957400179773132,0.8293269230769231,1.0,1.0,9/23,25.84%,TP53;RB1;CLTC;FYN;HSP90AA1;TEAD2;NCOA3;HSP90AB1;DFFB
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.267975741345267,-0.6957188503318315,0.8662420382165605,0.9422705154463668,1.0,4/11,24.32%,NDUFAF7;PRMT8;PRMT1;PRMT7
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.3188146313229023,0.6948387837180849,0.8349633251833741,1.0,1.0,6/20,19.56%,LPCAT1;LPCAT2;PNPLA3;LCLAT1;DGAT2;MOGAT1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.3589197946747039,0.691906124068787,0.8337950138504155,1.0,1.0,4/10,23.08%,ASH1L;SUV39H1;SETD5;SETDB1
prerank,signal sequence binding (GO:0005048),0.2944748801683872,0.6908876421675353,0.8587699316628702,1.0,1.0,9/35,21.01%,KCNIP2;KDELR2;TIMM22;BABAM2;AP2M1;CEMIP;KPNA1;TOMM20;IPO4
prerank,acetyltransferase activity (GO:0016407),-0.1958845190004509,-0.690878687465129,0.953125,0.9406155364298628,1.0,4/31,9.68%,ESCO1;ELP3;SAT1;NAT10
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.3118283525748227,0.6904444177087753,0.8460591133004927,1.0,1.0,1/23,1.63%,SH3PXD2B
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.3313356192490696,0.6902267441082867,0.8306451612903226,1.0,1.0,4/15,18.42%,CXXC1;RBBP5;SETD1B;WDR82
prerank,filamin binding (GO:0031005),0.35238449611994516,0.6901069851061854,0.8034682080924855,1.0,1.0,4/11,19.86%,MICALL2;RFLNA;FBLIM1;TMEM67
prerank,potassium channel regulator activity (GO:0015459),0.2823254287057618,0.6883806457388083,0.8739130434782608,1.0,1.0,11/49,22.71%,KCNIP2;WNK1;ENSA;NEDD4L;WNK4;SGK3;RASA1;AKAP9;FLNA;CHP1;SGK1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.26062988469285914,-0.6870749522738205,0.8398692810457516,0.9380703816739205,1.0,8/12,30.26%,SLC25A42;SLC25A23;SLC25A24;SLC19A1;SLC25A5;SLC35B2;SLC25A17;SLC17A9
prerank,actinin binding (GO:0042805),0.31515593703312283,0.6867137019894485,0.8386277001270648,1.0,1.0,6/21,16.60%,PKD2;TTN;NFKB1;KCNA5;CSRP1;CACNA1D
prerank,carboxypeptidase activity (GO:0004180),0.2946302940466776,0.6853366589818563,0.8561797752808988,1.0,1.0,7/35,17.36%,CTSA;CTSZ;NAALADL1;AGBL5;MINDY1;AGTPBP1;PEPD
prerank,alpha-actinin binding (GO:0051393),0.3041251319006717,0.685026253695498,0.8429752066115702,1.0,1.0,7/24,19.52%,PKD2;TTN;LDB3;KCNA5;PDLIM1;CACNA1D;PALLD
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.30139494351797314,0.6843360631840782,0.848851269649335,1.0,1.0,5/26,18.69%,CHSY3;B3GALNT1;CHSY1;B4GALNT1;CHPF
prerank,ion channel activity (GO:0005216),0.2716149096748222,0.682701127359859,0.9097510373443983,1.0,1.0,4/80,6.71%,P2RX1;TMC6;PKD2;CNGB1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.29471882378967196,0.682446024736222,0.8625429553264605,0.9978101646580058,1.0,5/34,10.59%,NDUFB8;NDUFA2;NDUFB4;NDUFV1;NDUFS6
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.29471882378967196,0.682446024736222,0.8625429553264605,0.9978101646580058,1.0,5/34,10.59%,NDUFB8;NDUFA2;NDUFB4;NDUFV1;NDUFS6
prerank,exopeptidase activity (GO:0008238),0.27766473826767357,0.6768783364714002,0.895361380798274,1.0,1.0,12/50,20.90%,CTSA;ZMPSTE24;CTSZ;NAALADL1;GGH;ERAP1;METAP2;PRCP;RNPEP;LAP3;DPP4;CNDP2
prerank,telomerase RNA binding (GO:0070034),-0.2191107996071141,-0.6767567456500222,0.9144385026737968,0.9417206376135133,1.0,9/22,23.23%,SNRPD3;PINX1;HNRNPU;WRAP53;DHX36;TERT;SMG6;PARN;GAR1
prerank,RNA cap binding (GO:0000339),0.32044010624414615,0.6753255964867216,0.851261620185923,1.0,1.0,4/16,17.89%,EIF4A1;LARP1;CYFIP1;AGO2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.35105378149225636,0.6726973605308504,0.8308823529411765,1.0,1.0,4/10,21.86%,KDM7A;RIOX2;KDM4C;KDM2B
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.2695522536069915,-0.6722080143899443,0.8202614379084967,0.9395440635163081,1.0,2/10,9.75%,FAP;DPP8
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.2959687954488449,0.6677701182062914,0.8427370948379351,1.0,1.0,3/25,7.82%,FMO5;MICAL1;KMO
prerank,pyrophosphatase activity (GO:0016462),0.275418390278604,0.665954225480207,0.8927410617551462,1.0,1.0,6/50,11.49%,DHX9;NUDT4;PPA2;ATCAY;ADPRM;ENTPD1
prerank,cGMP binding (GO:0030553),0.3428722188965366,0.6612852402656961,0.8447802197802198,1.0,1.0,2/11,10.59%,CNGB1;PDE11A
prerank,syntaxin-1 binding (GO:0017075),0.3034512237266522,0.6573113772567831,0.8708487084870848,1.0,1.0,5/22,20.01%,VAMP3;STXBP3;LRRK2;STXBP5;UNC13A
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.20067993417159327,-0.657021217719609,0.9084967320261438,0.946962034447107,1.0,3/28,9.39%,GRIK4;GABRA2;CHRNA7
prerank,magnesium ion binding (GO:0000287),0.25345618532025943,0.656403475263928,0.9528112449799196,1.0,1.0,37/135,25.64%,HPGDS;RAP2A;ERN1;NEK6;SNCA;PI4K2A;RP2;MAP3K5;CERK;ENDOV;PPA2;PDCD6;NLK;PRKACB;STK3;UBA2;LRRK2;NIM1K;TOP2A;STK4;SIK2;TESC;DIS3L2;MARK1;BRSK1;XXYLT1;NUDT3;NUDT12;HMGCL;ADPRH;IDH1;NT5C3A;ABL2;PSPH;MARK2;NUAK2;DXO
prerank,motor activity (GO:0003774),0.2669354170820651,0.6540454224712419,0.9088050314465409,1.0,1.0,7/60,10.27%,MYO1E;MYH9;STARD9;KIF14;KIF20B;KIF23;APPBP2
prerank,MAP kinase kinase kinase activity (GO:0004709),0.3277012246105947,0.647806227113684,0.8433048433048433,1.0,1.0,2/11,8.63%,MAP3K5;MAP3K1
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.20378319065585526,-0.6467564290016349,0.9695431472081218,0.9490493869537203,1.0,12/21,46.91%,KL;FGF9;FGF10;FGF7;FRS2;FGF1;FRS3;FGF18;KLB;FGF22;FGF5;FGF20
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.31710438672847,0.6452736083327312,0.8744884038199181,1.0,1.0,5/14,20.67%,IREB2;ACO1;SDHB;ETFDH;CIAO3
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.3116356612543255,0.6416324811329793,0.868,1.0,1.0,5/15,24.26%,NDST1;HS3ST4;NDST2;NDST4;HS3ST3A1
prerank,histone methyltransferase activity (GO:0042054),0.275120825611305,0.6388052149748575,0.9064994298745724,1.0,1.0,9/32,23.08%,FBL;DOT1L;SETD2;TTLL12;SMYD3;SUV39H1;EED;NSD3;SETDB1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.2852732539163235,0.6371951397423987,0.8980070339976554,1.0,1.0,2/27,3.62%,RNF180;RNF19B
prerank,store-operated calcium channel activity (GO:0015279),0.32542851828917024,0.6367620761016772,0.8632010943912448,1.0,1.0,1/10,4.89%,ORAI2
prerank,nucleotidyltransferase activity (GO:0016779),0.2964185695073074,0.6359277461961845,0.8720200752823086,1.0,1.0,4/19,16.57%,TENT4B;PAPSS1;YRDC;TUT7
prerank,histone acetyltransferase activity (GO:0004402),0.2740876356659573,0.6347214129095089,0.9038238702201622,1.0,1.0,6/30,16.66%,SRCAP;TAF1;BAZ1A;NAA40;KAT7;NAA50
prerank,snoRNA binding (GO:0030515),0.27444062901677657,0.6340894719417991,0.8946135831381733,1.0,1.0,6/30,15.86%,XRCC5;NUDT4;HEATR1;TSR1;IMP3;NUFIP1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.2624893299858327,0.633650169510569,0.8982300884955752,1.0,1.0,9/42,20.03%,SIRPA;EMB;ANXA1;NPTN;PDLIM1;CD47;VSTM2L;PALLD;CNTN4
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.27335953676378777,0.6323042928185288,0.9049773755656109,1.0,1.0,10/34,23.08%,SETD6;DOT1L;SETD2;TTLL12;ETFBKMT;SMYD3;SUV39H1;EEF1AKMT1;NSD3;SETDB1
prerank,NAD+ binding (GO:0070403),0.3094531881110305,0.6298983338636136,0.876510067114094,1.0,1.0,1/12,4.51%,HPGD
prerank,miRNA binding (GO:0035198),0.26967001801647617,0.628229423291798,0.9011494252873563,1.0,1.0,12/30,26.65%,RC3H1;PUM2;AGO4;AGO3;SOX2;TUT7;AGO2;ZC3H7A;ZC3H7B;AGO1;PUM1;ELAVL1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2466544229031997,0.6277516134779616,0.9717741935483871,0.9988366023523114,1.0,18/134,17.02%,SLC52A1;SLCO2B1;SLC7A8;SLC38A6;SLC36A1;SLC35B3;SLC25A38;SLC36A4;SLC16A1;ABCC1;SLC66A1;SLC25A18;CTNS;SLC35A3;SLCO1B1;SLC1A4;CD36;SLC13A3
prerank,cation channel activity (GO:0005261),0.2457076059532434,0.6263417407160495,0.9571428571428572,0.997922638552455,1.0,6/94,10.48%,P2RX1;AQP1;PKD2;TMEM38A;TMEM63A;CACNB2
prerank,iron ion binding (GO:0005506),0.2618124881228406,0.6257958302569583,0.9315217391304348,0.9963329418256102,1.0,9/48,19.67%,SNCA;HAAO;KDM7A;FTL;AGMO;FTH1;FDX1;TET2;FTO
prerank,AMP binding (GO:0016208),0.3168067262207811,0.6241662400223482,0.8659942363112392,0.9956750966229463,1.0,1/11,3.12%,PFKL
prerank,5'-3' exonuclease activity (GO:0008409),0.3003046208756826,0.6240139124634185,0.8845108695652174,0.9937725605314978,1.0,6/14,25.64%,EXO1;TRIR;DCLRE1C;DCP2;XRN2;DXO
prerank,phosphatase activator activity (GO:0019211),-0.23438226945002522,-0.6226099179143091,0.9149797570850202,0.9603854788287933,1.0,6/14,38.10%,CALM3;GTF2F1;CALM2;FRS2;B3GAT3;PPP1R15A
prerank,neuropeptide hormone activity (GO:0005184),0.2820443745193276,0.6191203659056558,0.8929889298892989,0.99550259528281,1.0,2/22,14.06%,PPY;NMB
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.29111869222029296,0.6150860255515206,0.8959390862944162,0.9967206231115926,1.0,1/17,3.98%,NME6
prerank,methyl-CpG binding (GO:0008327),0.2781826619716728,0.6124513950920825,0.9070904645476773,0.9967590758100381,1.0,7/22,24.57%,TET3;MBD1;LRWD1;ERH;CXXC5;MBD2;ZBTB21
prerank,NAD binding (GO:0051287),0.2689664564937636,0.612344256879661,0.9041420118343195,0.9948142657276241,1.0,3/26,9.08%,HPGD;SORD;QDPR
prerank,exoribonuclease activity (GO:0004532),0.3057077730499658,0.6102074618925399,0.8958333333333334,0.9943697406366819,1.0,4/12,22.63%,EXOSC1;EXOSC3;CNOT7;EXOSC2
prerank,DNA secondary structure binding (GO:0000217),0.2593979501862419,0.6051310478057119,0.922722029988466,0.996250683326029,1.0,7/31,19.93%,HMGB1;YY1;MEF2C;ERCC5;RAD51B;RAD51D;LIN54
prerank,cytochrome-c oxidase activity (GO:0004129),-0.21165252116021246,-0.5999818186609609,0.9471544715447154,0.9673675113985293,1.0,6/15,29.60%,COX5A;NDUFA4;COX15;COX5B;COX8A;COX10
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.29905817891089814,0.5931084021308319,0.9079320113314447,1.0,1.0,3/12,17.83%,XDH;SDHB;FDX1
prerank,amino acid:sodium symporter activity (GO:0005283),0.30199643124045933,0.5930832859782653,0.9164265129682997,1.0,1.0,1/11,9.15%,SLC6A15
prerank,acyl-CoA hydrolase activity (GO:0047617),0.28059881918497687,0.590440001408423,0.9080459770114943,1.0,1.0,6/17,24.73%,ABCD1;ACOT9;ACOT2;ACOT8;PLA2G6;ACOT7
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3080075384204042,0.5888906535539028,0.9190751445086706,0.9998127719137383,1.0,5/10,26.38%,NAA50;NAA25;NAA15;NAA80;NAA10
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2487782281472811,0.5875165885333992,0.9481981981981982,0.9986677852151368,1.0,11/33,24.74%,CNOT8;ANGEL2;EXOSC3;DIS3L2;REXO2;TOE1;PNLDC1;CNOT7;EXOSC2;DCP2;XRN2
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.24745509601273452,0.5864387700308039,0.9334085778781038,0.9973523311615484,1.0,12/34,24.74%,CNOT8;ANGEL2;EXOSC3;DIS3L2;REXO2;TOE1;PNLDC1;CNOT7;CNOT1;EXOSC2;CNOT2;XRN2
prerank,ATPase activator activity (GO:0001671),0.2672300989342889,0.5833912932973151,0.9186189889025894,0.9973699855072938,1.0,6/20,21.63%,AHSA1;ATP1B3;TOR1AIP2;ATP1B2;DNAJB6;DNAJC15
prerank,damaged DNA binding (GO:0003684),-0.14737339638983665,-0.5789933500925458,1.0,0.9718872506900174,1.0,20/44,36.19%,DDB2;DDB1;TDG;XRCC1;XPA;SMC6;SDE2;DCLRE1A;RAD18;POLQ;DCLRE1B;RPA3;FANCG;NEIL3;RPA2;CUL4B;PCNA;NTHL1;POLD1;MPG
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.246312704016161,0.5768078564360302,0.9394618834080718,0.9994926133601371,1.0,10/35,24.81%,GATB;ELAC2;ELAC1;BCDIN3D;TARS2;DUS1L;FTO;NT5C3A;DUS3L;GATC
prerank,lysine N-methyltransferase activity (GO:0016278),0.26149548337201967,0.5730017294536245,0.9261992619926199,0.9999456008584133,1.0,3/20,13.86%,SETD6;SETD2;ETFBKMT
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.24866908314813127,0.5701556637842589,0.9457013574660633,0.9995510106878475,1.0,2/33,3.62%,RNF180;RNF19B
prerank,poly(A) binding (GO:0008143),0.2617525559005126,0.5678473028514308,0.9321824907521579,0.9989474084265982,1.0,4/21,18.81%,PPIE;DDX1;PABPC4;RBMS2
prerank,nucleosomal DNA binding (GO:0031492),0.25511495093089764,0.5663234035405961,0.9357682619647355,0.9978570632600794,1.0,9/21,28.18%,ACTB;SMARCB1;CHD4;RBBP4;H3-3A;MBD2;SMARCC1;MTA2;HDAC1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.22902775604151676,0.5631343348105943,0.9626068376068376,0.997665636493847,1.0,7/57,11.91%,NDUFB8;NDUFA2;NDUFB4;NDUFV1;NDUFS6;CYB5A;CYB561D2
prerank,four-way junction DNA binding (GO:0000400),0.26215071798301776,0.5618502925043578,0.9387755102040817,0.9963634754222289,1.0,4/17,19.47%,HMGB1;YY1;RAD51B;RAD51D
prerank,methyltransferase activity (GO:0008168),0.22790878574795323,0.5587037395293276,0.9713656387665198,0.9962089929604453,1.0,11/46,21.50%,METTL4;PRMT3;MGMT;METTL3;COMT;BCDIN3D;SUV39H1;AS3MT;NSUN4;COQ3;EEF1AKMT1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.20323978150310795,-0.5564719946286558,0.9647058823529412,0.9748098516482195,1.0,15/15,79.70%,PLA2G12A;PLA2G4C;PLA2G4F;PLA2G4B;PLA2G4A;PLA2G3;PLA2G2C;PLA2G2D;PLA2G10;PLA2G1B;PLA2G2E;PLA2G2F;PLA2G4D;PLA2G4E;PLA2G5
prerank,NF-kappaB binding (GO:0051059),0.24794728825564671,0.5558658931075334,0.9602888086642599,0.9958982664825782,1.0,5/24,20.45%,SETD6;ANXA4;MTDH;FAF1;GSK3B
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.2793853198463826,0.55041515845504,0.9430656934306569,0.9967710950677288,1.0,1/11,5.64%,SLC35B3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.2739093494771068,0.5453793158602807,0.9513590844062947,0.9974034211380428,1.0,3/12,17.89%,LARP1;CYFIP1;AGO2
prerank,U6 snRNA binding (GO:0017070),0.26132350044805663,0.5445088358248582,0.9422818791946309,0.995912588629842,1.0,3/14,16.31%,DDX39B;PRPF8;LSM8
prerank,TBP-class protein binding (GO:0017025),0.24812008956353987,0.544134268749344,0.9578163771712159,0.9941711870285014,1.0,7/21,24.78%,TAF1;GTF2B;TAF11;HHEX;YEATS2;GTF2A1;THRA
prerank,pyridoxal phosphate binding (GO:0030170),0.24809782769215663,0.5428686786149892,0.9496932515337423,0.9928714394999237,1.0,6/20,20.09%,THNSL2;OAT;CBS;ACCS;PSAT1;PYGL
prerank,microtubule plus-end binding (GO:0051010),0.24791452877349102,0.5377120530129681,0.9475032010243278,0.993404266527499,1.0,6/20,22.70%,MAPRE1;CLIP2;DST;MAPRE2;FBXW11;CLASP1
prerank,calcium channel activity (GO:0005262),0.21045991894927843,0.5372389431020755,0.9856410256410256,0.9917287066648897,1.0,9/84,13.91%,PKD2;ORAI2;P2RX4;CACNA1A;CACNB4;CACNB2;CACNB1;CACNA1B;TRPV3
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.24578997644841355,0.5370600482857595,0.9708121827411168,0.9899051409952762,1.0,5/19,25.35%,GABRA5;GABRA4;GABRG1;GRIK3;GABRG2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.2395985077146686,0.5350355055989809,0.9698870765370138,0.98899528005298,1.0,9/24,28.81%,OSBP;OSBPL8;ARFIP2;PLEKHA5;GOLPH3;PLA2G4E;CERT1;SESTD1;OSBPL5
prerank,cyclic nucleotide binding (GO:0030551),0.24758754584999268,0.5323921297084525,0.9521472392638037,0.9882698953423256,1.0,3/21,11.39%,CNGB1;PDE11A;PDE4A
prerank,snRNA binding (GO:0017069),0.2141375449558029,0.5229657497513807,0.9728260869565217,0.9906093209476019,1.0,10/42,21.18%,LSM11;DDX39B;PRPF8;RBM41;LSM8;SNRPB2;SNRNP35;SF3B3;HEXIM1;TOE1
prerank,poly-purine tract binding (GO:0070717),0.22832569645595185,0.514282907333912,0.968384074941452,0.9923105618801884,1.0,5/27,18.81%,PPIE;MCRS1;DDX1;PABPC4;RBMS2
prerank,ubiquitin-specific protease binding (GO:1990381),0.2406139723159682,0.5054976585595551,0.9672131147540983,0.9935644210966869,1.0,8/19,28.38%,DERL1;CLTC;PTEN;PRKN;AMFR;SART3;VCP;SUMO1
prerank,protein phosphatase activator activity (GO:0072542),0.248868416443778,0.5004345359608932,0.9758389261744966,0.9934699414214047,1.0,7/13,31.96%,PTPA;PPP2R5C;PPP2R5B;IGFBP3;PHACTR4;CALM1;PPP2R5A
prerank,gap junction channel activity (GO:0005243),0.21333669740916195,0.47638010534425945,0.9706242350061199,0.9986072933228589,1.0,1/22,7.41%,GJB6
prerank,ion gated channel activity (GO:0022839),0.21360283716800366,0.4753119511464497,0.9840490797546012,0.9969772461522303,1.0,3/24,13.35%,TMEM63A;KCNT1;TTYH2
prerank,wide pore channel activity (GO:0022829),0.20952258479385572,0.4710181038322437,0.9781818181818182,0.9961677949021025,1.0,1/23,7.41%,GJB6
prerank,sulfotransferase activity (GO:0008146),0.18814711180277005,0.4389730174088787,0.9932508436445444,1.0,1.0,3/33,12.83%,SULT4A1;TPST1;CHST15
prerank,active ion transmembrane transporter activity (GO:0022853),0.1860968447798109,0.4379425288728867,0.9965986394557823,0.9991789899506239,1.0,6/37,21.38%,SLCO2B1;CYB5A;SLCO1B1;COX6B1;COX4I1;SLC16A7
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.21824829672627194,0.43455149406261445,0.9804804804804805,0.9978353847693275,1.0,1/11,6.79%,NUDT4
prerank,SUMO transferase activity (GO:0019789),0.2093019707779821,0.43395977137771674,0.9894039735099338,0.996058958768968,1.0,5/16,26.02%,HDAC4;PIAS1;NSMCE2;UBE2I;CBX4
prerank,transaminase activity (GO:0008483),0.2151707097574025,0.4248093486331064,0.9858956276445698,0.9955401188941373,1.0,3/11,23.45%,OAT;PSAT1;BCAT1
prerank,lipid phosphatase activity (GO:0042577),0.19110932340419715,0.3920913095925063,0.9906291834002677,0.9970012132900293,1.0,3/14,22.36%,PLPPR1;INPP5K;PLPP7
